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Summary
The implication of biologically active peptides from different organisms on one another in
complex ecological communities is largely unknown at this stage. The elucidation of the
nature of this influence may have practical implications in terms of organism resistance and
the conservation of an optimal agricultural environment. This study was aimed to elucidate
the effect of antimicrobial peptides from different co-habitational organisms, on each other,
both in terms of bioactivity and interaction. The two peptides investigated were gramicidin S,
a decapeptide from Bacillus brevis, and surfactin, a heptalipopeptide from Bacillus subtilis.
Preliminary studies were also done on iturin A and synthetic analogues of iturin A and iturin
C, both octalipopeptides from Bacillus subtilis.
Analytical antimicrobial assay systems were used to study the effect of surfactin on the
antibiotic action of gramicidin S towards three different target cells namely, a Gram-positive
bacterium (Micrococcus luteus), a Gram-negative bacterium, (Escherichia coli) and a fungus
(Penicillium corylophilium). The investigation of the antifungal activity was hampered by the
insensitivity and subjectivity of the majority of antifungal assays and necessitated the
development of two new testing methodologies.
The investigation showed that surf actin had an antagonistic effect on the antimicrobial
activity of gramicidin S against all three of the target cells. This antagonism is dose-dependent
at concentrations lower than required for surfactin to exert biological activity. Electrospray
mass spectrometry (ESMS) showed the formation of surfactin-gramicidin S complexes in 1:1
and 2: 1 ratios with enhanced complex formation in an apolar environment. Dissociation
experiments indicated that the peptide complexes were slightly less stable than the peptides
alone. The presence of NaCI up to 80 mM had little effect on the stability of preformed
complexes. Incubating surfactin with NaCI and CaCh before titration with gramicidin S also
did not affect complex formation. Furthermore, results from the pre-incubation studies with
CaCh indicated that surfactin-gramicidin S complexes might be formed through the
displacement of the metal ion. The mechanism of this displacement is unlikely to be direct
competition but rather the result of conformational' changes induced by peptide-peptide
interaction/interactions. A likely point of interaction the p-tums in the peptide ring.
Linear iturin A2 and iturin C analogues were synthesised (8-Beta and 8-Betac) with solid
phase peptide synthesis and purified using self-assembly and high performance liquid
III
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chromatography. The products of the syntheses wete analysed by ESMS and found to be
correct. The products, together with commercially obtained iturin A, were used in biological
assays and it was found that iturin A antagonises the antibiotic activity of gramicidin S but the
linear analogues had no effect. Complex formation between iturin A and gramicidin S was
observed using ESMS but no complexes were detected for the analogues, which reinforces the
hypothesis that antagonism is related to the formation of inactive complexes.
In general, the formation of peptide-gramicidin S complexes may indicate that a defence
mechanism may be present in which toxic peptides of the competitor organism are inactivated
by peptides from co-habiting organisms.
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Opsomming
Die invloed wat biologiese aktiewe verbindings van verskillende mikro-organismes in
komplekse ekologiese omgewings op mekaar het, is onbekend. Die ontrafeling van die rol
mag verskeie vrae ten opsigte van weerstandbiedenheid en ontwrigting van ekologiese
landbou-omgewings beantwoord. Die doel van hierdie studie was om die invloed wat
antimikrobiese peptiede, afkomstig van verskillende ko-habiterende organismes, op mekaar
het te ondersoek- beide in terme van biologiese aktiwiteit en interaksie. Die twee peptiede
wat ondersoek is, was gramisidien S, 'n dekapeptied geproduseer deur Bacillus brevis en
surfaktien, 'n heptalipopeptied, geproduseer deur Bacillus subtilis. Voorlopige ondersoeke is
ook uitgevoer op iturin A, en sintetiese iturin A en iturin C analoë, beide oktalipopeptiede van
B. subtilis.
Analitiese antimikrobiese toetsstelsels is gebruik om die effek van surfaktien op die
biologiese aktiwiteit van gramisidien S te bepaal. Drie teikenselle is gebruik nl. 'n Gram-
positiewe bakterium (Micrococcus luteus), 'n Gram-negatiewe bakterium (Escherichia coli)
en 'n fungus (Penicillium corylophilium) Die gebrek aan sensitiwiteit van bestaande
antifungiese toetsstelsels het die ontwikkelling van twee nuwe toetstelsels genoodsaak.
Die ondersoek het aangetoon dat surfaktien 'n antagonistiese effek op gramisidien S se
antimikrobiese werking teen al drie teikenselle het. Die antagonisme is waarneembaar by
surfaktien konsentrasies veel laer as wat nodig is vir biologiese aktiwiteit. Elektrosproei-
massaspektrometrie (ESMS) van surfaktien en gramisidien S mengsels het aangedui dat
komplekse in 'n 1:1 en 2: 1 stoichiometrie voorkom. Die vorming van peptiedkomplekse word
ook deur 'n nie-polêre omgewing bevorder. Die stabiliteit van die peptiedkomplekse is ook
geëvalueer met dissosiasie eksperimente en daar is gevind dat die komplekse minder stabiel is
as die peptiede alleen - dit is 'n aanduiding van kompleksdissosiasie. Die teenwoordigheid
van NaCI tot en met 80 mM het 'n minimale invloed op die stabiliteit van voorafgevormde
peptiedkomplekse gehad. Inkubasie van surfaktien met NaCl en CaCh voor titrasie met
gramisidien S, het ook nie die vorming van peptiedkomplekse beïnvloed nie en die studies het
aangetoon dat die komplekse moontlik gevorm word deur die verplasing van die alkalie-
metaalioon. Dit is onwaarskynlik dat die meganisme van ioon-verplasing direkte kompetisie
is, maar eerder as gevolg van interaksie in een van die p-draaie.
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Liniêre iturin A2 en liniêre iturin Canaloë (8-Beta en 8-Betac) is gesintetiseer met behulp van
soliede fase peptiedsintese en gesuiwer deur middel van "self-assembly" en "high
performance liquid chromatography (HPLC)". Volgens die ESMS analise is die korrekte
produkte verkry. Die analoë en kommersieel beskikbare iturin A is aan biologiese toetsing
onderwerp en daar is gevind dat iturin A, maar nie die analoë nie, die antibiotiese effek van
gramisidien S ophef. Die vorming van iturin en gramisidien S komplekse, wat met ESMS
waargeneem is, versterk die teorie dat opheffing van aktiwiteit verband hou met die vorming
van inaktiewe komplekse. Verder, die analoë het nie komplekse met gramisidien S gevorm
me.
Dit blyk vanuit hierdie studies dat die vorming van peptied komplekse moontlik deel kan
uitmaak van 'n tipe verdedigingsmeganisme waar toksiese peptiede van kompeterende
organismes, deur peptiede van ko-habiterende organismes, geïnaktiveer word.
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"If I have seen farther than others, it is because I was
standing on the shoulders of giants."
-- Isaac Newton
I dedicate this work to all the giants in my life - most of aU, my mother a giant
standing 1.6 meters tall.
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Preface
The Second World War was certainly one of the defining moments in the history of
humankind. A moment that gave us the A-bomb, the cold war and unbeknown to many, a new
war - a war not fought on the battlefields but a war fought everyday in and around us. The
Second World War saw the introduction of penicillin in 1940 and the first case of clinical
immunity was observed in 1942. Five years later 38% Staphylococcus aureus strains were
penicillin-resistant - and thus the battle lines were drawn. Human beings are at a distinct
disadvantage in this war for survival, as we do not fully comprehend the intricacies and
complexity of the microbial environment -the same environment in which the battles are
fought.
The antimicrobial peptides used in this investigation, gramicidin S, surfactin and iturin A, are
produced under stress conditions, specifically oxygen stress. This study was launched to
elucidate the influence of the peptides on each other and relate this to organism survival A
multitude of studies have been initiated to elucidate the mechanisms of action for the peptides
in isolation. The studies were initiated to explore clinical, agricultural, and industrial
applications of the peptides and peptide analogues. However, not a single study investigated
the influence that the peptides might have on one another in terms of biological activity.
Although the peptides are of great commercial importance, their fundamental purpose should
never be forgotten. These peptides are created by nature to facilitate producer survival in
complex ecological communities and are as such secreted not in isolation but together with
numerous other compounds from a variety of organisms.
This thesis describe a possible alternative bacterial defense mechanism and by implication an
alternative model for bacterial resistance. The first chapter is dedicated to a short overview of
the antibiotic peptides used in this study and the following five chapters will describe and
discuss the experimental results obtained. To facilitate future publication of this work, each
chapter is written with publication format in mind and therefore is, to a certain extent,
independent units. Unfortunately, this approach does lead to a repetition, but every attempt
was made to keep this to a minimum.
XIX
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In summary, the aim of this thesis is to elucidate a possible alternative function for surfactin
in host-defence and to evaluate the feasibility of extending this project to include iturin A and
C. The following objectives were set to meet this aim:
1. The synthesis of iturin C (8-Betac) and iturin A2 (8-Beta) analogues as well as the
analyses of commercially available compounds used in this study (Chapter 2)
2. Development of an antifungal assay system with sufficient sensitivity (Chapter 3);
3. Investigation of the influence of surfactin on gramicidin S antimicrobial activity using
the developed assay system (Chapter 4);
4. Mass spectrometric investigations of peptide interactions to explain the results
observed with biological testing (Chapter 5).
5. Investigation of the influence of iturin A and iturin analogues on gramicidin S
antimicrobial activity (Chapter 6)
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Chapter 1
Literature overview on selected cyclic peptides produced by
Bacillus subtilis and Bacillus brevis
1.1 Introduction
In complex ecological communities, as found in soil and aquatic ecosystems, many defence
strategies have evolved among co-inhabitants in the fight for survival. These strategies
involve both the physical environment and the active production of compounds. The physical
environment can be used as a weapon through adaptation such as sporulation to withstand
conditions that competitors cannot. Active resistance revolves around antibiotic production
that includes extra-cellular enzymes such as proteases. DNA replication inhibitors, and
antimicrobial peptides [1, 2, 3]. Antibiotic production is a characteristic of many micro-
organisms including Gram-positive bacteria from staphylococcus, streptomyces, and bacilli
species [4]. This study will focus on one defence strategy - antimicrobial peptides - produced
by two co-habiting bacilli, Bacillus brevis and Bacillus subtilis. Furthermore, a newly
discovered defence strategy involving the antimicrobial peptides from the bacilli will be
presented in this thesis.
1.2 Cyclic Peptides from Bacillus
Antimicrobial peptides can be classified into two broad categories: 1) gene products and 2)
<.
secondary metabolites. Peptides belonging to the first group are directly translated from the
organism genome and synthesised through the ribosomal mechanism. Magainins, melittin,
and secropins are representatives of this class [5, 6]. The second group of peptides are
synthesised through non-ribosomal multi-subunit synthetases, which activate, isomerise,
modify amino acids, and incorporate non-amino acid moieties in the primary peptide
structure. The synthetases are also responsible for cyclisation of the primary sequence to form
the peptide ring structure - gramicidin S, surf actin, and the iturin family of peptides
Stellenbosch University http://scholar.sun.ac.za
represent this group. Gramicidin S, together with tyrocidin A-E is produced by B. brevis [7,8,
9, 10, 11]. Both surfactin and iturin A is produced by B. subtilis. Furthermore, iturin A
together with iturin AL and C, mycosubtilin, bacillomycin F, D and L and
bacillopeptinlbacillomycin Le belongs to the iturin group of pep tides [12, 13, 14, 15, 16, 17].
The iturins share many structural features such as a constant LDDLLDL chiral sequence, a ~-
D-amino acid residue, and a ring structure closed by a laetam ring. Peptidic variants of
surfactin have been isolated from Bacillus licheniformis (lichenysin [18, 19, 20, 21] and
antiadhesin [22]) and Bacillus pumilus (pumilacidin [23]). The common denominator to all
these peptides is the pronounced amphipatic character that is essential to peptide function.
This discussion will be limited to four cyclic peptides produced by soil-borne saprophytic
bacteria from the genus Bacillus namely gramicidin S from B. brevis as well as iturin A, iturin
C and surfactin from B. subtilis. Phylo-genetically the genus is divided into five groups of
endosporulating bacteria with B. subtilis in group II and B. brevis in group III [4]. The
bacteria of group II all produce acids from sugars and are facultative aerobes and can
therefore grow and sporulate under strict anaerobic conditions given glucose and nitrate as
terminal electron acceptor [4]. The bacilli of group III are strictly aerobic and do not utilise
sugars as major carbon or energy source. Their energy requirements are met by acetate and
amino acids, especially glutamate [4].
The history of the four cyclic peptides date back more than half a century. Investigation into
two of the B. subtilis peptides, iturin A and surfactin began in 1946 and 1968 respectively [13,
24]. Gramicidin S was first isolated from B. brevis cultures in 1944 [25]. These peptides
generated considerable interest from pharmaceutical" agricultural, and industrial sources as
alternatives to current antibiotics and synthetic surfactants. Unfortunately, interest waned as
the complicated nature of biological interaction and high production cost became apparent.
1.2.1 Chemical Structures
1.2.1.1 Gramicidin S
Gramicidin S is a cyclic amphipatic decapeptide [26] consisting of two antiparallel
pentapeptides, D-Phe-Pro-Val-Orn-Leu, linked between D-Phe and Leu (Figure 1). The two
tetrapeptide sequences Val-Om-Leu assumes a double stranded ~-sheet structure which
1-2
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terminates in two type II p-turns defmed by Pro-D-Phe residues. Intra-molecular hydrogen
bonds between the two Val and Leu residues stabilise the rigid structure. The four
hydrophobic side chains of the valine and leusine residues are on one side of the ring structure
plane, and the two hydrophilic ornithine residues on the other, thereby conferring an
amphipatic character on the molecule [27,28,29,30].
Figure 1 The structure of gramicidin S with the basic ornithine residues located on one
side of the plane and the hydrophobic valine and leucine on the opposing side of
the plane [26].
1.2.1.2 The Iturins
The iturin family of peptides share several common features such as a constant LDDLLDL
chiral sequence of seven residues and a cyclic structure closed by a laetam ring at the p-D-
amino acid (Figure 2). The p-D-amino fatty acyl-L-Asn2-D-Tyr3-D-Asn4 peptide moiety is
common to all the iturins except iturin C and bacillomycin F [31, 32].
The two iturins under investigation, iturin A and C, contain the following amino acid
sequences: iturin A; L-Asn-D-Tyr-D-Asn-L-Gln-L-Pro-D-Asn-L-Ser and
iturin C; L-Asp-D-Tyr-D-Asn-L-Gln-L-Pro-D-Asn-L-Ser (Table 1).
1-3
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Table 1
lturin A
Iturin AL
Iturin C
Figure 2
Variations in the amino acid sequence of natural occurring iturin variants [12,
13, 14, 15, 16]
Peptide sequence (N~C)
7 8Position 1 3 4 62 5
The structures of only two of the iturins, iturin A and bacillomycin F, have been elucidated
through NMR spectroscopy and molecular modelling techniques [33, 34]. Garbay-
L-Asn D-Tyr D-Asn L-Gln L-Pro D-Asn L-Ser
D-Tyr D-Asn L-Gln L-Pro D-Asn L-Ser
D-Tyr D-Asn L-Gln L-Pro D-Asn L-Ser
D-Asn7
H m2CONH2\/
/C---CO
HN /
/ HN /H
L-Pro6 /CO "",--C
" / \
ern l HOCH2CO L-Ser 8I "l /" • HN Il . c. idN ... ...•••••.•. ReH I-' -ammo latty aci .
""CO···· I R = n-Cll, l-C12 or a-C12
n-, I v(CH2hCONr2 q;2 / NH
L-Gln sCZ NH •.•••••. i oe \C ~2CONH2/ r····· OC--- \ L-Asn2
OC\ i r / H
H2NCO~ ~/c-~b .>
D-Asn4 H c-C
\
CH2 D-Tyr3
OH
The structure if iturin A, The L-Asn2 residue is replaced by L-AsP2 in iturin C
[31].
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Jaureguiberry et al. [33] proposed the first three-dimensional structure for iturin A that was
later further refined by Marion et al. [33 16]. Two type II p-turns in the tetrapeptide units
stabilises the cyclic structure of iturin A in the tetrapeptide moieties p-amino fatty acyl-Asn--
D-Tyr3-D-AsI4 (turn A) and Gln--Prox-Asn=Sers (turn B). The two turns are linked by a third
tum (tum C) consisting of Asn2-D-Tyr3-D-AsI4-Glns. This tum can be classified as a type I'
or III' p-turn; alternatively the beginning of a 3lo-helix with distorted hydrogen bonds in the
turns. The peptide backbone confers a rigid conformation on the molecule, but the polar
residues have a larger decree of freedom that allows interaction with an aqueous environment
[31]. This conformation has also been referred to as an S conformation.
1.2.1.3 Surfactin
Surfactin, is an heptalipopeptide with the chiral sequence LLDLLDL that is similar to that of
the iturins (Figure 3). The ring structure with sequence L-Glu-L-Leu-D-Leu-L-Val-L-Asp-D-
Leu-L-Leu is closed by a p-hydroxy fatty acid by means of a lactone bond [35]. The spectrum
of the fatty acid moiety has been elucidated as iso, anteiso Cl3, iso, normal CI4 and iso,
anteiso CIS and iso C16 [36, 37, 38]. Natural occurring variant forms of surfactin differ at
residue seven with L-Leu being substituted with either L-Ile or L-Val [39,40]. In addition to
these natural variants, Peypoux and co-workers isolated a surfactin with Val, substituted with
alanine when surf actin was produced with alanine as sole nitrogen source in the growth
medium [41] (Table 2). Although considerable variation is possible in the primary structure of
surf actin, according to some sources surf actin are classified based on amino acid sequence as
surfactin A (Leu-), surfactin B (He7) and surfactin C (Val-) with the fatty acid moiety as C14-
CIS [42].
High-resolution IH NMR together with molecular modelling techniques led to the elucidation
of the three-dimensional structure of surf actin [43]. The compact topology of the molecule is
dictated by the cyclisation requirements, the chiral sequence, and favourable intra-molecular
interactions. Two conformational states, SI and S2, have been identified for surf actin [44]. In
the Slstate the ring structure is stabilised by a hydrogen bond between NH of GlUI and C=O
of'Val-. Three hydrogen bonds between NH of Leu7 and C=O of AspS, NH ofVal4 and Cs=O
of Leu2, and the NH of Leu6 and the c=o of the p-hydroxy fatty acid stabilise the peptide
ring in the S2 conformation. As a result, the backbone of the molecule folds into what has
been called a W conformation or alternatively a p-sheet conformation that is retained in an
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Variations in amino acid sequence of natural occurring surfactin variants [39,
40,41]
aqueous environment. It is interesting to note the similarities between the 3-dimensional
structures of iturin A and surfactin, both forming p-pleated structures [34,43,45].
The spatial arrangement of the constituent residues is such that the hydrophobic residues Leu,
and D-Leu6 face each other in the region of the acidic residues Glu, and Asps, which forms a
minor polar domain. On the other side of the ring structure the Val, faces the lipidic chain,
which constitutes a major hydrophobic domain. This spatial arrangement results in a
pronounced amphipatic character.
Table 2.
Peptide sequence (N~C)
2 3 4 5 6 7 Fatty acid
Glu Leu D-Leu Val Asp D-Leu Leu C13-16
Glu Leu D-Leu Val Asp D-Leu CI3-I5
Glu Leu D-Leu Val Asp D-Leu C13-I5
Glu Leu D-Leu Asp D-Leu Leu C13-I5
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Leu2 D-Leu3
Glu1 CH CH CH CH
,\3/ 3 \3/ 3
(
yOO) H «H yH
H H yH2 2H «H2 H CH2
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C::::O 'l NH
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CH CH I / \
/ \ / -, COOH H C CH
CH CH CH3 CH3 A 3 33 3 SP5
Leu? D-Leu6 Val,
Figure 3 The structure natural occurring surf actin with variation caused by
L- Ile and L-Val substitutions at D-Leu3_ R=n, i, a CII-14 [38].
1.2.2. Biosynthesis
Antibiotic peptides can be synthesised via two mechanisms, either through ribosomal
synthesis or non-ribosomal synthesis. The non-ribosomal synthesis route is also known as the
multi enzyme thiotemplate mechanism [46,47,48,49,50]. All four peptides used in this study
are produced using the non-ribosomal mechanism, which involves the gramicidin S, iturin,
and surfactin synthetases. This type of peptide synthesis is catalysed by large, multifunctional
enzyme of modular design. The biosynthetic pathway requires the activation of the amino
acid residues at the activation domain of the minimal module by ATP to form amino-acyl
residues, which are aligned in order of addition to the growing peptide chain. Activated amino
acids are covalently linked as a carboxy-thioester to an enzyme bound 4' -phosphopantetheine
(modifications to the residues such as epimerisation occur at this stage). Transpeptidation is
facilitated by a multiple carrier mechanism, which implies multiple 4' -phosphopantetheinyl
co-factors instead of a single arm mechanism. The peptide intermediate is transferred and
linked to another acyl-amino acid intermediate on the adjacent downstream condensation
domain to form a peptide bond. Synthesis is terminated by cyclisation, di- and trimerisation of
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peptide precursors or transfer of the peptide to functional groups such as a fatty acid.
1.2.2.1 Gramicidin S
Gramicidin S synthetase II and I synthesise gramicidin S in the presence of ATP and Mg2+
[49,50,51]. Isolation of the nucleotide sequence of the genes involved in enzyme synthesis
indicates that three genes denoted grsA, grsB and grsT encode the synthetase I, and synthetase
II proteins with a high homology to a thioesterase of fatty acid synthetase complexes [52, 53,
54, 55]. The genes for the synthetase complexes are arranged in the order grsA-grsB-grsT and
transcribed from a single promoter [53]. Synthetase I and II are responsible for the activation
and racemisation ofL-Phe to D-Phe and the activation of Pro, Val, Om, and Leu respectively.
The nucleotide sequence determination resulted in the accurate estimation of their respective
molecular weights (126 663 Da for synthetase I and 510 287 for synthetase II) [56, 57]. The
synthetase produces gramicidin S during the transition period between log and stationary
phase after which the peptide rapidly disappears [58].
Antibiotic production is dependent on the interaction between several factors such as medium
composition, temperature, and growth phase. Determination of optimal growth conditions is
especially important when culturing the organism for large-scale peptide production. Even
though oxygen has a pronounced effect on peptide production [59] most of the research has
been directed at finding optimal carbon and nitrogen sources for chemically defined media ...
This situation is further complicated by different responses by the various strains of B. brevis
to the same medium [60]. It must be noted that none of the sources quoted investigated the
effect of oxygen limitation on gramicidin S production. This is of particular importance given
that gramicidin synthetase is inactivated through oxidation and activated through reduction
[59].
1.2.2.2 Iturin A
Except for iturin A synthetase, none of the other iturin synthetases have been fully
characterised. Iturin A synthetase consists of two subunits, Its and lTagp. The activation of L-
Ser is catalysed by Its and lTagp catalyses the activation of L-Asn, D-Asn, L-Gln and L-Pro
[61]. The precise structure and mechanism of the iturin A multienzyme complex is still
unknown as is the mechanism of storage and secretion.
1.2.2.3 Surfactin
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Surfactin biosynthesis has been under investigation since 1968 when Kluge et al. [62]
proposed a thiotemplate synthesis mechanism. The surf actin synthetase consists of four
subunits, ElA, EJ8, E2, and E3with molecular masses of 460 kDa, 435 kDa and 160 kDa for
ElA, ElB, and E2 respectively [63, 64]. The forth subunit, E3 has not been purified to
homogeneity but the Mr is estimated at 40 kDa [64]. The genetic organisation of biosynthetic
genes consist of a two operons of 25 kDa denoted srfA and a 4 kDa, sfp segment located
downstream of srfA [65, 66]. The srfA operon consists of four modular open reading frames
denoted ORF1 (srfA-A), ORF2 (srfA-B), ORF3, (srfA-C) and ORF4 (srfA-D). The first three
reading frames encode the enzymes ElA, ElB, and E2 [67], and the fourth a protein with
sequence homology to mammalian type II thioesterases [66]. Associated, but not integrated
with srfA is sfp, which is essential for surfactin production. The encoded protein, termed sfp,
belongs to the 4' -PPTases that function as a primer for non-ribosomal synthesis [68]. All the
subunits are of cytoplasmic origin. The initiation intermediate of surfactin biosynthesis is p-
hydroxyacyl-L-Glu produced by an acyltransferase with E3 involved. The subunits ElA and
ElB catalyse the elongation of the initiation product into a lipopeptide followed by the
formation of a lipohexapeptide. This is achieved through a series of thioester bond cleavages
and simultaneous transpeptidation reactions. Termination of synthesis occurs when subunit E2
condensates Leu7 to the lipopeptide and the release of the lipopeptidyl intermediate from the
enzyme complex [47]. Three genes have been identified that controls swarming in B. subtilis
[69]. Although these genes are not directly related to surf actin production it is interesting to
note that one of the genes, swrC, confers resistance to surfactin.
Most of the research into the nutritional requirements of surf actin production was done with
batch cultures, usually in shake flasks [70, 71]. Synthetic and organic media were developed
from these experiments and the need for a nitrogen/iron/manganese molar ratio of 920:7.7:1.0
were established [72]. Acidification of growth medium was observed during iron enrichment
and necessitated pH control as demonstrated by Wei etal. [73]. The best carbon sources were
established as glucose, fructose, and saccharose, while glycerol greatly reduced surf actin
production. The developed media supported bacterial growth very well, but had little success
in stimulating surf actin production. The surfactin yield with these media ranged between 0.1
giL and 1.1 giL [72, 74]. In contrast to other biosurfactants, surf actin biosynthesis was not
stimulated by hexadecane [70]. However, successful surfactin production was also achieved
by oxygen limitation in which case the production increased to 7 giL [75]. The importance of
oxidative processes in the production of surf actin was further illustrated by the work of
Stellenbosch University http://scholar.sun.ac.za
Roubin et al. [76]. The authors have shown surfactin over production in a mutant strain with
isocitrate dehydrogenase activity 30 times lower than the parent strain. This mutation resulted
in a four-fold increase of surfactin production. The same effect was also achieved by adding
citric acid to the medium and oxygen limitation. Equally important is the source of nitrogen as
terminal electron acceptor. Davies et al. [77] found that nitrate depletion resulted in a
dramatic increase in surfactin. Using nitrate as sole nitrogen source did not benefit surfactin
production but the transition from oxygen to ammonia to nitrate as electron acceptors was
necessary for optimal production. Unfortunately, these studies were performed with different
strains of B. subtilis and no comparative studies exist to objectively evaluate the influence of
media and oxygen limitation on a specific strain.
1.2.3 Structure-function relationships and mechanism of action
The amphipatic character of the peptides endows them with a natural ability to disrupt
membranes and as such be antibiotic. However, recent research suggests that these molecules
are more than mere "glorified detergents". This idea is supported by the identification of
intracellular targets for the peptides [78, 79, 80, 81, 82]. The mechanism of action of most
antimicrobial peptides follows a fixed sequence which, involves: a) recognition of the target
cell membrane, b) interaction with or transport across the cytoplasmic membrane, c) the
formation of active complexes, and d) disruption and/or inhibition of normal physiological
processes that lead to cell death.
Gramicidin S has a broad-spectrum antibacterial and antifungal activity [83, 84, 85]. Iturin A
is active against many plant and animal fungi, but has limited antibacterial activity where as
surf actin is active against mycoplasma and Gram positive bacteria [13, 85, 86, 87]. In
addition, iturin A and surf actin has been shown to have a profound synergistic activity [88,
89].
1.2.3.1 Gramicidin S
The absence from of a fatty acid moiety - as found in the other peptides - in the gramicidin S
structure necessitate the incorporation of the amphipatic character in the spatial orientation of
the residues. This achieved by orientating the hydrophobic residues to one side of the plane
and the charged residues in the other side of the half-chair ~-pleated conformation [25] of the
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peptide ring. To investigate the structure-function relationship the native peptide, as well as
substitution, insertion, and deletion analogues were investigated [83, 90, 91, 92, 93, 94]. From
these studies, it became clear that the ê-amino group of the Om residues as well as the D-Phe-
Pro residues at the p-turn are essential for activity. A series of cyclic gramicidin S analogues
were synthesised with the number of residues varying from 6-21. Of the analogues containing
ten or less residues, only those with 6, 8 and 10 residues showed activity against gram-
positive bacteria. Itwas found that gramicidin S analogues containing 10, 11 and 12 residues
had markedly higher activity than those containing less than 10 or more than 12. It is also
interesting to note that of the analogues synthesised with residues varying from 6-14 those
with less than eight residues and the analogue in which D-Phe was omitted showed no
activity. Furthermore, Grotenbreg et al. [95] illustrated the importance of the proline residue
in the peptide structure by synthesising a gramicidin S analogue without Pro that retained the
p-sheet structure. The analogues with the proline residues replaced azidoproline,
benzyloxycarbamate derivatives, and succinylamide derivatives of the residue lead to severe
loss of antimicrobial activity. This indicates the critical importance of both ring size and the
p-turn residues L-Pro and D-Phe [83, 95]. Substitution of the Om residues with neutral
residues [92], Glu, or GIn [96] led to total loss of activity illustrating the importance of the
positively charged L-Om residues on activity. This is may be related to electrostatic
interaction with anionic membrane lipids and environment.
On microorganisms other than B. brevis, the gramicidin S mechanism of action involves both
the cell membrane and intracellular targets [78, 79, 80, 81, 82, 97, 98]. The mechanism of
action of gramicidin S also includes effects on the producer, B. brevis [99, 100, 101]. It has
been shown that gramicidin S rapidly adsorbs to Escherichia coli cells [98]. Upon adsorption,
gramicidin S disturbs membrane integrity. The mechanism of distortion may differ between
Gram-positive, Gram-negative, and eukaryotic cells [91, 81, 102]. It has been demonstrated
that gramicidin S increases the permeability of both the outer and the cytoplasmic membranes
of Gram-negative cells (E. coli) with the concomitant release of intracellular components.
Divalent cations such as Mg2+ and Ca2+ are essential to the stability of the lipopolisaccharide
(LPS) moiety of the outer membrane [102]. Gramicidin S may compete with these cations for
binding to the outer membrane. It is tenable that such binding may result in the destabilisation
of the polysaccharides thereby enabling a second molecule of gramicidin S to reach the
cytoplasmic membrane. Interaction between gramicidin S and the membrane lipids would
then lead to the disruption of the permeability barrier. It is interesting to note that LPS
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binding affinity does not correlate with antibacterial activity [91]. Furthermore, gramicidin S
has also been shown to interact with the monovalent cations u',K+, Na+, Rb+, and Cs+ [103,
104] through interaction of the p-tum carbonyl groups.
Investigation of the interaction of gramicidin S with dipalmitoylphophatidylcholine (DPPC)
and dimyristoylphosphatidylcholine (DMPC) model membranes, using differential scanning
calorimetry (DSC), showed a decrease in the Tm of both membranes (1.5-5 °C for DPPC and
4-6 °C for DMPC). However, I1H of chain melting trends were unaffected by the addition of
gramicidin S in the case of DPPC, but lowered in the case of DMPC [105, 106, 107]. In
contrast to these findings Prenner et al. [108] found a decrease in I1H values. This indicates
that gramicidin S induced membrane disruption is in part achieved through the facilitation of
gel to liquid crystalline state transition. Findings of a FTIR study by Akinoglu and co-workers
[109] support the work of Prenner et al. They found that gramicidin S destabilised a model
DPPC membrane. These findings [105, 106, 107, 108] underscore the heated debate regarding
gramicidin S mechanism of action in relation to membrane action. Pache et al. [97] found that
gramicidin S had no effect on the mobility of 12-deoxylstearic acid in dipalmitoyl lecithin
bilayers and concluded that gramicidin S interaction with membranes occurs at the polar head
groups. However, Kiricsi et al. [110] found that gramicidin S restricts the segmental
movement of spin labelled C14 acyl chain in DMPC at a peptide: lipid ration of 1:10. In
addition, Prenner and co-workers [111] found that the addition of cholesterol to DMPC model
membranes attenuated the action of the antimicrobial peptide.
Studies with 14C-Iabled gramicidin S and gramicidin S analogues showed that the peptide
adhered more readily to protoplasts derived from gramicidin S susceptible bacteria (such as B.
subtilis and S. aureus) than to insensitive bacteria (such as E. coli) [81]. In both cases, peptide
adhesion increased linearly with peptide concentration up to the minimum inhibitory
concentration (MIC) where after the adhesion rate slowed. At the MIC, enough peptide was
adsorbed onto the membrane to cover the cell surface [112]. The adhered peptide could not be
removed from protoplasts by washing with aqueous salt solutions, but could largely be
removed by the addition of phospholipids. This shows that, although interactions with the
negatively charged head groups are essential for the initial peptide-membrane interaction, the
molecule rapidly partition into the hydrophobic bilayer. Orlova and co-workers, working with
gramicidin S resistant S. aureus, demonstrated the importance of this interaction [113]. They
found that the resistant organisms differ from the wild type strains in the Gly/Ser ratio of the
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peptidoglycan as well as the degree of amidation of the a-carboxyles of Glu in the
muropeptide. The overall effect was a decrease in the net negative charge of the membrane.
Wu et al. [114] demonstrated the peptide's ability to rapidly depolarise the inner membrane of
a barrier defective strain of E. coli. Depolarisation occurred at concentration well below the
MIC [114], indicating the formation of ion channels in the bacterial membrane. Katsu et al.
[98] reported a good correlation between the MIC values and the ability to increase the
permeability of the inner membrane to K+. These findings, together with the conductance
data, provide compelling evidence that the primary target of gramicidin S is the lipid bilayer
of bacterial membranes.
Even though the lipid bilayer is thought to be the primary target of gramicidin S it has also
been shown that the peptide interacts with and affects certain membrane proteins and
intracellular components. Studies with protoplasts from Micrococcus luteus showed a marked
decrease in respiratory chain function. At sub-lytic concentrations gramicidin S increased
membrane permeability to respiratory chain substrates resulting in a decrease in the activity of
several respiratory chain enzymes [112]. The activity of Ca2+-ATPase from human red blood
cells is also inhibited [82] - this inhibition is not the result of the inhibition of calmodulin as
the stoichiometry involved showed that it is unlikely that gramicidin S interacts with the small
number binding sites on the enzyme. Inhibition is more likely the result of increased
membrane permeability. In contrast, gramicidin S increased the activity of the
calcium/calmodium dependent guanylate cyclase from Paramecium [99] and particulate
guanylate cyclase from rat lung [115]. Gramicidin S has also been shown to interact with
certain membrane bound transport systems [100].
Gramicidin S mechanism of action also extends to the producer organism. Interaction does
not inhibit vegetative growth of B. brevis, but delay spore outgrowth with up to eight hours
[100, 101]. Outgrowth of gramicidin S negative mutants started at 80 minutes, as did a rapid
increase in respiration that continued for up to 200 minutes. During this time, RNA
biosynthesis started at 100 min and peaked at 180-190 minutes. Protein synthesis developed
at 190 minutes and continued until 250 minutes. In contrast, wild-type spores showed no
outgrowth before 250 minutes with negligible respiration. This delay in outgrowth may be
connected with the inhibition of amino acid transporters rather than nucleotide transporters as
measured by [14C]uracil and [14C]lysine uptake. Gramicidin S did not show any interference
with e4C]uracil uptake in vegetative cells [100]. This observation led to the hypothesis that
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gramicidin S is not only an antimicrobial peptide but also a bacterial hormone.
1.2.3.2 Iturin A and C
The combination of the CI4-C17 p-amino fatty acid moiety with the polar peptide ring imparts
an amphipatic character on the iturins, which promotes interaction with cell membranes. This
amphipathic character causes these molecules to spontaneously aggregate into micelles in an
aqueous environment [116]. Their surfactant nature leads to the formation of mono layers at
the air/water interface thus lowering the surface tension of aqueous solutions. The decrease of
the critical micellular concentration (CMC) of iturin A is inversely proportional to aliphatic
chain length [117]. Substitution of the fatty acid moiety with p-Ala led to total loss of activity
and illustrates the importance of the fatty acid in its activity [118].
Substitutions and deletions in the peptide sequence elucidated the relative importance of not
only the individual amino acids, but also their importance in terms of conformation and
spatial orientation of the molecule as a whole. This is illustrated by the loss of antifungal
activity by the addition of a carboxyl group near the fatty acid moiety as found in the inactive
natural analogue, iturin C. This iturin has a L-Asp in position 2 at the C-terminal end of the
fatty acid [17, 119] . No further investigation on the mechanism of action of iturin C has been
done since its initial isolation in 1968 because no antimicrobial activity was then observed
[17,24]. Modification of the two invariant a-amino acid residues, D-Tyr and L-Asn, through
O-methylation or O-acetylation eradicates all activity against S. cerevisiae [120]. This
modification also leads to loss of haemolytic activity probably because of interference with
lipid interaction [121]. Substitutions in the region flanking the N-terminal seems to be part of
the evolutionary design of these peptides as modifications can occur in this region without the
same devastating effect on peptide function that occurs with modifications at the C-terminus.
Rautenbach et al. [122, 123] did extensive work on the metal ion selectivity of iturin A and
N-terminally modified analogues using electrospray mass spectrometry. They found that the
number of sodium ions bound were dependent on analogue chain length, which is probably
due to the elimination of carbonyl oxygens at the N-terminus. The iturin A analogues
exhibited a selectivity with respect to alkali metal ion binding with Na+>K+>Rb+, which
indicates a size limitation in the interaction with the binding cavity or cavities. Furthermore,
of the cyclic peptides bound to single sodium ion, the cyclic 7-beta analogue (iturin A2 with
L-Asn2 deletion) was in a higher abundance compared to the cyclic 8-beta analogue
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(synthetic iturin A2), indicating that a single cation binding site is probably situated inside the
peptide ring [122]. Rautenbach et al. [123] also demonstrated the sequence specific
stabilisation of iturin A and analogues by bound sodium. Mass spectrometric fragmentation
data revealed that sodium interacted with peptide bond carbonyl oxygens in the p-turns of the
iturin A analogue, and may be part of the stabilisation of the structure. They postulated that
the peptide ring carboxyl oxygens in one of the p-turns chelate alkali metal ions. This
chelation would result in a cationic environment required for the formation of iturin A
dependent anion selective pores that were observed by other investigators [12, 124].
Iturin A exerts its effect on the cell membrane as well as on intracellular targets. Interaction
with the cell membrane leads to a disruption of the permeability barrier and an initial leakage
of K+. This is followed by a release of proteins, nucleic acids and the release of vesicles,
which contain membrane lipids and iturin A [125, 126, 127]. The recognition of membrane
components such as lipids may be part of this mechanism and may account for target cell
specificity. The presence of cholesterol, ergosterol, oleic acid, phosphatidylcholine (PC),
phosphatidic acid, and petro selenic acid in the membrane of S. cerevisiae inhibit the action of
the peptide on this organism [128, 129]. This may also explain the lytic action of iturin A on
erythrocytes since erythrocyte membranes contain PC and cholesterol in its membrane.
Similarly, the resistance of the producer, B. subtilis, may be explained by the absence of PC
and sterols from the outer membrane leaflet [12].
This action, which is dependant on the fatty acid moiety, is thought to be the result of peptide
aggregation in the membranes with resultant formation of pores of unknown size and structure
[130,131, 132]. The invariant Tyr plays a key role in membrane interaction and aggregation.
A comparison between iturin A and another peptide of the same family, mycosubtilin, lends
some insight into the mechanism of action of the former. Mycosubtilin, which is also a
lipopeptide, differs from iturin A in residues seven and eight. The D-Asn7 and L-Serg are
replaced by L-Ser7 and D-Asng [130, 131]. Aggregates formed in DMPC membranes contain
only iturin A molecules while that of mycosubtilin contain both mycosubtilin and DMPC in a
1:2 ratio [131, 132]. The difference in the ability to interact with membrane lipids may
account for the increased biological activity of mycosubtilin. Mycosubtilin interacts with
cholesterol in a 1:2 ratio where as a l :1 ratio is found with iturin A [132]. The immiscibility
of the complexes coupled to the interaction with monovalent cations leads to the formation of
ion selective pores [122, 133, 134, 135, 136]. This is demonstrated by the slow increase in
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membrane conductance, which is independent of the membrane potential [12]. Membranes
treated with iturin A are slightly anion selective [133, 135]. The ability to bind cations may
cause iturin A to act as an ion carrier transferring cations across membranes [122, 130].
Besson et al. [137] and Rautenbach [138] showed the transition of iturin A from a possible
random conformation to organised secondary structures in lipid membranes using circular
dichroism. This may be of significant relevance to biological activity. These results have been
supported by the work of Grau and co-workers [116139]. Furthermore, it was also shown that
iturin A molecules have a strong tendency to interact with each other. This interaction
changes with increasing concentration from a micelle to another form of aggregate, probably
a lamellar vesicle. Furthermore, it has been suggested that that iturin A might form an
integrated bilayer, which is consistent with results obtained with molecules of comparable
amphipathic structure such as lysophosphatidylcholine [116].
It has also been suggested that iturin A activates phospholipases in membrane vesicles of S.
cerevisiae. At this stage it is unclear whether activation occurs because of direct interaction or
indirectly through stereoselective interaction with phospholipids substrates [128]. Other
interactions may also take place if the synergistic effect of surfactin on the action of iturin A
is taken into account [88, 89].
Recent studies suggest that the biological activity of iturin A also extends to the producer
organism, B. subtilis. Ahimou and co-workers [140] found that upon secretion the molecule
adsorb unto the producer, thereby changing the cell surface hydrophobicity. This may
facilitate bacterial colonisation through enhanced interaction with environmental surfaces
[140]. Similar mechanisms of adhesion have been found for Serratia mareeseens and Serratia
rubidaea [141].
1.2.3.3 Surfactin
Unlike the other lipopeptides used in this study, surf actin exhibits true biosurfactant and
foaming properties for which it is renowned and has been described as the most powerful
biosurfactant known [24, 142]. This property is the result of a pronounced amphipatic
character imparted on the molecule by the p-hydroxy fatty acid and Glu and Asp residues [35,
36]. The p-hydroxy fatty acid moiety allows interaction with lipid bilayers and the polar
residues contribute the molecule's metal chelating properties [143]. This selective chelating
effect can be explained in terms of the partial neutralisation of the two acidic residues. These
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residues form an "ionic basket" which can easily stabilise monovalent and divalent cations
[143]. As a result, surfactin can transport mono and divalent cations through an organic
barrier [143]. The selective affinities for divalent cations can be explained by the partial
neutralisation of the acidic residues by Na+ and K+ where as Ca2+ causes complete
neutralisation [144]. Cation selectivity studies have shown ion selectivity with K+ >Rb+>Na+
>Cs+ = Li+ [145]. Binding affinity measurements shows that surfactin can discriminate
between Ca2+ and Mg2+. The best fitting cation is Ca2+, which stabilises the surfactin
conformation and serves as an assembly template for the micelliation process [44, 146].
Furthermore, the stable p-sheet conformation facilitates the stacking of surfactin in stable rod
shape micelles with an aggregation number n = 173. In addition Osman and co-workers [146]
showed that Ca2+ induces a-helical conformation in surf actin up to 0.3 mM and 0.5 mM for
surfactin monomers and micelles respectively. Although the authors reported a a-helical
conformation structure size of the molecule would probably not allow this conformation.
Therefore, the structure observed was more likely a 3Io-helix. At higher concentrations Ca2+
p-sheets were observed [146, 147].
Morikawa and co-workers [148] further illustrated the importance of the Asp and Glu residues
as well as environmental conditions. They found that methylation and amidation of the
residues lead to a 20% increase in surfactant activity but water solubility was lost. In contrast,
the addition of amino methane sulfonic acid drastically decreased activity. Environmental pH
was found to have a profound influence and higher peptide activity was recorded under
alkaline conditions. Acidic conditions, on the other hand, drastically reduced surfactin
activity. It is interesting to note that a mutation of the Asp residue to Asn (thereby forming
lichenysin [20]) caused a marked increase in surfactant and ion chelating properties where as
the Asn to Asp mutation of iturin A (thereby forming iturin C [17]) lead to complete loss of
biological activity.
Surfactin, as the name denotes, has powerful surfactant properties (it lowers the surface
tension of water from 72 ml-Im" to 27 mNm-1 at concentrations as low as 20 IlM) that forms
the basis of its mechanism of action [149]. Surfactin's cellular effect results from the
disruption of membrane integrity [150]. The basis of this disruption is the ability to interact
with phospholipids although interactions with cations have to be considered given the
molecule's ionic nature. Maget-Dana et al. [151, 152] found that these interactions facilitate
peptide penetration into the membrane. A recent study showed that solubilization of the
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membrane at high peptide concentrations is in part responsible for biological activity [153].
Another part of the activity can be explained by the formation of cation selective "pores" at
concentrations significantly below the surfactinllipid ratio required for membrane
solubilization [145]. Surfactin showed antibiotic action against bacteria, mycoplasma, and
enveloped viruses [87, 154]. The latter function is of special interest in a pharmaceutical
context as the HIV virus belongs to this class of viruses. In addition, surfactin can
differentiate between mycoplasma and viruses [149]. Other biological activities include
antitumoral agent, a hypocholesterolemic, fibrin clot inhibitor, and starfish oocyte inhibitor
[24, 149, 155].
The synergism between iturin A and surfactin sparked interest in the field of biological
control. It was shown that iturin A inhibited the growth of various plant pathogenic fungi at
low dosages [12]. Surfactin, which can form mixed micelles with iturin A, considerably
augments the latter peptide's antifungal activity [88, 68, 156]. Ahimou and co-workers also
found that surfactin, like iturin A, adheres to the producer cell surface. Furthermore Kinsinger
et al. showed that rapid surface motility in the presence of surf actin is dependent on extra-
cellular K+ concentration [157].
1.3 Peptide Applications
Emergence of multi-drug resistant micro-organisms accentuated the need for continued
development of antimicrobial agents. Overexposure to antibiotics in medicine and agriculture
, !
led to the evolution of these resistant strains [158, 159, 160, 161]. Moreover, many of the
synthetic pesticides and insecticides may become useless due to revised safety regulations and
concern over non-target effects [162, 163, 164, 165]. The broad-spectrum of antimicrobial
activity coupled with membrane specificity makes these secondary metabolites an attractive
alternative to current antibiotics. The cyclic peptides described here are already in use or
exhibit potential to be used as biological control. Unfortunately, a plethora of complications
has limited the general use of these compounds.
Even though the primary aim of many of the investigations concerning these molecules has
been directed at antimicrobial applications, these molecules also possess other biological
activities. In addition to agricultural and medicinal potential, important industrial applications
are associated with surfactin as it may prove to be a natural alternative to many synthetic
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surfactants currently in use.
1.3.1 Gramicidin S
Gramicidin S has already been patented as a topical antimicrobial agent [166, 167], but the
strong haemolytic character has prohibited systemic use of its antimicrobial action. [83].
Fortunately, the dissociation of haemolytic and antimicrobial activity through manipulation of
ring size and amphipathicity has been demonstrated [83]. These developments may in future
pave the way to analogues with systemic application. The possible use of gramicidin S as
biological control agent in agriculture has also been demonstrated [168, 169, 170]. Even
though gramicidin S shows potent antimicrobial activity, widespread use has been hampered
by high production costs and adverse systemic side effects. At this stage, the most promising
use of this peptide is in biological control. Gramicidin S producing bio-films has successfully
been used to combat the corrosion of mild steel in nuclear power plants by inhibiting the
growth of sulfate reducing bacteria [171].
1.3.2 The iturins
The iturin family has been investigated as alternative antifungal agents. A broad-spectrum
antifungal activity makes this group of peptides promising candidates for agriculture,
medicine, and food preservation. A recent study by Deleu et al. [172] showed that, in addition
to biological activity, iturin A has surfactant properties with the ability to resist creaming-
flocculation. This characteristic extends this peptide's potential applications to industry as
well as bioremediation.
Unfortunately, as with gramicidin S, large-scale use of the iturins has been hampered by a
variety of factors. These include high production cost and peptide delivery to the target.
Chemical syntheses of these compounds are not a viable production method due to the
difficulty and high cost of synthesis and purification. However, high production costs may be
counteracted by lower susceptibility to proteolytic degradation that in turn lowers the required
dosage. The resistance to proteolytic degradation is imparted on the molecule through the
inclusion of D-amino acids and ~-amino fatty acid as well as the cyclic structure. Crude iturin
A was used in clinical trials as topical treatment for dermatomycoses in both animals and
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humans and was shown to have great potential because of a broad-spectrum of activity, low
toxicity and low allergenic effect [173]. The adverse environmental effects and mammalian
toxicity of many synthetic fungicides has drawn renewed attention to natural alternatives
[174]. The iturins provide another alternative biological control agent whether used in purified
form or as a product of the producing organisms [175].
The co-producer of iturin A and surfactin, B. subtilis RB-14 effectively inhibited damping-off
of tomato seedlings caused by Rhisoctonia solani [176]. Brown fruit rot (caused by Monolinia
fructicola) of stone fruits was controlled by B. subtilis B-3 [177]. One field study showed a
marked reduction of mycoflora on stored feed grains at iturin A concentrations as low as SO-
100 ppm [178].
1.3.3 Sur/actin
Although experiments have shown that surfactin possesses a broad range of biological
activities, the primary focus was the industrial applications of surf actin especially in relation
to surfactant characteristics [149]. These characteristics may find applications in diverse
industrial fields such as food formulation, cosmetics, road construction, pesticides, detergents,
enhanced oil recovery, and bioremediation [179, 180]. Surfactin has successfully been used in
situ for volatile organic compounds (VOe) contaminated soil remediation [181]. The viability
of heavy metal extraction from soil using surfactin needs to be determined as other biological
substances are far more effective [182]. Surfactin is preferred to the synthetic surfactants
because of the bio-degradability of the natural product. Unfortunately, surf actin is unable to
compete with chemically synthesised products due to poor strain yield, expensive growth
media, and complicated purification processes [75, 183]. The biological application of
surf actin is at this stage limited to biological control when secreted together with iturin A
[168]. In this regard it is interesting to note that surf actin possesses insecticide activity against
Drosophila melanogaster where as iturin is ineffective [184]. It possesses activity against
bacteria and mycoplasma, but not in the same range as gramicidin S [85, 185]. Furthermore
surf actin has been shown to selectively inhibit growth of cyanobacteria [186]. Bacteriostatic
activity on Micrococcus lute us has been demonstrated when the organism was cultured in
minimal medium [185]. Systemic applications such an antitumoral and antiviral agent are
hampered not only by production costs, but also by its high haemolytic activity. Surfactin,
1-20
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along with other bio-surfactants, have been shown to inhibit colonisation and bio-film
formation of pathogenic bacteria on medical equipment and have successfully been used as
adjuvant for the generation of monoclonal antibodies [42]. Further medical interest in
surfactin was stimulated when it was shown that surfactin enhanced intratracheal delivery of
insulin in rat lung [187] and that [Yah] surfactin enhances the activation plasminogen [188].
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Chapter 2
Syntheses, purification and analyses of peptides
2.1 Introduction
All the peptides used in his study, gramicidin S, iturin A and surfactin could be commercially
obtained, except for iturin C. Solid phase peptide synthesis was used to first synthesise the
linear analogues of iturin C (8-Betac) and iturin A (8-Beta). Although one of the aims was to
synthesise iturin C, it also presented the opportunity to investigate the importance of structure
and cyclisation in interaction with gramicidin S. Therefore, the linear iturin analogues 8-Betac
and 8- Beta were purified and analysed for use in this investigation (Chapter 6).
Peptide analogues of natural occurring peptides have successfully been used to elucidate the
structural characteristics required for antimicrobial action. Analogues of gramicidin Shave
been used to investigate the importance of peptide sequence, and ring size [1, 2, 3, 4, 5, 6].
Similarly, analogues of surfactin have been employed to evaluate the importance of the acidic
residues and fatty acid chain length [7, 8, 9]. Using iturin analogues, the importance of fatty
acid chain length, the invariant L-Tyr and L-Asn residues as well as the influence of peptide
chain length on metal ion chelation [10, 11,12, 13] were revealed.
2.1.1 Peptide synthesis
The history of solid phase peptide synthesis (SPPS) dates back to 1959 with the pioneering
work of R.B. Merrifield. The success of the Merrifield protocol was demonstrated by the first
solid phase synthesis of a biological peptide, bradykinin (1964) [14] and the first active
enzyme, ribonuclease A (1969) [15].
Solid phase peptide synthesis involves four steps: 1) the immobilisation of the first amino acid
to a functionalised insoluble matrix, 2) elongation of the peptide chain through the sequential
addition of activated amino acids which are protected against side-chain reaction with labile
protection groups, 3) the removal of excess reagents and by products trough filtration and 4)
termination of the synthesis through the release of the crude peptide from the solid support
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followed by purification. All current synthesis protocols proceeds from the C-terminal amino
acid to the N-terminal amino acid. Synthesis in the C~N direction dictates the activation of
the a-carboxyl group (to assist peptide bond formation) of the unbound amino acid as well as
the reversible protection of the a-amino group (to limit polymerisation). The first step in
SPPS involves the coupling of the first amino acid (C-terminal amino acid) to the solid
support via ester formation with a functionalised linker. A two-dimensional protection scheme
is employed in SPPS, the first involve a "semi-permanent" protection of the a-amino group of
the incoming amino acid and the second a "permanent" protection of the functional side-
chains of the bonded amino acid in the formed peptide chain. Successful SPPS depends not
only on a successful coupling step, but also on the conditions under which the respective
protection groups are removed. During the synthesis procedure, conditions are carefully
controlled to ensure that deprotection of the a-amino group occurs at the appropriate step
during the synthesis, while keeping all other protection groups intact. After completion of the
synthesis, conditions are altered allowing the liberation of the peptide from the solid support
and the removal of the remaining protection groups.
The original SPPS protocol, as devised by Merrifield, a-amino group protection was provided
by the acid-labile Na-tertiary-butyloxycarbonyl (tBoc) group. This group was cleaved from
the amino acid using trifluoroacetic acid (TFA) [16]. Side-chain protection was conferred by
ether, ester, and urethane derivatives based on benzyl alcohol, which could only be cleaved
with hydrofluoric acid (HF) in the presence of carbonium ions [16] Several problems were
associated with this protocol such as premature release of the peptide, trifluoroacetylation, as
well as side reactions during HF cleavage [16]. In addition, the resin cleavage procedure
required Teflon® coated equipment and the use and neutralisation of a strong acid (TFA)
during each coupling step.
The problems experienced with the Merrifield protocol led to the development of N9_
fluoroenylmethyloxycarbonyl (Fmoc) protection scheme by Atherton, Sheppard, and Dryland
(reviewed in [16, 17, 18]). This method of synthesis is based on the protection of the a-amino
group with the base-labile Fmoc group [19], which can easily be removed through a p-
elimination mechanism. The elimination of this group is initiated by secondary amines such
as piperidine, which also scavenges the formed dibenzofulvene intermediate thus preventing
re-addition to the peptide chain [16]. Side-chain protection in this protocol is conferred by
tertiary butanol-based ether, ester, and urethane derivatives, which can be cleaved with TFA
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with the concomitant release of the peptide chain from the solid phase. The developers of this
method also introduced the use of a rigid solid support in the form of functionalised
dimethylacrylamide cross-linked within Kieselguhr. The use of such a rigid solid support
enabled the development of continuous flow synthesis [20].
Since peptide bond formation does not occur spontaneously, it follows that the process is
mediated through the activation of the group/groups of involved in bond formation. The
Merrifield protocol requires the activation of the a-carboxyl group, which are achieved
through various methods. These methods include the use of carbodiimides to form
anhydrides, active esters of the amino acids, phosphonium-based in situ activation agents such
as benzotriazol-I-yl-oxy-tris-dimethylaminophosphonium hexafluorophosphate (BOP) [16,
17, 18] or its less toxic analogue benzotriazol-I-yl-oxy-tris-pyrrolidinophosphonium
hexafluorophosphate (PyBOp®) [18, 20] and aminiurnluranium salts as in situ activation
agents such as O-(benzotriazol-I-yl)-I,I,3,3 tetramethyl uronium hexafluorophosphate
(HBTU) [21].
The active amino acid esters employed in peptide synthesis are p-nitrophenyl [16], 3,4-
dihydro-4-oxo-I,2,3-benzotriazin-3-yl (DhBt) [18] and pentafluorophenyl (Pfp) [16, 18]
esters. These esters are generally used with I-hydroxy-benzotriazole (HOBt) as acylation
catalyst. The reactivity of the active esters was found to be lower than the symmetrical
anhydrides, but the addition of HOBt greatly increased the reactivity and thus the reaction rate
of the esters [22]. Both Dhbt and Pfp esters are suitable for peptide synthesis system that
employs a polar, aprotic solvent such as N'N' -dimethylformamide (DMF).
Activation of the a-carboxyl group can also be accomplished through the formation of a
active anhydride. Carbodiimides such as dicyclohexylcarbodiimide (DCC) and N',N'-
diisopropylcarbodiimide (DIPCDI) are commonly used for this form of in situ activation.
The other general method of activation used in the syntheses required the use in situ activation
agents such as of PyBOp® in the reaction mixture. Addition of PyBOp® to the reaction
mixture, in the presence of a base (such as diisopropylethyl amine) creates highly active
"oxybenzotriazolyl esters [16]. Such coupling reagents rely on the formation of
oxybenzotriazolyl esters for amino acid activation. This form of activation eliminates the time
consuming process of symmetrical anhydride preparation and offers a cost effective
alternative to active esters.
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With most coupling methods, the use of HOBt as trapping" agent is recommended, because it
leads to the formation of the racemisation-resistant oxybenzotriazolyl esters[18].
2.1.2 Peptide cyclisation
Cyclic peptides, of the "head-to-tail" variety, offer a variety of attractive characteristics, not
found in linear peptides, for drug development. The absence of ionisable termini makes them
resistant to in vivo degradation, resulting in higher bioavailability. Furthermore, cyclisation
reduces conformational flexibility thereby enhancing receptor selectivity. Unfortunately,
peptide cyclisation is not as straight forward as linear peptide synthesis and depends on a
variety of factors. Peptide cyclisation has been reviewed extensively in literature [23,24] and
will be discussed in the broadest terms only. The synthesis of cyclic peptides from linear
precursors can be performed in both solution phase and on solid phase.
Although solution phase cyclisation utilises the same coupling reagents as SPPS, another
dimension to peptide bond formation is introduced, namely solubility and conformational
variation in different solvents [24]. Kurome and co-workers [24] used a variety of solvents
during the synthesis of auraobasidin and found a finalproduct yield of 45% was obtained in
dichloromethane (DCM), whereas the use of DMF did not result in cyclisation. This
difference in product yield can be attributed to the difference in conformation of the linear
precursor in the solvents.
Success has been achieved with all conventional activators activators, but recent reports
suggest that uroniumlaminium salts are more efficient at achieving cyclisation [24].
Contradictory to these findings, recent reports suggested that uranium-type reagents with
tetramethyluronium moieties are involved in end-capping of the a-amino group involved in
cyclisation [23]
Other strategies of involve cyclisation on solid supports and enzyme-catalysed cyclisation.
Solid support cyclisation strategies involve the coupling of the C-terminal residue to the resin
via the amino acid side chain, cleavage upon cyclisation ("cyclitive cleavage") [23, 24], and
enzyme-catalysed cyclisation [25]. The coupling of the C-terminal amino acid side chain to
the resin is most commonly used method, but the emergence of specialised linkers for
"cyclitive" cleavage is pushing this method to the fore. Enzymes that are involved in the
cyclisation of natural cyclic peptides can also be used to cylicise the linear precursor. The
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use of enzyme-catalysed cyclisation is at this stage considered "cutting edge" [25] (reviewed
in [23]).
2.1.4 Separation and analyses
After synthesis of a peptide, it is necessary to purify the peptide and confirm its chemical
integrity and purity. A variety of separation and analytical techniques are available to the
modern peptide chemist. Techniques in general use are chromatography and mass
spectrometry. Other physical techniques such as circular dichroism, infrared spectrometry,
and nuclear genetic resonance spectrometry are also used for structural analyses.
High performance liquid chromatography (HPLC) offers the advantage of being both a
separation and an analytical tool. In this study, HPLC was used for both purification and
separation. HPLC was first introduced between 1967 and 1969. This form of liquid
chromatography revolutionised the field of separation science by offering the same quality of
separation with greatly reduced analysis separation times. All types of chromatography are
based on the selective partitioning of solutes between a mobile and a stationary phase. The
separation and analytical reverse phase chromatography HPLC used in this study, is based on
differences in hydrophobicity. A solvent gradient with decreasing polarity allows the analytes
to desorb from the hydrophobic packing material in increasing order of hydrophobic
character. This allows the more polar peptide synthesis by-products to elute first, followed by
the synthesised peptide and more hydrophobic contaminants.
The development of "soft ionisation" techniques (reviewed in [26]) extended the use of mass
spectrometry to large biomolecules, and especially peptides and proteins. Mass spectrometry,
therefore, became a very important tool to evaluate the purity and chemical integrity of
synthetic peptides. A variety of ionisation techniques such as matrix assisted laser
desorption/ionisation (MALDI), electro spray ionisation (ES) atmospheric pressure chemical
ionisation (APCl), and atmospheric pressure photo ionisation (APPI) are particularly suited to
the analysis of bio-molecules.
The ionisation source utilised on all the analyses in this study wed an ES source. Electrospray
ionisation is based on the formation of highly charged droplets in a strong electric field. The
ions created are liberated through desolvation by heat, vacuum, and dry gas. Ions can be
generated through several mechanisms such as electron ejection, electron transfer, transfer
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of a charged molecule from a condensed phase to the gas phase, protonation and
deprotonation, as well as cationisation.
The ions are subsequently passed through a mass filter/analyser and are separated according
to the mass to charge (m/z) ratios before being detected by either an electron multiplier or a
scintillation counter. Two mass analysers were used in this study, the one a quadrupole and
the other a time-of-flight analyser (TOF). A quadrupole analyser filters ions by passing them
through four electromagnetic staves arranged perpendicular to one another. The radio
frequency of the magnetic field generated are manipulated that only molecules with a certain
m/z have stable trajectory through the analyser [27]. TOF-MS is based on the acceleration of
gas-phase ions through an electric field into a field-free drift region. The constant acceleration
voltage gives all ions the same kinetic energy, and the ions are propelled through the field-
free drift region based on their specific mass-to-charge ratios. Smaller ions will move faster
than larger ions for mass separation and the time needed to travel the length of the drift region
can be related to the mass of the ion [28,29] - hence the "time-of-flight".
In addition to the use of a mass spectrometer for analyte detection, it was also used for peptide
identification through tandem mass spectrometry (MS/MS). Tandem mass spectrometry, also
known as collisionally induced dissociation or collision activated dissociation, involves the
decomposition/fragmentation of a selected molecular ion through the collision of the ion with
a neutral gas. The ion is selected in the first mass analyserlfilter before being passed into the
fragmentation cell containing the collision gas. The product ions are subsequently analysed by
the second mass analyser. The fragmentation of the peptides generally occurs at the peptide
bond [30, 31, 32], but this may vary according to peptide sequence [33, 34] and protonation
sites [30, 35, 36]. Cyclic peptides in general undergo ring opening at a proline residue [30, 33,
34]. The nomenclature used in describing fragmentation product ions from linear peptides
were originally devised by Roepstorff and Fohlman [37] and later revised by Biemann [38]
(Figure 1). An alternative nomenclature for cyclic peptides have been proposed by Ngoka and
Gross [39] and adapted by Williams and Brodbelt [40]. According to the Roepstorff &
Fohlman nomenclature, the scission at a peptide bond at the N-terminal side of the peptide is
denoted as bn with n the number of the peptide bond. Therefore, scission of the first peptide
bond, between the first and the second residues, will create a bl fragment. Similarly, a scission
at a C-terminal peptide bond is denoted Ym with m being the peptide bond as counted from the
C-terminus. For a four residue peptide the scission of the peptide bond between residue four
and three will result in a Yl fragment (Figure 1). Scission of the bonds flanking the peptide
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bond from the N-terminus are denoted a (i.e. resulting in decarboxylation of the preceding
residue), and c (i.e. resulting in deamination of the following residue). Similarly scission of
the bonds flanking the C- terminal peptide bond results in the formation of x (i.e. resulting in
decarboxylation of the residue following the peptide bond) and z (i.e. resulting in deamination
of the residue preceding the peptide bond) fragments. The system devised by Ngoka and
Gross takes into account the more complicated nature of cyclic peptide fragmentation and
allows for the unambiguous assignment of fragments - especially were repeat amino acid
residues are involved. Instead of this nomenclature system, we opted to use the revised system
of Biemann. This decision was based on the presence of a Pro residue(s) in two of the cyclic
peptides in this study, which favours ring opening at the amino side of this residue. Therefore,
the Pro residues of gramicidin S and iturin A were taken as the N-terminal residue of the
linear peptide formed after ring opening. The lactone bond of surfactin is also the preferential
site for ring opening for surfactin leaving its ~-hydroxy fatty acid as N-terminal residue.
X 4 Y 4 Z4 X 3 Y 3 Z3 X 2 Y 2 Z2 X 1 Y 1 Z 1
fs
C-COOH
I
H
a1 b1 C1 a2 b2 C2 a3 b3 C3 a4 b 4 C 4
Peptide backbone product ions
Z 1
+
RsHC=COOH
y" 1
X1
+
O=C- N -CHRSCOOH
H
Z2
+
R4HC-C- N-CHRs=COOHH
Figure 1 Peptide backbone product ions generated during tandem mass spectrometry [37,
38]. Figure reproduced with permission from M. Rautenbach [17].
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2.1.5 Peptides in this investigation
Iturin A and surfactin are commercially available as lipopeptide mixtures from bacterial
extracts. Gramicidin S, of which no known variations exist, could also be commercially
obtained. These three peptides or peptide mixtures are of particular interest in the
investigation, and most of the work of this thesis focussed on them (see Table 1 for their
primary structures). As all these compounds are prepared from bacterial extracts, variations
may exist in batch composition. In order to ensure comparability between our experiments,
these products were analysed by analytical high performance liquid chromatography (HPLC)
and electro spray ionisation mass spectrometry (ESMS) to ascertain their purity and
composition.
The composition and yield of bio-synthetically obtained surfactin is greatly dependent on the
nutrients supplied in the producer culture [41]. As a result, three, main surf actin variants are
produced named surfactin A, B, and C with residue 7 as Leu, Ile and Val respectively and
fatty acid composition C14-1S. In addition surfactin variants have been isolated with Val.,
mutated to Ala, as well as the fatty acid chain Cl3 and C16 (see Chapter 1 for structures). This
natural variation in surfactin composition necessitate~_.the evaluation of surf actin composition
of commercially obtained surfactin.
The group of compounds, collectively known as iturin A, consists of three compounds with
the same primary structure, but varying fatty acid chain length [42, 43]. In addition, iturin A is
co-produced with surfactin and mycosubtilin in some B. subtilis strains [44, 45, 46]. The
ability of B. subtilis to co-produce compounds as well as the influence of nutrition on extract
composition dictated the need to verify the commercial product composition.
Iturin C was not commercially available, so this necessitated its synthesis. Linear analogues
of iturin C2 (8-Betac) and iturin A2 (8-Beta) with the 'fatty acid moiety as p-
aminotetradecanoic acid (P-NC14) were synthesised (Table 1). Iturin A2 contains a lipid
moiety, p-D-amino tetradecanoic acid (P-NC14), but only the highly insoluble HCI salt of a
racemic P-NC14 preparation was available to us [17]. Previously solubility problems were
experienced with the synthesis of the Fmoc-derivative of the P-NC14 [17], therefore the tBoc
derivative was used. The use of tBoC-PNC14 limited the inclusion of the residue at the N-
terminal of the final coupling reaction. The use of a racemic mixture of P-NC14 in the
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synthesis would therefore result in a racemic mixture of lipopeptide products. The cyclic
peptide iturin A2 was previously prepared through the cyclisation of 8-Beta [17]. A similar
approach was followed in the synthesis iturin C2, namely cyclic 8-Betac. The synthetic
products were then purified by semi-preparative HPLC and analysed by analytical HPLC and
ESMS.
Table 1 Primary structures of the commercial peptides and the iturin analogues
synthesised in this study. The "N-terminal" of the cyclic peptides is as expected
during ring-opening under mass spectrometry conditions. The "-,, before the N-
terminal and after the C-terminal residue denotes a cyclic structure. Possible
variations in the lipid moieties are: $ n-,i-, a-C13-16, #n-, i-, a-CI4-16.
(Abbreviations: ~-OHC = ~-hydroxy fatty acid; ~-NCI4 = racemic ~-
aminotertadecanoyl; other amino acids are abbreviated by the standard 3-letter
abbreviation including the D- or L-configuration).
amino acid residue N~ C
Peptide 1 2 2 4 5 6 7 8 9 10 Mr
Gramicidin
-L-Pro L-Val L-Orn L-Leu D-Phe L-Pro L-Val L-Orn L-Leu D-Phe- 1141.2
S [47]
L-Leul
Surfactin
-pOHC L-Glu L-Leu D-Leu
L-Val/
L-Asp D-Leu Ilel 1021.8'
[48] Ala Val
lturin A
-L-Pro D-Asn L-Ser D-p- L-Asn D-Tyr D-Asn L-Gln- 1042.2
[49,50,51] NC#
lturin C
-L-Pro D-Asn L-Ser
D-p- L-Asp D-Tyr D-Asn L-Gln- 1043.2
[49] NC#
8-Beta DIL-p- L-Asn D-Tyr D-Asn
L-
D-Asn L-Ser L-Gln 1060.2
[17] NC14 Gln-
8-Betac
D/L-p- L-Asp D-Tyr D-Asn
L-
D-Asn L-Ser L-Gln 1061.2
NC14 Gln-
* Mr calculated using LsVal, and L-Leu/I1eg
2.2 Materials
N, N'-dimethylformamide (DMF, 99%), diethyl ether, piridine, chloroform (>99%), glacial
acetic acid, ethanol (>99.8%), butan-l-ol (99.5%), dichloromethane (DCM), phenol,
potassium cyanide (KCN), di-phosphorous-pentoxide, 2',7' -dichlorofluorescein, ninhydrin,
aluminium oxide 90, molecular sieve (0.3 nm pore size) and Kieselgel 60-F254 were from
Merck (Darmstadt, Germany). Potassium hydroxide, anhydrous sodium sulphate, and self-
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indicating silica gel were from Saarchem (Krugersdorp, South Africa). Ethyl acetate and 2-
methyl-butan-z-ol (t-amyl alcohol; 98%) were from BDH Chemicals (Poole, UK). Fluka
Chemicals (Buchs, Switzerland) supplied I-fluoro-2,4,-dinitrobenzene, N, N'-
diisopropylethyl amine (DIPEA) and CaH2. Gramicidin S, trifluoroacetic acid (TFA, >98%
and 99.5%) and piperidine (98%) were from Sigma (St Louis, USA). Romill Ltd (Cambridge,
UK) supplied the acetonitrile (ACN) (HPLC-grade, UV cut-off 190 nm) and methanol
(HPLC-grade, UV cut-of 205 nm). Nova-Pak® CI8 (5 urn particle size, 60 A pore size, 150
mm X 3.9mm) reverse phase analytical column, 0.45 micron HVLP membrane filters were
from Waters-Millipore (Milford, USA). Macherey-Nagel supplied the Polygosil packing
material (CI8, 60 DA, irregular particle size, 250mm X IOmm) packing material for the semi-
preparative HPLC column. Analytical grade water was prepared by filtering water from a
reverse osmoses plant through a Millipore Milli Q®water purification system. The purified 8-
Beta reference peptide was kindly donated by Dr. M Rautenbach, University of Stellenbosch.
Fmoc-D-Asn(trt)OH, Fmoc-L-Pro(OH), Fmoc- D-Tyr(tBu)OH and Fmoc-L-Asn-OPfp were
from Advanced Chemtech (Kentucky, USA). Calbiochem-NovaBiochem (La Jolla, USA)
supplied benztriazol-l-yl-oxy-tris-pyrrolidinophosphonium hexafluorophosphate (PyBOp®),
I-hydroxy-benzotriazole (HOBt) and Fmoc-Gln-OPfp. The Fmoc-L-Asp(otBu) and Fmoc-L-
Ser(tBu)-Pepsyn KA-resin (0.09 meq/g) and diisopropylcarbodiimide (DIPCIDI) were
supplied by Milligen-Millipore (Milford USA). Fluka Chemicals (Buchs, Switzerland)
supplied 2-(BOC-oxyimino )-2-phenylacetonitrile (BOC-ON)., The HCl salt of ~-
aminotetradecanoic (~-NCI4) acid was donated by Dr. R. Levitt, formerly from Fine
Chemicals, South Africa.
2.3 Methods
2.3.1 Preparation of solvents and reagents
2.3.1.1 Distillation and testing ofN, N'-dimethylformamide
DMF is the primary solvent for Fmoc synthesis method and may contain impurities such as
secondary amines and H20. The presence of these impurities will lead to the loss of the Fmoc
and active ester groups. Reaction of water with DMF leads to the formation of dimethylamine
and formic acid. Distilled, high purity DMF was used during the synthesis to avoid side
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reaction with the amines, water, and other impurities. Before distillation, the DMF was placed
on a rotary shaker with 10-20 gIL dry potassium hydroxide pellets to remove residual water.
Volatile impurities such as secondary amines were removed by fractional distillation under
reduced pressure (4 -7 mm Hg vacuum) with a dry nitrogen bleed. The high boiling point of
DMF (l63°e at atmospheric pressure) necessitated distillation under vacuum to avoid solvent
decomposition at high temperature. The first 10% of the distillate was discarded and the
constant boiling fraction collected (45°e at 10 mm Hg, [14]). Distilled DMF was stored in
dark glass bottles at room temperature. Only DMF that passed Sanger's test for amines (see
below) were used within 24 hours of distillation. The distillation procedure was done
according to Rautenbach [17].
2.3.1.2 Sanger's test for amines
Because of the liability of the Fmoc group in the presence of secondary amines, all DMF was
tested before use with Sanger's test for amines [52]. The test was carried out by mixing equal
volumes of I-fluoro-2, 4-dinitrobenzene (1 mg/mL FDNB in 95% ethanol) and DMF and
leaving the mixture for 30 minutes in the dark at room temperature. The absorbance was
measured at 381 nm, and 0.5 mg/mL FDNB was used as blank. The blank was only accepted
if the absorbance was 0.20±0.OI absorption units. Suitably pure DMF had an absorbance of
0.02 to 0.07 absorbance units above the blank.
Sanger's test for amines was also performed on the DMF used in the final washing steps to
ensure the complete removal of piperidine used in the deblocking steps of the synthesis
protocol. A sample was taken from the final DMF wash and' mixed with equal volume
Sanger's reagent and determined spectrophotometricly at 381 nm without prior incubation.
Synthesis continued if a zero reading was obtained.
2.3.1.3 Distillation of piperidine and pyridine
Quality control of piperidine and pyridine is essential for the same reasons as DMF quality
control. Fractional distillation over 10-20 giL potassium hydroxide with nitrogen bleed at
atmospheric pressure was used to purify the solvents. The first 10% of the distillate was
discarded and the constant boiling fraction (I04°e for piperidine and 108°e for pyridine) was
collected and stored in dark bottles [53].
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2.3.1.4 Distillation of N'N-diisopropylethylamine
Distillation of N'N-diisopropylethylamine (DIPEA) was performed over ninhydrin (1-2 gIL)
under nitrogen flow, and the fraction boiling above 116°C was collected. The first distillate
was the redistilled over KOH and under nitrogen flow. The constant boiling fraction at 127°C
was collected, aliquoted, and stored under nitrogen in airtight 4 mL vials at -lOoC [20].
2.3.1.5 Distillation of Dichloromethane (DCM) (adapted from [54])
Dichloromethane was pre-dried over activated (dried at 100°C for 72 hours) molecular sieve
for 48 hours. Trace amounts of H20 were subsequently removed by treating the DCM with
CaH2 (5g/L). The distillation of DCM was performed over CaH2 The constant boiling fraction
was collected at 40°C after a small run-off was discarded.
2.3.1.6 Preparation of NI3-t-butyloxycarbonyl-p-aminotetradecanoic acid
NP-t-butyloxycarbonyl-p-aminotetradecanoic acid was synthesised according to Rautenbach
[17] (original method adapted from [55]). The HCI-salt of p-aminotetradecanoic acid (1.05 g,
3.75 mmole) was suspended in 5 mL DMF. TEA (2 mL) was added to the suspension while
stirring at 50°C in an oil-bath. A 1.2 fold excess (1.16 g;' 4.6 mmole) of 2-tertiary-
butyloxycarbonyl-2-oxyimino-2-phenylacetonitrile (BOC-ON) was dissolved in 1.5 mL DMF
and added drop-wise to the suspension. The resulting yellow suspension was stirred for a
further two hours until clear. The reaction mixture was evaporated under vacuum to oil at
45°C. Diethyl ether (25 mL; filtered through activated aluminium oxide) was used to dissolve
the oil and extracted twice with 5 mL saturated citric acid (59.2% mlm at 20°C) to remove
residual BOC-ON and p-aminotetradecanoic acid. The aqueous fractions were combined and
extracted twice with 5 mL diethyl ether. The combined diethyl ether fractions were washed
twice with 25 mL water and dried twice with anhydrous sodium sulphate. The diethyl ether
,
was evaporated under vacuum and the resultant oil dissolved in 10 mL heated acetonitrile
(40°C). The solution was cooled in an ice bathed and left overnight at 4°C. The resultant
crystalline product was filtered and washed with chilled acetonitrile and dried overnight under
vacuum at room temperature.
Thin layer chromatography was performed on aluminium backed Kieselguhr 60-F254 and
developed in chloroform:methanol:acetic acid (85:10:5). [16]. Plates were carefully air-dried
and visualised under UV-light (254 nm) before being sprayed with 0.025% 2',7'-
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dichlorofluoroscein in 95% ethanol. The sprayed plates were· developed at 110°C for 5
minutes and visualised under UV-light. The plates were then sprayed with 0.2% ninhydrin in
95% and developed at 110°C for 5 minutes to detect residual amino groups.
2.3.1. 7 Quality control and Kaiser test
All the amino acid derivatives used were tested before synthesis. This involved the
determination of melting points and the Kaiser test for free primary amino groups [56]. The
Kaiser test were performed by dissolving 5 mg of derivative in 100 J.lLDMF and adding 100
J.lLof each Kaiser solutions. Colours were evaluated after 5 minutes in an 80°C water bath by
comparison to a standardised colour chart [57]. Only amino acid derivatives with the correct
melting points and negative Kaiser tests were used in syntheses.
Three reagents are required for the Kaiser test: (1) 500 mg ninhydrin in 10 mL 95% ethanol;
(2) 40 g phenol in 10 mL 95% ethanol; and (3) 2 mL 0.001 M KCN solution diluted to 100
mL with distilled pyridine. A 100 J.lLof each solution were added to 5 mg of the amino acid
derivative and the. The mixture was heated in a water bath for 5 minutes at 80°C.
2.3.2 Peptide syntheses
2.3.2.1 Syntheses of linear peptides
Glassware used during peptide synthesis and removal of the completed peptide from the resin,
was first rinsed three times with 60% ethanol/water and the three times with deionised water.
After drying the glassware were pyrolysed at 650°C for 90 minutes. Alternatively, the
glassware were treated with chromic acid (5mg/mL potassium dichromate in H2S04), washed,
and dried before use. All dry reagents were desiccated for at least 30 minutes under vacuum in
a desiccator containing self-indicating silica gel and di-phosphorous pentoxide before use.
The peptides were synthesised at room temperature using the Fmoc-polyamide principle using
a shake-flask bench procedure according to Rautenbach [17]. The peptides were synthesised
on commercially available Pepsyn-KA-resin (0.09 milli-equivalent per gram dry resin), with
Fmoc-L-Ser(tBu) already attached. The resin was swollen before the synthesis in high purity
DMF (20 mLigram) for 30 minutes. The masses of the derivatives needed for peptide
elongation were calculated from the resin capacity. A three times molar excess of Fmoc-
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amino acids, HOBt (catalyst and "trapping" agent), and PyBOP (in situ activator), as well as a
six fold molar excess ofN,N'-diisopropylethyl amine (DIPEA) were used for coupling Fmoc-
D-Asn(Trt)OH, Fmoc-L-Pro-OH, Fmoc-D-Tyr(tBu)OH, Fmoc-L-Asp(OtBu)-OH residues
and the P-NCI4 fatty acid moiety. The dry reagents were dissolved in minimum volume of
DMF not exceeding 1.5 mL. The Fmoc pentafluoro esters derivatives of L-Asn (Fmoc-L-Asn-
OPfp) and L-Gln (Fmoc-L-Gln-OPfp) were coupled using a three times molar excess of
amino acid derivative and HOBt. The coupling reaction times varied from 60 to 90 minutes or
until completion of the reaction as determined with the Kaiser test [56]. Four drops of each
Kaiser solution were added to ether washed and dried resin sample taken during the synthesis.
A Kaiser positive test was detected when the primary amino groups on the peptide chain and
the reaction changed colour. The colour varied with the derivative coupled and the sequence
of amino acids. Colours ranging from deep blue, orange and brown were detected. In a Kaiser
negative test the beads remained a cream-yellow colour and the reaction mixture yellow.
Resin samples were taken at the expected end of the coupling step. If this test was positive,
the coupling time were extended until a negative test was obtained. Another resin sample was
taken at the end of the deblocking step and had to be positive before the synthesis proceeded
further.
Analytical Fmoc test was performed by deblocking _asmall analytically weight amount of
resin (typically 10 mg). The resin was washed with ether and dried under vacuum before
weighing. Piperidine (20% piperidinelDMF) was added to the resin (200 flLlflmole expected
Fmoc-groups) and allowed to react for 30 minutes at room temperature. The characteristic UV
absorbance of the liberated Fmoc-fulvene groups [18, 19] was measured at 290 nm after 50
times dilution of deblocking mixture with DMF. Coupling efficiency was calculated from the
following equation [17]:
0/ C li ffici f h li (dilution *A290 + 0.9975)
/0 oup mg e lcmecy 0 t e coup mg step = -'----------=.:~--__:_
0.2848
Light path = 1 cm; resin capacity = 0.1 mmoles/1000 mg
After completion of a coupling step, as determined by negative Kaiser test, the resin was
thoroughly washed with DMF to remove all traces of the reaction mixture. Piperidine (20% in
DMF) was added to the resin to remove the Fmoc-group of the previously coupled amino
acid. The reaction was allowed to proceed for 30 minutes after which the liberation of the
2-14
Stellenbosch University http://scholar.sun.ac.za
Fmoc-group was monitored at 290 nm and the deblocked a-amino group on the resin with the
Kaiser test. The piperidine was washed from the resin with DMF until the DMF used in the
washing process tested negative with Sanger's test.
The different peptides were synthesised up to the hexapeptide unit D-Tyr-D-Asn-L-Gln-L-
Pro-D-Asn-L-Ser and split into three batches. The ~-amino acid residue was coupled to one
batch to produce 7-Beta (not used in the is study). L-Asn-~NCI4 and L-Asp-~NCI4 were
coupled to the remaining batches to form 8-Beta (linear iturin A) and 8-Betac (linear iturin C)
respectively.
2.3.2.2 Removal of completed peptides from the resin
The resin was washed after the final coupling reaction and DMF, t-amyl alcohol, acetic acid,
and again with t-amyl alcohol, and finally with peroxide free diethyl ether before being dried
under vacuum. The peptides were cleaved from the resin by treating the resin for three hours
with six bed-volumes 95% TFA and 5% phenol as scavenger [17]. After cleavage, the resin
was removed by filtration and washed with one bed-volume 95 % TFA, two bed-volumes
methanol and the mixture evaporated under vacuum using a Buchi Rotavapor at 45°C. The
resin was then washed with four-bed volumes 50% acetonitrile/water that was added to the
oily residue obtained with the first evaporation. The acetonitrile was evaporated as above and
the peptide re-suspended in 50% acetonitrile and lyophilised.
2.3.2.3 Cyclisation of the peptides (adapted from [17])
Cyclisation using PyBOp®: The linear analogue (8-Betac) was either dissolved in DMF (15
umole in 3 ml) and diluted ten fold in DCM or dissolved in DCM (30 mL) and then titrated
with DMF to a clear solution. The peptide solution was then cooled to O°C in an ice bath
before PyBop®, HOBt (30 umole each) and DIPEA (60 umole) in 0.5mL DCM was added
while stirring. The reaction mixture was stirred at room temperature (~ 23°C) for three days
',
before a sample was taken and additional PyBOp® was added. This mixture was left to react
for a further seven days at room temperature while continuously stirred. The reaction mixture
Il
was dried under N2 stream before being dissolved in minimal volume 50% ACN/water and
lyophilised.
Cyclisation using DIPCDI: As previous attempts at cyclisation usmg PyBOP were
unsuccessful, the activated anhydride approach was investigated. A small quantity of 8-Betac
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2-16
(1.5 IlM) was dissolved in DCM (4 mL) and titrated with DMF until clear. The coupling
reagent 263 ul, (1.2 times molar excess) was dissolved in 4 mL DCM. The peptide solution
was added drop wise to the DIPCDI solution over a period of 60 minutes, while stirring over
ice. The mixture was left to react at room temperature for three days. The reaction was
quenched by adding 2 times molar excess glacial acetic acid (192.6 ul.) to the reaction
mixture 30 minutes before removing the excess solvent under N2 stream. The resultant residue
was stored at -20°C before HPLC purification.
2.3.3 Purification of the lipopeptides
2.3.3.1 Purification through self assembly (adapted from [58])
The lipopeptides were dissolved in minimum volume of 50% ACN/water and left to self-
assemble (self-associate/aggregate) for seven days. The pellet and supernatant was separated
through centrifugation and the pellet dissolved in 50% ACN/water and lyophilised.
2.3.3.2 High Performance liquid chromatography (HPLC)
The synthesised peptides were purified after self-assembly by semi-preparative HPLC [17].
The lyophilised pellets containing peptide were dissolved (1.5 mg/mL) in 50% ACN/water
and centrifuged for 10 minutes at 1000 g to remove any particulate. The peptide solution was
subsequently purified on a CIS Polygosil column (irregular particle size, 60 °A pore size, 25
mm X 10 mm). The chromatographic system comprised of two Waters 510 pumps, Waters
Model440 detector and a WISP 712 auto-sampler. The system was regulated by a MAXIMA
software control system. A linear gradient at a flow rate of 3 mL/min was generated over 13
minutes from 70% eluant A (0.1% TFA in water) to 100% eluant B (10% eluant A and 90%
ACN). The separation was monitored at 254 nm. Samples were lyophilised before further
analyses were performed.
2.3.4 Analyses of peptides
2.3.4.1 Analytical HPLC
All peptides were analysed for purity on a CIS Nova-Pak® column (5 micron particle size, 60
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°A pore size, 150 mm X 3.9 mm) using the same solvents and gradient program as for the
semi-preparative HPLC, except that the flow rate was 1.0 mL/minute (Table 2.2).
2.3.4.2 Electrospray mass spectrometry
A Waters Q-TOF Ultima mass spectrometer, fitted with electrospray ionisation sources, was
used for ESMS analyses of sample. Sample analyses and collisionally induced dissociation
(CID) were performed in positive mode.
All the samples were prepared in 50% acetonitrile/water at 2 mg/mL (or 20 !-lM). Samples
were dissolved immediately before analysis and 10 ul. injected into the ESMS through a
Rheodyne injector valve at 50 !-lLianalysis with 50% acetonitrile as carrier solvent. A
capillary voltage of 3.2 kV was applied with ionisation source temperature at 80°C. The cone
voltage for the analyses was set at 40 or 60V. Data was collected in continuum mode through
m/z = 100-2000 with a scan time of Is and inter-scan time of O.1s in the Waters Q-TOF
Ultima mass spectrometer. Combining the scans across the elution peak and subtracting the
background produced representative scans.
Collisionally induced dissociation was performed on the Q-TOF Ultima mass spectrometer
with a collision gas pressure of 11 psi argon gas in the fragmentation cell with collision
energy of 35 eV. Data acquisition was in the positive mode through the m/z = 200 -1400 at a
scan time of 1s and inter-scan time of 0.1s with. The sum of an average of 150 scans was used
to compile the mass spectra.
2.4 Results and Discussion
2.4.1 Analyses of commercially obtained peptides
2.4.1.1 Gramicidin S
Analytical HPLC was performed on the gramicidin S from Sigma to ascertain purity. The
sample used throughout this study was found to be >99% pure. A single 254 nm absorbing
fraction in the gramicidin S preparation eluted at 13:30 minutes as shown in Figure 2.
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Figure 2 Analytical HPLC chromatogram of gramicidin S using a Nova-Pak CIS column.
A linear gradient generated over 13 minutes with eluant A 0.1% TFA in water
and eluant B 10% eluant A and 90% ACN. The fraction eluting at Rt = 13:30
minutes was evaluated with ESMS.
ESMS analysis of the gramicidin S (Figure 3A) also showed that the peptide is of high purity.
Singly (m/z = 1141.24, expected m/z = 1141.70) and doubly charged molecular ions were
detected with m/z of 570.72 (expected m/z = 571.35). Expected m/z-values for all the peptides
were calculated from the mono-isotopic mass of the constituent amino acid residues [59]. In
addition, two isotope species were also detected at 1142.28 and 1143.36, with a doubly
charged isotopes at m/z = 572.16. Three other species were detected with m/z of 1183.38,
1155.40, and 1127.38. The specie with m/z of 1183.38 corresponds to an acetonitrile adduct
of gramicidin S and the other two signals to Mr (gramicidin S) ±14. These may be unknown
contaminants or may correspond to Leu5/LeulO mutated to either Val (m/z = 1127.38;
expected m/z = 1127.44) or Valj/Valj mutated to Leu (m/z = 1155.40; expected m/z =
1155.49), although no mutations on the gramicidin S structure have been reported. A trace
signal was also detected at m/z = 881.34, which is the b8 fragment ion of gramicidin S.
Tandem mass spectrometry (MS/MS) was performed (Figure 3B) on the molecular ion with
m/z = 1141.2. Fragment assignment was done according to the nomenclature devised by
Roepstorff and Fohlman [37] and revised by Biemann [38]. The major fragments detected
were species with m/z-values of 881.58 (bs), 831.49 (Y7), 666.84 (Y6), 571.34 ([M+2H]2+ or
b-), 457.28 (b9/Ys) and 311.20 (b3). In addition a series of isotope signals (marked with *,
Figure 3B) were detected with m/z-values of 1027.64, 1028.65, and 1029.66. These species
could not be assigned to fragments generated with ring opening at Pro residue. However,
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this series of species do correspond to the molecular ion with either of the Om residues
excised (see Addendum A for fragment analysis).
2.4.1.2 Surfactin
Analytical HPLC of surf actin supplied by Sigma (Figure 4) showed that at least three
.-
peptides were present in the commercially product (Fraction I-III). The fractions were
distributed as follows: I = 19.4%, II = 45.7% and III = 31.7%. Closer inspection of the
chromatogram showed that fraction II consisted of two fractions with the minor fraction
comprising 2.2% of the total.
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ESMS and CID spectra of gramicidin S. Positive mode ESMS spectrum (A)
isotope variations are indicated by il, i2 and i3 corresponding to m/z ratio's with
1 amu higher than the Mr calculated from mono-isotopic residue mass. Spectrum
B shows the results of CID of the molecular ion with m/z =1141.24, which
rendered fragments previously reported in literature. The unknown fragments
are denoted with "*". (Also see Addendum A)
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Figure 4 Analytical HPLC chromatogram of surfactin (Sigma). The same analysis
conditions were used as for gramicidin S (Figure 3).
ESMS of this surfactin sample revealed the molecular species corresponding to the m/z ratio
of five known forms of surfactin (m/z = 994.92, calculated m/z = 994.85; 1008.91, calculated
1008.80; 1022.90, calculated 1022.83; 1036.94; calculated 1036.85), as well as the Ca2+
adduct of the molecular ion with m/z = 1022.83 (m/z =1062.72) (Figure 5A). The limited
amount of this specific batch of surfactin did not allow for the separation of sufficient
amounts of surf actin to identify each in the three HPLC fractions (Figure 4). However,
fragmentation analyses showed that surfactin variants with C13-CIS fatty acids were present
(see below). As a CI8 reverse phase purification system was used, it is conceivable that the
surfactins were partitioned according to fatty acid chain length. ;Since the peptides elute in
increasing order of hydrophobicity, it is likely that fraction I (Rt = 9:46 min) contains
surfactin variants with fatty chain length C13, fraction II (Rt = 10:36 min) the CI4 variants, and
fraction III (Rt = 11:07 min) the CIS variants. A similar pattern was observed for iturin A (see
below). Interestingly, the surfactins eluted later than the iturin variants, with the possible C13
fraction eluting at the same time as the iturin CIS fraction. This indicated that, in this case,
hydrophobicity might not be the sole determining factor in retention time with our solvent
system containing TFA as modifying agent.
The molecular ions present that corresponds to known surf actin variants were analysed with
MS/MS (Figure 5B) and the results obtained for the molecular ion with m/z = 1022.90,
corresponded to previously obtained results for this surfactin variant [60, 61]. The major
fragments detected that corresponded to published results were m/z = 685.19 (Y6), 442.09
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(Y4 or b6/Y6), 335.9 (b2) and 228 (al) (see addendum B for explanation of fragmentation
pattern). From the fragmentation data, the composition of this specie was calculated as
Leu/Ile-, Cwsurfactin. The other variants identified were AI~, Cwsurfactin (m/z = 994.92),
Leu/Ile7, Cu-surfactin (m/z =994.92); Val- Cu-surfactin (m/z = 1008.91), Leu/Ile-, Cn-
surfactin, (m/z = 1008.91); Leullle, Cu-surfactin (m/z = 1022.90); Leu/Ile7,Cwsurfactin (m/z
= 1036.90) (see Addendum B for fragment assignment and analysis).
2.4.1.3 Iturin A
HPLC of the commercially obtained extract of iturin A revealed six 254 nm absorbing
fractions (Figure 6). Two major fractions, Fraction I and II eluted at 9: 18 minutes and 9:48
minutes, followed by two minor fractions (Fraction III and IV) at 10:30 minutes and 11:12
minutes. Two more minor fractions, which eluted between 12 and 13 minutes, were not
further analysed. Analysis of the eluate revealed that fraction II may consist of two or more
compounds that co-eluted. Fractions I-IV were collected and subjected to ESMS- TOF
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ESMS and CID spectra of spectra of surfactin. The positive mode ESMS
spectrum (A) shows the three variants with m/z = 994.92, 1008.91, and 1022.90
denoted as MI-4 with isotope variations denoted by i. The CID spectrum of
surfactin with m/z = 1022.90, generated with tandem mass spectrometry, is
given in (B) (also see Addendum B)
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MS/MS for identification. The distribution of the iturin fractions were as follows: I = 51.1%,
II = 31.1 %, III = 6.4% and IV = 5.0%.
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Analytical HPLC chromatogram of iturin A from Sigma. Analyses conditions as
for surfactin were used for gramicidin S (Figure 2).
The ESMS analysis of the iturin A sample showed the mixture contained singly charged
compounds with m/z-values of 1043.75,1057.76,1071.71, as well as a molecular ion with m/z
of 1079.71 that corresponds to the sodium adduct of 1057.75 (Figure 7A). In addition, doubly
charged molecular ions were detected for aforementioned species with m/z-values of 523.4,
535.01, 541.99 and trace amounts of a specie with mlz = 572.08, which is possibly y"5+Na-
H. The iturin A variants separated with HPLC as follows: fraction I contained the molecular
ion with m/z of 1043.75, corresponding to iturin A2, fraction II the molecular ion with m/z of
1057.32 corresponding to iturin A with a C IS ~-amino fatty acid residue, fraction III the
molecular ion with m/z =1071.32 corresponding to iturin AL with a CI6 ~-amino fatty acid
residue and fraction IV the molecular ion with m/z of 1085.41, which was attributed to the
related peptide mycosubtilin [42, 62].
Fraction I was subjected to TOF-MS/MS and the fragmentation products detected of the
molecular ion with m/z =1043.32 corresponded to previously published results obtained for
iturin A2 [63]. The major fragments detected (Figure 7B) corresponded to published results
[63] and have m/z values of 832.38 (Y6), 801.33 (b6), 638.09 (bs), 523.6 (b4), 407.72 (Y3), and
229.54 (b3) (see Addendum C for fragment assignment and full fragment analysis). The other
fractions were not fragmented as the differences correspond to variation in the fatty acid
moiety. It must be noted that fraction IV were only present in trace amounts and were not
further analysed.
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Figure 7 ESMS and CID spectra of iturin A. The ESMS spectrum (A) shows the three
iturin A variants, iturin A2, iturin A CIS and iturin AL denoted as M 1-3. The CID
spectrum of iturin A2 (m/z = 1043.75) generated with tandem mass spectrometry
is given in (B) (also see Addendum C).
2.4.2 Preparation of two synthetic linear iturin analogues
Iturin C was not commercially available, therefore it was necessary to synthesise this peptide.
However, as the cyclic iturin C2 is synthesised from a linear intermediate (8-Betac), the
syntheses presented the opportunity to investigate the structural properties required for
peptide-peptide interaction with the intermediate. Iturin A was commercially available, so we
only synthesised the iturin A2 linear analogue, 8-Beta. Previously, it was shown that 8-Beta
shares a number of functional characteristics with iturin A2, su~h as preferential binding to
sodium and aggregation [12,17]. Furthermore, it was shown through molecular modelling
techniques that the 8-Beta retains at least one of the p-turns present in the peptide backbone
structure [17].
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2.4.2.1 Synthesis of t-BOC-~NC14
The HCI salt of the ~-aminotetradecanoic acid used in this study was not protected at either
the carboxylic acid or at the ~-amino group. In addition, the ~-NCI4 was a racemic mixture
and would therefore result in an optically impure synthesis product (see later on). Protection
of this residue was imperative to limit polymerisation during the synthesis. Previous reports
[17] indicated that N-terminal protection of this residue is 1) extremely difficult and 2) the
resultant product has a very low solubility in DMF and it would difficult to attain the required
molar excess. Therefore, the amino terminus was protected with a tBOC group. Synthesises of
the t-BOC-~-NCI4 moiety of the lipopeptides were evaluated with thin layer chromatography.
A single spot (R, = 0.7) for the product was detected with 2' ,7'-dichlorofluoroscein reagent
and no visible BOC-ON or ~-NCI4 contamination was detected. The product showed a
negative Kaiser test and a melting point of 56-58°C (56-58°C expected, [17, 55]). Both the
quality control results correlated to previous reports [17, 55].
2.4.2.2 Peptide syntheses
A benefit of using the Fmoc-based peptide synthesis protocol is that the synthesis can be
spectrophotometrically followed because of the inherent UV-absobtion of the Fmoc group.
We monitored the removal of the Fmoc group throughout the syntheses in order to attain the
coupling efficiency. The average coupling efficiency of 97.4±3.8% was acceptable. However,
analysing the coupling efficiency of each residue revealed the problematic couplings occurred
with the some of the acid amide residues (Figure 8). The substantial decrease in the detected
Fmoc fulvene, from that of Ser Asn, was expected, as a substantial amount of resin was lost
because of solid support fining and difficulties experienced with the transfer of the resin from
the reaction vial to the sintered funnel. After the initial loss, the absorption values remained
within the expected 10% error margin of the analysis for the coupling of ASfi4,Pr06, and ASn7.
The Tyr, value was too high, but still within the 10% analytical error of the Fmoc-analysis.
However, the values observed for GIns and ASP2were marginally below the 10% margin at
87% each with Asn2 at 88%. This indicated that incomplete coupling might have occurred at
those points. The synthesis resulted in crude mass yields of 120% for both 8-Beta and 8-Betac
indicating that a substantial amount of scavengers/side protection groups were present.
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2.4.2.3 Purification of peptides
Naidoo [58] successfully purified a bola-amphiphilic compound (i.e. a molecule with two
hydrophilic moieties connected by a hydrophobic linker) from crude product mixtures by self-
assembly to form large insoluble complexes. The same procedure was followed for the crude
lipopeptide preparations, because of their known aggregation character [17]. The HPLC
analysis of the supernatants and pellets showed that several contaminants were removed for
both the crude lipopeptide mixtures (Figure 9A and 9B). The peptide fractions with Rt
=9:39/9.45 minutes for 8-Beta and 9:33/9.38 minutes for 8-Beta,; were found, as expected, in
the pellet.
Figure 8
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Absorption values detected from deblocking reactions during the synthesis of 8-
Beta, (Asp as final amino acid with Fmoc group) and 8-Beta (Asn as terminal
amino acid with Fmoc group).
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Chromatograms recorded with a Waters analytical Cl8 HPLC column of the
supernatant and pellet of 8-Beta (A) and 8-Betac (B) after self-assembly
The mass spectra of the purified fractions (Figure lOA and B) showed molecular ions with
m/z values of 1062.08 and 1061.02, corresponding to 8-Betac and 8-Beta respectively. In
addition to the molecular ions, sodiated peptides (m/z = 1085.08 and 1084.02) and the
dehydrated peptides, 1045.07/1043.53 were also detected. Trace amount of tritylated peptide
(m/z = 1304.65 and 1303.65) as well as free trityl (mlz = 243.1) were detected. Furthermore,
the spectrum (Figure lOA and B; and the CID spectrum (see later on Figure 16A and Band
Addendum D) indicated that peptides with the correct amino acid sequence were synthesised.
Therefore, the principles of SPPS were successfully applied.
The expected peptide fragments were detected with m/z 317.35 (y"3 calculated m/z = 317.3)
and m/z = 746.82/745.76 (be+H) for both peptides (former m/z value corresponds to 8-Beta
and latter to 8-Betac, the same sequence is maintained for the rest of this discussion). In
addition, fragments were detected that did not form under the crp conditions used (see later
on Addendum D). The fragments were attributed to: a hydrated a7+H fragment m/z
949.16/948.02 (calculated at m/z = 948.97 and 947.97); b7+H fragment with m/z of
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820.98/ 819.84 (calculated at m/z = 820.98 and 819.68); and a7-CO+H fragment with m/z of
899.94/998.90 (calculated at m/z = 900.2 and 899.2). In addition to the native peptide
fragments, a sodiated peptide fragment, b7+Na-CO-17, was also detected with m/z of
934.95/933.68 (calculated at 934.97and 933.97). All the fragments detected correlated with
previously obtained results [13, 17]
Self-assembly process resulted in concentrating low molecular weight species and the
tritylated peptides (m/z = 1305.35 for 8-Betac and 1304.36 for 8-Beta), in the supernatant as
the Trt signal intensity (m/z = 243.3 increased in supernatant spectra (results not shown). As
sufficient time was allowed for deprotection and liberation of the peptides, this is likely the
result of the trityl group re-attaching to an Asn. The reattachment of Trt to Cys has been
documented and it is possible that a similar reaction might have occurred [64].
The mass spectra show that this method is a feasible method of purification given that
sufficient difference in self-assembly character exists between the compound of interest and
the contaminants.
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ESMS spectra of the 8-Betac pellet (A), and the 8-Beta pellet (B). The fragments
are identified according to the nomenclature devised by Roepstorff and Fohlman
as revised by Biemann [37, 38].
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The self-assembled products of 8-Beta and 8-Betélcwere further purified by semi-preparative
HPLC. Two fractions (Fraction I and II) were collected during purification (Figure 11Aand
B) of each of the linear analogues. The first two fractions eluted at Rt = 8:48 and 9:21 for 8-
Beta, and 8:36 and 9:19 for 8-Beta. It is interesting to note that the 8-Betélc fractions had
longer retention times than the 8-Beta fractions even though 8-Betélc is more polar than 8-
Beta. The longer retention time of 8-Betélc relative to 8-Beta seemed anomalous to the
arnphipatic character. Increased solvent interaction, as apposed to hydrophobic interaction,
was expected resulting in a shorter rather than longer retention time. However, because TFA
is added as modifying agent in the solvents, the mode of separation may also depend on ion-
paring interactions.
The last fraction collected contained a fraction with strong UV absorbance at 254 nm that did
not correlate to the small amount of dry mass collected. It is likely, that this fraction comprised
of cleavage by-products. The final yield of 8-Betac, as determined by mass, from semi-
preparative HPLC was 34% for fraction I, 22% for fraction II and 30% for the rest of the
absorbing fractions collected, giving a final yield of 56% for purified 8-Betac. Purification of
8-Beta yielded 30% for fraction I, 20% for fraction II and 30% for the rest of the collected
absorbing fractions, giving a final yield of 50% of purified 8-Beta.
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Figure 11 Semi-preparative HPLC purification of 8-Betac (A) and 8-Beta (B) from
synthesis pellets. A CIS Polygosil column (irregular particle size, 60 °A pore
size, 25 mm X 10 mm) was used with a linear gradient over 13 minutes from
30% eluant A (0.1% TFA in water) to 100% eluant B (10% eluant A and 90%
ACN). All the eluting fractions other than Fractions I and II were combined as
fraction III.
ESMS analysis indicated (Figure l2A and B) successful purifications of 8-Betac and 8-Beta
from the synthesis products. Fraction Icollected during HPLC purification of 8-Betac showed
in addition to the singly charged molecular ion of 8-Betac (m/z of 1062.52 with isotope signals
at 1063.53 and 1064.53), the presence of both the singly charged (m/z of 1085.52) and doubly
charged (m/z of 542.76) ions of the sodiated peptide. The expected fragmentation products
(Y"3+H; m/z =318.00, bs; m/z = 746.82; denoted F in Figure l2B) (see Addendum D for
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i1
[M+Hr
1062.52
fragment analysis) were also present. ESMS analysis showed that fraction II also contained a
molecular ion with the correct m/z ratio of the synthesis product (result not shown). This is
consistent with the racemic products obtained from the use ofthe racemic ~NC14 moiety [17].
In addition to the synthesis product, fraction II collected during 8-Beta purification also
contained trace amounts of tritylated peptide as well as trityl.
Figure 12 ESMS- TOF spectra of fractions I collected during the purification of 8-Betac
(A) and 8-Beta (B). The peptide backbone fragments are denoted F and isotopes
as il-3
2.4.2.4 Analysis of the purified linear iturin analogues
Analytical HPLC of the linear analogues showed that the two purified synthetic peptides were
of high purity, but of racemic nature. The purity was calculated from the HPLC profile at 254
':
nm as 92.6% for S-Beta, (8-Betac I accounting for 41.6% and 8-Betac II for 51%) and 95.5%
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for 8-Beta (8-Beta I accounting for 42.5% and 8-Beta II for 53% of the sample.
HPLC retention times were comparable to previously obtained results (Figure 13A and B)
[17]. The retention times for 8-Beta enantiomers were 8:42 min and 8:52 min respectively
(Figure 13B) (viz. 8:52 min and 9:02 min as found by Rautenbach [17]). As this is, to the best
of our knowledge, the first synthesis of 8-Betac, as no reference could be found for
comparison. However, given the similarities between the peptides, as well as the use of a
racemic P-NCI4 mixture, results comparable to 8-Beta were expected. The results (Figure
13B) show that the two peptides eluted at 8:48 min and 8:57 min respectively. The peptides
were collected and subjected to ESMS and both fractions rendered molecular ions with an
m/z-value of 1062.36, which support the assumption the two fractions are S-Beta,
enantiomers.
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Figure 13 Analytical HPLC chromatograms of 8-Betac (A) and 8-Beta (B) using a Nova-
Pak CI8 column. A linear gradient generated over 13 minutes with eluant A
0.1% TFA in water and eluant B 10% eluant A and 90% ACN. The enantiomers
are labelled I and II as used by Rautenbach [17]
The integrity fidelity of the intended synthesis products was determined with TOF-MS/MS.
Although no reference to the linear analogue of iturin C could be found in literature, its
identification was done by comparing the fragmentation spectrum of the analogue (Figure
I4A) with 8-Beta donated by M. Rautenbach. Similarly, the synthesised 8-Beta (Figure I4B)
was compared to the donated peptide. The fragmentation spectrum of 8-Beta in this synthesis
showed identical fragments to that of the previously characterised 8-Beta (results not shown).
We found the expected major fragments with m/z-values of 747.00 (be+H), 712.98 (bs+H-34),
636.07 (b4+H20), 389.99 (bsY6) 317.99 (Y3"), 278.96 (b4Y6lb3Y7)(Figure I4A and B,
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Addendum D). The N-terminal fragments of 8-Betac were detected at 1 amu higher than the 8-
Beta fragments, which is consistent with the Asn, to Asp, mutation.
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Figure 14 CID mass spectra of 8-Betélc(A) and 8-Beta (B). The product ions observed for
8-Beta correlates with previously published results [13, 17]. The product ion
identified as b4/Y6 may also be b3/Y7. The ion with m/z of 694.99 may be a bs-
2NH3-OH fragment.
2.4.3 Preliminary studies into the preparation of iturin C
The cyclisation methods used in this study were previously employed in the synthesis of iturin
A2, which yielded 48% cyclisation efficiency, with approximately a 50:50 distribution of the
two enantiomers [17]. The procedure, using PyBOP as activation agent, was utilised in the
cyclisation of 8-Betélc. Unfortunately, the same decree of success was not achieved with this
cyclisation. Initially, no cyclisation occurred when the' peptide was dissolved in DMF before
being diluted in DCM. This result is consistent with other reports [17,24] and is related to the
conformation of the peptide backbone and/or backbone solvation in this solvent.
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A subsequent attempt at cyclisation was performed ~d the cyclisation product (m/z = 1042.7)
was detected after three days, with ESMS in the negative mode (Figure J5A). In addition to
the cyclic peptide, the linear analogue (m/z = 1060.55) and a peptide dimer (m/z = 1051.82)
were also detected. Because linear peptide remained in the reaction, the reaction was allowed
to proceed for a further seven days. The similarities in hydrophobicity of the resultant two
cyclic peptides and the linear analogues would have resulted in a difficult separation.
Therefore, an extended reaction time was allowed in an attempt to obtain a reaction mixture
that contains either cyclic product or dimer/polymers to facilitate purification. Analysis of the
reaction mixture after 10 days showed that trace amounts of the linear analogue and the cyclic
product were still present, but that the dominant dimer signal was replaced by a ion at m/z =
1012.28 (Figure J5B), indicating polymerisation. Neither the cyclic product, nor the polymers
could be detected with negative mode ESMS, and the spectrum were recorded in the positive
mode. Similar results were obtained with DIPCDI as activation agent. Due to the complexity
of this synthesis (see conclusions below), as well as financial and time constrictions, we
decided to pursue the synthesis of iturin C in a future investigation.
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2.5 Conclusions
Although the commercially obtained peptides were bought from reputable companies, the
analysis shows that considerable variation exists from supplier to supplier and also between
batches obtained from the same supplier (i.e. surfactin obtained from Sigma at different times
differed in the number of surfactin variants present (data not shown as the latter was not used
in this study). It is therefore important to ascertain the compositio~ of the product before use -
especially if analytical studies are planned. The commercial surf actin were determined as
99.6% pure using HPLC, which met the manufacturers specificat~on of >98% and the sample
was found to be of high enough purity for use is our investigation. The iturin sample however,
contained only 89% iturin A according to our HPLC analysis, whereas the supplier indicated
Figure 17
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Mass spectrum of the reaction mixture using PyBOp® after three days (A) and
10 days. The spectrum after three days were recorded in the negative mode and
shows 8-Betac ([M-Hn, a dimmer (jdimmer]"), and iturin C2 ([iturin C2]-. The
spectrum after 10 days was recorded in the positive mode.
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that the sample is approximately 97% pure. Fraction IV (refer to Figure 6) comprised 4.9% of
the sample and an MS analysis showed that component of this fraction is likely to be
mycosubtilin.
Successful syntheses and purification of both 8-Betac and 8-Beta were accomplished. The
majority of the contaminants in the crude peptide mixtures could easily be removed from the
synthesis mixture by using a novel purification via self-assembly/aggregation. The remainder
of the contaminants were successfully removed from both the peptide preparations with
preparative HPLC. The final HPLC analyses showed that both the peptides were indeed of
high purity with >92% purity for 8-Betac and >95% for 8-Beta.
The low peptide yields can be attributed, in part, to the mass of the synthesis contaminants in
the crude mass, as well as to peptide lost the incomplete deprotection of the tritylated acid
amide. It is known that the deprotection Trt protected N-terminal Asn proceeds very slowly
and therefore four hours of cleavage is recommended [18]. Since the Asn residues are not
terminal residues, therefore the three hours allowed for cleavage and deprotection should have
been sufficient. Therefore, it appears that the trityl group reattached to the peptides [64]. In
addition, losses in peptide material could be due to peptides sticking to plastic-ware used in
preparation. Rautenbach [17] previously found that up to 30% loss could occur due to this
problem. Peptides were centrifuged in Eppendorf tubes to remove undissolved particulate
before HPLC purification.
The problems experienced with the cyclisation of 8-Betac to form iturin C illustrates the need
for the development of a different cyclisation strategy, other than the one successfully
employed during the synthesis of iturin A2 by Rautenbach [17]. The low level of cyclisation,
regardless of the reagents used, indicated that cyclisation in this instance is not only a function
of solvent and reagents, but may also be greatly influenced by peptide conformation. Our
results illustrated that a one-size-fits-all approach is not always effective, even when working
with related peptides, and that the strategy should be tailor-made for each peptide. The only
difference between iturin C and iturin A is the Asn to Asp mutation at position two. It is
conceivable that the charge repulsion, due to the ~-carboxyl group of the Asp in the
unprotected peptide leads, to either low concentration of activated precursor or a sterically
unfavourable conformation for peptide bond formation. Given the high degree of
polymerisation it appears that sufficient activation, possibly of both the u- and ~-carboxyl
groups, was achieved and that the latter scenario seems the more likely. However, the use of
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an unprotected precursor did add a complicating factor to the synthesis of the cyclic peptide.
As most activating agents cannot discriminate between the a-carboxyl group of the terminal
Ser residue and the ~-carboxyl group of the Asp residue, accessibility of this side-chain
introduced another site for polymerisation. Clearly, a different approach to the synthesis of
this peptide is required. A more suitable approach may be the synthesis and use of a protected
precursor or a solid support strategy. Both approaches would require unique and expensive
solid phase peptide synthesis resins. Alternatively a linear analogue with Pro residue as C-
terminal residue can be employed (this would limit racemisation [23] and shift the Asp
residue to the centre of the molecule).
The research that is reported in the following chapters depended on high purity peptides. This
is especially true for mass spectrometric analyses (Chapters 5 and 6), which requires not only
high purity but also peptides of known composition. To this end, the composition of the
commercial peptides was conclusively established. Some difficulties were experienced in the
synthesis of the linear analogues, but final analysis showed that the synthetic peptides were of
suitable purity for use in this investigation.
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Addendum A
M/z observed Proposed fragment Calculate rnlz Sequence
1141.4 M+H 1141.46 PVOLFPVOLF
881.58 bg 881.13 PVOLFPVO
831.49 Y7 831.06 LFPVOLP
813.50 YrH20 813.06 LFPVOLP
718.45 Y6 717.90 FPVOLF
684.45 b6+17 684.84 PVOLFP
666.44 b9/yg-17 666.89 LFPVOL
571.34 bs 570.73 PVOLF
457.28 Y3-17 456.61 VOLP
429.29 Y3-CO-17 428.61 VOLP
311.2 b3+H 311.39 PVO
261.17 Y2+H 261.33 FP
197.16 b2+H 197.25 PV
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AddendumB
Mlz observed Proposed fragment Calculate mJz Sequence
1022.93 M+ 1022.33 P-OHCI4ELLVDLL
686.08' Y6+H20 684.85 LLVDLL
583.14 ~+H 582.78 P-OHCI4ELL
470.13 X4+H 469.63 VDLL
452.13 b3-17 452.63 P-OHCI4EL
442.092 Y4+Hor b6/Y6 441.54 VDLL
361.07 Y3+H20 359.40 DLL
339.08 b2-17 339.46 P-OHC'4E
329.05J b6ys 328.34 LVD
246.03 b,+H2O 246.35 P-OHC'4
228.014 b, 228.35 P-OHC'4
'Pragmentation of m/z =994 resulted in three product ions with m/z = 686.08, 672.1 and
658.09 coresponding to [Leu/Ile-] surfactin, [Val-jsufactin and [Alaajsurfactin
respectively. Collisionaly induced dissociation of m/z = 1008 rendered product ions
with m/z = 686.09 and 672.09 corresponding to [Leu/Ile-jsurfactin, [Val-jsufactin
repsectively. Surfatin with m/z = 1022 and 1036 rendered only this specific product ion.
2Pragmentation of m/z =994 resulted in three product ions with m/z = 442.10, 428.08
and 414.10 coresponding to [Leu/Ile-] surfactin, [Vah] sufactin and [AI~] surf actin.
Collisionaly induced dissociation of m/z = 1008 rendered product ions with m/z = 442.1
and 428.09 corresponding to [Leu/Ile-] surf actin, [Val-jsufactin repsectively .Surfatin
with mJz = 1022 and 1036 rendered only this specific product ion.
3pragmentation of m/z =994 resulted in two product ions with m/z = 329.05 and 311.06
coresponding to [Leu/Ile-jsurfactin or [Val-jsufactin and [Alaajsurfactin respectively.
4pragmentation of m/z =994 and mJz = 1008 resulted in three product ions with m/z =
211.30, 428.00 and 242.00 coresponding to surfactins with fatty chain length of Cl3 -
C15. Collisionaly induced dissociation of m/z = 1022 and 1036 rendered product ions
with rn/z = 428.00 and 442.00 corresponding to CI4[LeulIle7]surfactin and
CIS [Leu/Ile-] surf actin repsectively
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Addendum C
Mlz observed Proposed fragment Calculate m/z Sequence
1043.37 M+H 1043.2 PNSpNCwNYNQ
1026.35 M-17 1026.2 PNSpNCwNYNQ
1009.33 M-2X17 1010.04 PNSpNCwNYNQ
932.38 b7 +17 931.91 PNSpNCl4NYN
801.33 b6 800.81 PNSpNCl4NY
638.09 bs 637.74 PNSpNCl4N
621.02 bs-17 620.74 PNSpNCl4N
506.49 b4-17 506.64 PNSpNCl4
407.72 Y3 406.29 YNQ
390.46 Y3-17 389.29 YNQ
296.40 b3 298.32 PNS
208.29 Y2-2X17 208.23 NQ
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AddendumD
Productions identified after CID of 8 Beta. The reference peptide 8 Beta II rendered the
same fragments. Al the fragments detected for 8Beta were detected for 8 Beta, at 1 amu
t th 8Btgrea er an ea.
M/z observed Proposed fragment Calculate rnIz Sequence
1061.78 M+H 1061.2 P-NCI4NYNQPNS
1044.79 M-H20 1044.2 P-NCI4NYNQPNS
746.01 bs+H 745.9 p-NCI4NYNQ
729.01 bs-17+H 728.9 p-NCI4NYNQ
712.00 b5-2 X 17+H 712.8 p-NCI4NYNQ
635.09 b4+H2O 634.8 P-NCI4NYN
618.07 b4+H 617.8 p-NCI4NYN
601.07 b4-17+H 600.8 P-NCI4NYN
573.09 b4-CO-17 573.8 P-NCI4NYN
562.97 bs-184+H 562.9 NYNQ
550.09 b4/Y6+CO+H 549.32 DYNQ
545.96 bs+OH-184+H 545.9 NYNQ
504.11 b3+H 503.7 P-NCI4NY
452.09 b4+17-184 451.8 NYN
435.00 b4-184+H 434.8 NYN
417.98 b4-17-184+H 417.8 NYN
389.99 bsY6-17+H 389.3 YNQ
324.08 b7Y4-NH3+H 324.3 QPN
320.98 b3-184+H 320.7 NY
318.00 Y3+17 317.28 PNS
300.98 Y3"-2X 17 300.28 PNS
278.96 b4Y6/b3Y7 278.28 YNINY
243.95 b6/Y3 244.24 QP
220.93 y2 220.2 NS
212.93 b7Y3 212.2 PN
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Chapter 3
Development of two novel antifungal testing methodologies
Abstract
A number of antimicrobial peptides with antifungal activity are produced by Bacillus strains,
for example, iturin A and surfactin by Bacillus subtilis. The well-known gramicidin S, a
cyclic decapeptide produced by Brevibacillus brevis, has a broad-spectrum antimicrobial and
cytotoxic activity, but the antifungal activity of this peptide on post-harvest pathogens of
stone fruit and grape has not yet been fully established. The aim in this study was to develop a
sensitive analytical assay to determine the effect of gramicidin S on a group of post harvest
pathogens using Penicillium cf. corylophilium as model organism. Since most agar-based
antifungal assays are qualitative with only limited sampling capacities, we developed assays
in 96-well microtiter plates, one broth assay for P. corylophilium and the other an adapted
agar-based assay. Our broth assay correlates light dispersion at 620 nm with fungal growth
and yields repeatable results within 24 hours. Since both the test organism and the peptide are
added in solution, many of the inadequacies of conventional agar-based radial diffusion
assays are eliminated. The agar-based assay is also performed in a microtiter plate and offers
a high sampling rate and a relatively short assay time of 16 hours.
3.1 Introduction
The discovery of antibiotics and antimicrobial peptides ushered m an era with vast
possibilities and new challenges. One of these challenges is to accurately assess the
antimicrobial potency of newly discovered and synthesised molecules. Gramicidin S was the
peptide of choice because of its broad-spectrum antimicrobial activity [1, 2]. Although
extensive research has been done on gramicidin S as biological control agent, no reference
could be found to the test organism Penicillium corylophilium or other plant pathogenic fungi.
This presented a unique opportunity, not only in terms of assay development, but also in
terms of establishing the inhibition parameters of gramicidin S on these types of
phytopathogens.
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Gramicidin S is a cyclic amphipatic decapeptide that consists of two pentapeptides, D-Phe-
Pro-Val-Om-Leu, linked between D-Phe and Leu [3]. It is active against gram-positive and
gram-negative bacteria, as well as exhibiting broad-spectrum antifungal activity. Association
of gramicidin S with cell membranes leads to the release of phospholipids, followed by a
disruption of the permeability barrier and cell lyses [3,4,5,6].
Because of their clinical importance, a great number of assays have been developed for
pathogenic bacteria and yeast and consequently guidelines were laid down for the selection of
clinical testing systems [7, 8]. The standardised testing systems include the agar radial
diffusion assay [9, 10, 11], broth macro- and microdilution assays [12, 13, 14] and the micro-
gel diffusion assay [15]. Unfortunately, one area of assay development has been lagging - the
assessment of antifungal activity of antimicrobial peptides on fungi that is not of clinical
importance. Even though these organisms do not directly influence human quality of life, they
do have serious implications for food production and preservation. The determination of
antifungal peptide activity is wrought with complications that include peptide inactivation by
agar [16], and oxygen diffusion through the growth medium [13]. We have developed a
standardised antifungal testing methodology with 1 j..lM, for the assessment of antifungal
activity of gramicidin S on fungi that approximates natural growth conditions. This assay was
standardised by comparison with an adapted methodology developed by Broekaert et a!. [13].
The assay was adapted to a relative growth system measuring inhibition in terms of total
fungal growth possible under assay conditions instead of biomass determinations.
Furthermore, this methodology allows peptide-membrane interaction in the aqueous phase
after which the growth medium is rapidly absorbed by the underlying agar. The assay is
performed in 96-well microtiter plates. The advantages of using a microtiter-based system are,
amongst others, an increased sampling rate and the small amounts of antibiotic used in the
assay. A previous study showed the relationship between light dispersion and fungal growth
as measured by biomass [13]. The use of biomass determinations, although highly accurate, is
cumbersome and time consuming. By using the aforementioned relationship, we have
developed an assay in terms of total growth possible under assay conditions, i.e. inhibition
values are expressed relative to reference growth (well with fungi without peptide). The
criteria set for these assays were 1) incubation time should not exceed 24 hours; 2) growth
during this period should allow for the needed sensitivity; and 3) as the peptides used are
active in micromolar concentrations, the assay must reflect activity in the same concentration
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range. The assay methodology presented here offer fast, analytical quantification of antifungal
activity with the added advantage of visualisation if required.
3.2 Materials
The Plant Pathology Department, University of Stellenbosch, Stellenbosch donated
Penicillium cf corylophilium. Gramicidin S was from Sigma (St Louis, USA). Casein was
supplied by BDH laboratory supplies (Poole, England). The microtiter plates (Nunc-
lmmuno™ Maxisorp) were from Nalge NUNC (Roskilde, Denmark) Dulbecco's phosphate
buffered saline (PBS) was prepared as previously described [17] from KCL, NaCI, KH2P04
and NA2HP04 which were supplied by Capital Enterprises (Hillcrest, RSA), Saarchem
(Midrand, RSA) and Merck (Midrand, RSA) respectively. Potato dextrose broth (PDB) was
from Difco Laboratories (Detroit, USA). Chemically pure agar was from Saarchem
(Krugersdorp, South Africa). Tween 80 was supplied by Fluka Chemie (GmbH). Analytical
quality water was prepared by passing water from a reverse osmoses plant through aMillipore
(Milford, USA) Milli Q® water purification system.
3.3 Methods
2.3.1 Growth and harvesting offungi
P. corylophilium was grown at 25°C on potato dextrose agar (PDA). Spores were harvested
from 14-day-old cultures with 10 ml sterile analytical water containing 10 ~LIL Tween 80
and filtered through a double layer of gauze before being diluted.
3.3.2 Microdilution broth antifungal assay
Microtiter plates were blocked with 0.5% casein in Dulbeco's PBS for 1 hour, sterilised, and
dried under UV-light for a further 4 hours. Normal procedures to ensure sterility were
followed during the rest of the assays. After counting, spores were diluted with PDB to final
spore concentrations of 60 X 103,45 X 103 and 30 X 103 spores/well. Of the suspensions, 80
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ul. were added to each well of the microtiter plates except for columns A and H, which were
reserved respectively as growth controls and sterility controls. The wells that served as growth
controls received 20 ul. analytical water and the remaining wells received 20 ul. of peptide
dissolved in analytical water. All wells contained a final volume of 100 ul.,No less than eight
determinations were done per concentration value. Test substances were added to the wells
before spore germination (approximately 4 hours after harvesting). All light dispersion
measurements were done at 620 nm with a Titertek Multiscan Plus Mk II (Flow
Laboratories). Measurements were taken at 3-hour intervals up to and including 24 hours.
3.3.3 Microagar antifungal assay
All equipment, media, and materials were treated as described above. The plates were
prepared as for the microdilution broth antifungal assay and 90 ul, of 1.5% sterile PDA added
to each well. Reverse pipetting was used to add the PDA at 70° C to the wells [15]. The plates
were subsequently dried under UV light for another 60 minutes. Spore suspensions (40 ilL)
were then added to the wells to a final spore concentration of 5000 spores/well in PDB.
Gramicidin S was added to the wells in 20 ul. volumes to yield a concentration range of 1.7-
21.8 11M.The final volume in each well was 150 ul., The plate layout was as described under
micro dilution broth assay. Light dispersion at 620 nm was determined at 2-hour intervals
starting at 15 hours and ending at 24 hours. Results were visualised by incubating the plate for
72 hours.
3.3.4 Data analysis
Relative growth in each well in the broth assay was calculated in terms of the light dispersion
per well divided by the mean light dispersion of the wells containing growth medium, spores,
and acetonitrile. Subtracting the relative growth calculated from 1 and multiplying the value
by 100 rendered percentage inhibition. The ICso was calculated from the x-value halfway
between the top and bottom plateau. Auto-initial values with no fixed constants, as well as
stricter criteria for convergence values, were used to determine the various slopes. Statistical
analyses of data also performed with GraphPad Prism included 95% confidence levels,
Students t-test, correlation coefficients, and the absolute sum of squares, and standard error
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J.!Lwere added to each well of the microtiter plates except for columns A and H, which were
reserved respectively as growth controls and sterility controls. The wells that served as growth
controls received 20 ul, analytical water and the remaining wells received 20 ul. of peptide
dissolved in analytical water. All wells contained a final volume of 100 J.!L.No less than eight
determinations were done per concentration value. Test substances were added to the wells
before spore germination (approximately 4 hours after harvesting). All light dispersion
measurements were done at 620 nm with a Titertek Multiscan Plus Mk II (Flow
Laboratories). Measurements were taken at 3-hour intervals up to and including 24 hours.
3.3.3 Microagar antifungal assay
All equipment, media, and materials were treated as described above. The plates were
prepared as for the microdilution broth antifungal assay and 90 ul, of 1.5% sterile PDA added
to each well. Reverse pipetting was used to add the PDA at 70° C to the wells [15]. The plates
were subsequently dried under UV light for another 60 minutes. Spore suspensions (40 ilL)
were then added to the wells to a final spore concentration of 5000 spores/well in PDB.
Gramicidin S was added to the wells in 20 ul. volumes to yield a concentration range of 1.7-
21.8 IlM. The final volume in each well was 150 J.!L.The plate layout was as described under
microdilution broth assay. Light dispersion at 620 nm was determined at 2-hour intervals
starting at 15 hours and ending at 24 hours. Results were visualised by incubating the plate for
72 hours.
3.3.4 Data analysis
Relative growth in each well in the broth assay was calculated in terms of the light dispersion
per well divided by the mean light dispersion of the wells containing growth medium, spores,
and acetonitrile. Subtracting the relative growth calculated from 1 and multiplying the value
by 100 rendered percentage inhibition. The ICso was calculated from the x-value halfway
between the top and bottom plateau. Auto-initial values with no fixed constants, as well as
stricter criteria for convergence values, were used to determine the various slopes. Statistical
analyses of data also performed with GraphPad Prism included 95% confidence levels,
Students t-test, correlation coefficients, and the absolute sum of squares, and standard error
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of the mean. Three-dimensional graphs were generated using GNU PLO T, MS-Windows
v3.7, 1999, Williams T, Kelley C
3.4 Results and discussion
The need for high throughput, but sensitive antifungal assays, prompted the development of
these methodologies. P. corylophilium was the organism of choice because of the ease with
which it is cultured. Since some fungi do not culture well in liquid medium, we anticipated
the need for an assay methodology that will allow quantitive evaluation of antimicrobial
agents on these organisms.
3.4.1 Microdilution broth antifungal assay
Microdilution broth assays for antimicrobial testing have extensively been discussed [9, 18,
14]. From these discussions it has been proposed that the Amsterdam method [9] should be
used as standard testing methodology. The ease of operation of the Broekaert methodology
however makes it a likely candidate for fungal susceptibility testing. Therefore, we decided to
adapt this methodology to be an even more user-friendly testing system and use it as a control
for our new testing method. Spore dilution experiments were performed to determine the
optimal spore concentration for P. corylophilium in the broth assay. The results indicate that,
for our purposes, a spore concentration of 45 X 103 spores/well yielded optimum results.
Spore concentrations of 60 X 103 spore/well resulted in rapid growth, but with a loss in
sensitivity. The assays with 30 X 103 spores/well on the other hand led to assay times beyond
24 hours - a time period which exceeds the time criterion (contamination problems during
long incubation periods) set at the onset of assay development (data not shown). Although
contamination was detected in some instances 2-3 days after the assay, no contamination was
detected during the assay period of between 0-24 hours.
Time course studies showed the sensitivity of the broth assay with respect to time and 0%
inhibition reference point. The lCmin, IC5o, and ICmax all increased with time (Figure 1; Table
l,p 3-12). However, after 24 hours these values remained more or less constant and
subsequent measurements showed a loss of sensitivity i.e. "0% inhibition " was obtained in
most wells (data not shown). The relationship between growth, peptide concentration, and
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3-6
time is illustrated by the 3-dimensional graph (Figure 1) with maximum growth at 24 hours as
reference point for 0% inhibition.
0.9 --= 0.8 -....
~ 0.7 -
0 0.6 -
lo. 0.5 -bJ)
QI 0.4j;>-.... 0.3....eo: 0.2-QI 0.1
~ 0
25
-0.5 0
0.5 1
log Gramicidin S (!-lM)
Time (hours)
Figure 1 Effect of assay time and peptide concentration with respect to fungal growth.
The time optimised broth assay rendered satisfactory results with gramicidin Sand P.
corylophilium as the organism. Highly repeatable sigmoidal dose-responses were obtained
with the microtiter plate antifungal assay. From these dose response curves the lCmin, ICso and
ICmax were determined at 2.81 IlM, 5.29 !-lM,and 10.96 IlM respectively (Figure 2, Table 1(p
3-12)). The statistical analyses of the non-linear analyses rendered r2 = 1 with the absolute
sum of squares = 0.000 41 and 95% confidence level for the ICso of 5.2-6.3 IlM.
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Figure 2 Log dose response curve obtained after 24 hours with the broth assay with a
minimum of four determinations per data point. Statistical analysis yielded r2 =
1.00 and absolute sum of squares = 0.000 416.
3.4.2 Microagar antifungal assay
Culture-plate based agar and agarose type assays are unsuitable for analytical evaluation of
antibiotics on these organisms, as these assays are at best subjective with the added
complication of peptide inactivation by the agar. We therefore developed the microtiter plate
antifungal agar assay to ensure peptide-membrane interaction in the solution phase with the
subsequent absorption of the solution phase into the solid phase. This allows for optimal
antifungal action, yet provides a solid support with an air interface that these fungi need for
successful culturing.
Standardisation of inhibition parameters is an important component in assay development and
it was therefore imperative that the inhibition parameters obtained with the two assays should
show a good correlation. As the agar assay allows peptide-membrane interaction in the
solution phase, the inhibition parameters obtained with this assay should theoretically be in
the same range as the microtiter broth antifungal assay, if the same spore count and peptide
concentration is used. Therefore, the same spore count of 45 X 103 spores/well was used and
3-7
Stellenbosch University http://scholar.sun.ac.za
gramicidin S added over the same concentration range.
The microagar antifungal assay also allowed for the spectrophotometric determination of
antifungal activity with agar solid support. Highly repeatable sigmoidal dose response curves
were obtained with this assay and the inhibition parameters for gramicidin S on P.
corylophilium were established as ICmin = 3.1 IlM, ICso = 4.3 IlM, and ICmax = 7.4 IlM (Figure
3; Table 1, p 3-12) after 16 hours. The statistical analyses of the non-linear analyses yielded r2
= 0.999 with the absolute sum of squares = 0.0004 and 95% confidence level for the ICso of
4.1-7.5 IlM. A picture of a plate after 72-hour incubation is shown in Figure 4.
As expected, the inhibition parameters obtained with the microagar antifungal assay did show
good correlation with the microtiter broth antifungal assay, although all the values were
slightly lower. The differences between the ICmin and ICso values differed with only 0.35 IlM
and 0.98 IlM respectively. However, the ICmax value showed considerable deviation from the
value obtained with the microtiter broth antifungal assay with a difference of 3.5 IlM. These
differences, especially the difference in ICmax, may be because the dilution effect of agar on
both gramicidin S and the spores are less than that in the broth assay.
100 •
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Figure 3
log [gramicidin SJ
Log dose response curves obtained with antifungal agar assay after 16 hours
with a minimum of four determinations per data point. Statistical analysis
rendered r2 = 0.999 and absolute sum of squares = 0.000 401
3-8
Stellenbosch University http://scholar.sun.ac.za
ICmin ICmax
Figure 4 Visualisation of the agar assay was done by incubating the microtiter plate for 72
hours. The dark wells show the fungal growth while the white or clear well show
the inhibition of the fungal growth.
Table 1 Summary of inhibition parameters against the test organisms
P. corylophilium (Broth
Assay, 24 h)
ICso
10.96±0.12.81±0.1 5.29±0.4
P. corylophilium (Agar
Assay,16) 3.16±07 4.31±0.1 7.46 ±1.3
3.5 Conclusions
The broth assay gave repeatable analytical results within analytical error limits being r2 Z
0.998 and p= 0.78. However, the following caveat must be kept in mind when using and
planning similar assays: this is a relative assay system and all values will be influenced by the
reference wells. The advantage of using a relative system as opposed to an absolute system- ~ ~
(i.e. using biomass determinations) is the ease of operation, the speed at which results can be
obtained and small volumes required. Furthermore, relative systems allow for compensation
with respect to solvent and environmental influence. In an absolute system, the rate of cell
growth can seriously influence the lCmin, ICso and ICmax values, which is not always the
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3-10
case with a relative system. The advantage of a two-phase system that approximates natural
.conditions can be seen in the radically reduced assay time of 16 hours. Therefore, this
methodology offers one day results. Furthermore, the inhibition parameters established may
pave the way for direct application of the B. brevis product.
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Chapter 4
Biological activity studies on the effect of surf actin on the
antimicrobial activity of gramicidin S
A revised version of this chapter will be submitted for publication to Applied and
Environmental Microbiology (Co-authors: M Rautenbach and JL Snoep)
Abstract
Antibiotic production as defence mechanism is a characteristic of a wide variety of organisms.
These defence molecules vary greatly and may take the form of extra-cellular enzymes such
as proteases, enzymes and DNA replication inhibitors and antimicrobial peptides. In this
study, peptides from two co-habiting bacteria were investigated. The two peptides in this
study, gramicidin S from Bacillus brevis and surfactin from Bacillus subtilis, have been
shown to target both membrane and intercellular components of target organisms. Evidence is
presented that another function may exist for surfactin, that of a shielding molecule or anti-
antibiotic. Itwas found that surfactin antagonises the antimicrobial action of gramicidin S in a
dose-dependant manner against a variety of target cells. This antagonism is possibly the result
of the formation of an inactive complex between surfactin and gramicidin S.
4.1 Introduction
In diverse ecological communities various defence strategies have evolved to effectively
compete for available resources. These strategies include the utilisation of changing
environmental conditions and production of compounds. The development of cellular events
such as sporulation enables the organism to incorporate the physical environment in a defence
strategy. Active resistance is dependent on the production of antibiotic compounds such as
extra cellular enzymes, DNA replication inhibitors and antimicrobial peptides [1, 2, 3, 4].
Antibiotic production is a characteristic of many microorganisms including gram-positive
bacteria from staphylococcus, streptomyces and bacilli species. A third mechanism may exist
which can best be described as extra-cellular antibiotic shields or a decoy-based resistance.
One possible example of this type of antibiotic shield is that of vancomycin from
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Streptomyces orientalis that specifically binds to penicillin from Penicillium species [5]. We
investigated a possible second example mechanism after antagonistic behaviour was observed
between the antimicrobial peptides gramicidin S and surfactin from Bacillus brevis and
Bacillus subtilis respectively.
Gramicidin S is a cyclic amphipatic decapeptide that consists of two pentapeptides, D-Phe-
Pro-Val-Orn-Leu, linked between D-Phe and Leu [6]. The peptide is p-pleated with the four
hydrophobic side chains of the valine and leusine residues located on one side of the ring
structure and the two hydrophilic ornithine residues in the other. Interactions with alkali metal
ions have also been demonstrated as well as the involvement of backbone carbonyl oxygen in
this interaction [7]. It is active against gram-positive and gram-negative bacteria, fungi as well
as exhibiting haemolytic activity [8, 9, 10, 11]. Association of gramicidin S with cell
membranes lead to the release of phospholipids followed by a disruption of the permeability
barrier and cell lyses [8, 9,]. Sporulation of B. brevis is also retarded by gramicidin S; this
action is of special interest as gramicidin S is produced under stress conditions such as oxygen
and nutrient limitation [12, 13, 14, 15]. In complex ecological communities, oxygen and
nutrient limitation frequently signals fungal sporulation or rapid microbial growth.
Surfactin consists of the heptapeptide L-Glu-L-Leu-D-Leu-L-Leu:-L-Val-L-Asp-D-Leu-L-Leu
linked via a lactone bond to a p-hydroxy fatty acid, with 13-15 e atoms, which forms the
hydrophobic part of this molecule. Two other natural occurring forms have been isolated with
either L-Val or L-Ile at position 7 in the peptide chain [16, 17, 18]. Surfactin was first
recognised as a powerful biosurfactant and as such cytotoxic [16,17]. The Glu and Asp
residues form an "ionic basket" that selectively binds monovalent and divalent cations and
transport them across membranes [19]. Biological activity against gram-positive organisms
has been demonstrated [20] as well as antifungal activity in conjunction with co-produced
iturin A [21, 22]. Surfactin, like gramicidin S, exerts biological activity on the producer strain.
Ahimou and co-workers [15] found that upon secretion, the molecule adsorbs onto the B.
subtilis membrane thereby changing cell surface hydrophobicity.' This may facilitate surface
bacterial colonisation through enhanced bacterium-surface interactions [23]. Surfactin is also
produced under stress conditions -specifically oxygen limitation at 35 oe [24,25].
Even though a large body of scientific evidence has been gathered on the mechanism of action
for both peptides, it is not yet complete. Previous studies investigated peptide-cell interaction
to measure and explain peptide activity in relation to host defence. However, we believe that
to explain peptide function in an ecological context, it is necessary to investigate peptide-
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peptide and peptide-cell interactions of different co-existing producers. In this paper, evidence
for another possible host-defence mechanism involving both gramicidin S and surf actin will
be presented.
4.2 Materials
Tryptone soy broth (TSB) was supplied by Biolab Diagnosties (Midrand, RSA) and Difco
Laboratories (Detroit, USA) supplied the Potato Dextrose Broth (PDB). The components for
Luria Broth (LB), NaCI, tryptone and yeast extract were from Saarchem (Midrand, RSA),
Unipath (Hampshire, England) and Difco Laboratories (Detroit, USA) respectively. Agar
powder was from Saarchem (Krugersdorp, South Africa). Microtitre plates (Nunc™-Immuno
Maxisorp) were from Nalge NUNC International (Roskilde, Denmark). Culture dishes were
from Quality Scientific Plastics USA. Surfactin, gramicidin S and gramicidin D were from
Sigma (St Louis, USA). The model peptide ESFl-SAGR and vancomycin were donated by
JW Hastings. Acetonitrile (99.9%, far- UV grade) and casein were from BDH laboratory
supplies (Poole, England). Merck (Midrand, RSA) supplied the NaH2P04 and Na2HP04.
Analytical quality water was prepared by filtering water from a reverse osmoses plant through
aMillipore Milli Q®water purification system (Milford, USA).
4.3 Methods
4.3.1 Culturing of target organisms
Eschericia coli HB 101 and Micrococcus lute us NCTC 8340 were cultured from freezer
stocks on tryptone soy agar (TSA) and Luria agar (LA) respectively at 37°C for 48 hours
before selected colonies were grown overnight in TSB and LB respectively. Both organisms
were then sub-cultured in TSB at 37°C. Broth microdilution assays [26] were performed with
5 X 105 CFU/mL suspensions and inhibition measured spectrophotometrically after 24 hours
at 620 nm on a Titertek Multiscan Plus Mk II(Flow Laboratories) microtitre plate reader. All
microtitre plates were blocked with 0.5% casein in Dulbecco's Phosphate Buffered Saline
(PBS) [27] and sterilised under UV light before use.
Penicillium cf. corylophilium spores were grown at 25°C on PDA and harvested from l4-day
old cultures by flooding the plates with 10 mL sterile distilled water and gentle rubbing with a
sterile spatula [28]. The harvested spores were then filtered through a double layer of gauze
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before being diluted in PDA to 45 X 103 spores/well. Test substances were added to the spore
containing wells and incubated for 24 hours at 25°C. Inhibition was measured
spectrophotometriclyat 620 nm with a Titertek Multiscan Plus Mk II (Flow Laboratories). All
microtiter plates were blocked with 0.5% casein in Dulbeco's Phosphate Buffered Saline
(PBS) and sterilised under UV light before use.
4.3.2 Electrospray Mass Spectrometry
ESMS was performed with a Micromass Quattro triple quadrupole mass spectrometer fitted
with an electro spray ionisation source. Surfactin was dissolved in 50%, gramicidin S in 50%
acetonitrile/water. Samples were prepared by combining the peptides five minutes before
analysis. Injections into the ESMS were through a Rheodyne injector valve at 20 flLlanalysis
with the final carrier solvent concentration 50% acetonitrile. A capillary voltage of 3.5 kV
was applied with the ionisation source temperature at 80 °C. The cone voltages for the all the
analyses were 60V with the skimmer lens offset at 5V. Data acquisition was in the positive
mode, scanning the mass range through mlz = 200-2000 at a scan rate of 100 atomic mass
units/second.
4.3.3 Data analysis
Relative growth in the antimicrobial assays was calculated by dividing the light dispersion per
well by the mean light dispersion of the wells containing growth medium, spores, and
acetonitrile (taken as 100% growth or 1.00 relative growth). Subtracting the relative growth
calculated from 1 and multiplying the value by 100 rendered percentage inhibition. Data were
analysed using GraphPad Prism 3.0 (GraphPad Software Incorporated) for curve fits and
statistical analyses. Sigmoidal dose response curves (variable slope with no weighing of data)
were fitted to all assay results. Of the eight or more determinations per concentration, only the
mean was considered for fitting the curve. The 50% inhibitory concentration was determined
from the x- value halfway between the top and bottom plateau [29].
4.4 Results
Adding surf actin at increasing concentrations caused distinct antagonism of the antimicrobial
activity of gramicidin S towards different target cells (Figures 1-3).
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In our assay system gramicidin S had an ICso of 4.2 J.lMagainst P. corylophilium as target
organism. Surfactin caused dose-dependent antagonism of the antifungal activity of
gramicidin S (Figures 1 and 4). At 18 J.lM surfactin all gramicidin activity was inhibited
except at the highest gramicidin S concentration at which point approximately 60% inhibition
of fungal growth was achieved and ICso of gramicidin S increased by > 1000%. All the
surfactin concentrations used caused the inhibition curves to shift to the right, i.e. a higher
concentration gramicidin S was required to obtain the same result as in the control without
surfactin (Figures 1 and 4). Even though antagonism of gramicidin S activity diminished with
decreasing surf actin concentrations the addition of 4.5 J.lMsurfactin (approximately the ICso
concentration of gramicidin S) still resulted in 27% antagonism. Furthermore, the order of
addition did not influence the affect the observed results. Surfactin alone was not active
against P. corilophillium at any of the concentrations used.
Gramicidin S had an ICso of 22 J.lM towards E. coli as target organism. As with the other
target organisms, antagonism was also observed with this gram-negative bacterium (Figures 2
and 4). Unlike with P. corylophilium, the antagonism of gramicidin S activity on E. coli was
not dose-dependent in the sense that a direct correlation between existed between surf actin
concentration and effect on gramicidin S activity. It rather appeared that a "critical" surf actin
concentration (> 10 J.lM)was needed to affect gramicidin S activity (Figure 4). The addition
of surfactin above this concentration resulted in the shifting of the dose-response curve to the
right. However, the gramicidin S activity could not be completely abolished - even at 40 J.lM
surfactin, but this high concentration surf actin did cause >200% change in the ICso of
gramicidin S towards E. coli. Surfactin alone was not active against E. coli at any of the
concentrations used. Furthermore, the order of peptide addition did not affect the antagonism
profiles observed.
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Figure 1 Dose-dependent antagonism of gramicidin S antifungal activity towards P.
corilophillium by surfactin. Standard error of the mean for each datapoint (n = 24
for gramicidin S; n = 8 for gramicidin S + 18 flM surfactin and gramicidin S + 4.5
flM surf actin) is shown, with R2>0.99 for all curves. The surf actin results were
obtained from two independent experiments in quadroplicate and the gramicidin S
results from 6 independent experiments in quadruplicate
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Figure 2 Surfactin induced antagonism of gramicidin S activity against the target organism
E. coli. Standard error of the mean for each datapoint (n = 16 for gramicidin S; n
= 12 for gramicidin S + 10 flM surfactin and gramicidin S + 40 flM surf actin) is
shown, with R2>0.99 for all curves. The surf actin results were obtained from three
independent experiments in quadroplicate and the gramicidin S from 4
independent experiments in quadruplicate.
Gramicidin S had an leso of 6.4 flM against M luteus as target organism. The antagonism
(Figures 3 and 4) shows an interesting deviation from the profile observed with P.
o Gramicidin S
Á Gramicidin S +
10 J.1Msurfactin
• Gramicidin S +
40 J.1Msurfactin
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corylophilium and E. coli. Unlike the other test organisms, M luteus was sensitive to the order
in which surfactin was added. When surfactin was added at 30 j.lM, after the addition of
gramicidin S, only slight antagonism at the higher concentrations of gramicidin was detected
(Figure 4, Table 1). However, when the target organism was incubated with 30 j.lM surfactin
for 5 minutes before the addition of gramicidin S, a shift of >240 % in the ICso of gramicidin
S was observed. (Figure 4, Table 1).
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Figure 3 Antagonism of gramicidin S activity by surf actin with M luteus as target
organism. Standard error of the mean for each datapoint (n = 46 for gramicidin S;
n = 16 for gramicidin S + 18 j.lM surf actin and for gramicidin S + 4.5 j.lM
surfactin) is shown, with R2>0.99 for all curves. The: results were obtained from
four independent experiments in quadruplicate.
1.5 2.0
Pre-incubation of M luteus with 2.5 j.lM surfactin lead to >50% decrease in the ICso
concentration of gramicidin S (Figures 3 and 4). Surf actin alone was not active against M
luteus at any of the concentrations used. However, at 100 j.lM surf actin almost all gramicidin
S activity against M luteus was suppressed (results not shown), although at this concentration
surfactin on it own showed about 20% M luteus growth inhibition.
The combined action of surfactin and gramicidin S differed for each of the three target cells.
The effect observed with P. corylophilium and E. coli were insensitive with respect to order of
peptide addition, whereas a change in addition order had a pronounced effect on M luteus.
With respect to biological effect, surfactin concentrations below al: 1 molar ratio between the
peptides at the respective ICso of gramicidin S resulted in synergism towards Gram-positive
target cells. However, with E. coli and P. corylophilium as target cells, concentrations
resulting in the same molar ratio did not result in enhanced gramicidin S activity. An increase
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in surfactin concentration above the ICso concentration of P. corylophilium resulted in an
almost linear increase in gramicidin S activity antagonism (Figures 1 and 4).
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Figure 4 Change of ICso values of gramicidin S towards bacterial target cells as a response
to surf actin addition.
In contrast little or no effect was observed with for E. coli and M luteus (without pre-
incubation with surfactin) up to, what appears to be, a critical concentration after which a
rapid increase in antagonism was observed. Similarly, after the initial synergism observed,
when M luteus was pre-incubated with surfactin, a small increase in antagonism was
observed up to 10 ~M, after which a sharp increase in antagonism was observed.
These results indicate that membrane associated interaction, as well as solution interaction
between the two peptides may occur. Membrane associated surf actin will cause a localised
high surf actin concentration and this may be important in the defence against gramicidin S by
the surf actin producer B. subtilis. In order to investigate the specificity of this phenomenon,
the test peptides were added to M luteus in combination with other compounds (Table 1).
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Table 1 Influence of various compounds on biological activity as measured by change in
ICsoof gramicidin S towards M. luteus
Test compound or
ICso(JlM)combination I
Surfactin inactive'
30 JlM3 surfactin + Gramicidin S 13.8 ± 1.1
Gramicidin S 6.4 ± 0.4 4
Gramicidin S + 30 JlM surfactin 6.9 ±1.0
0.3 mg/mL BSA inactive
0.3 mg/mL BSA + Gramicidin S 7.5±1.1
ESF1-SAGR 32.4 ± 1.1
30 JlM surfactin +ESFI-SAGR 33.1 ± 1.1
Vancomycin 2.8 ± 1.0
30 JlM surfactin + Vancomycin 2.5 ± 1.0
% L\ JCso
116
8
17
2
-11
I compound written first was added first and incubated for 5 minutes before
addition of second compound
2 surfactin showed about 20% inhibition of bacterial growth at 100 11M,
but no effect at the concentrations used.
3 30 11Msurfactin is equal to 0.3 mg/mL
4 average of 17 assays in quadruplicate
Gramicidin S, together with BSA, showed that the protein did not cause a statically significant
change in the ICso of the peptide (P>0.05). The controls used for surfactin were vancomycin,
a non-related glycopeptide [30] and ESFl-SAGR, a cationic a-helical model peptide [31].
The addition of surfactin did not alter the biological activity of either the glycopeptide or
ESF1-SAGR.
To explain the antagonism of gramicidin S activity by surfactin, gramicidin S, surfactin, and a
peptide mixture were analysed with electro spray mass spectrometry (ESMS). ESMS was used
because of the soft-ionisation process that are beneficial for the detection of non-covalent
interactions between bio-molecules [reviewed in 32].
The expected molecular ions for gramicidin S ([M+2Hf+, m/z = 571; [M+Ht, m/z = 1142)
were detected (Figure 5A) as well as the different surf actin variants ([M+Ht, m/z = 995,
1009, 1023, 1037,) (Figure 5B).
Analysis of al: 1 molar mixture of the peptides showed the formation of doubly charged
molecular ions corresponding to complexes (m/z = 1069, 1076, 1083, 1090, 1097) consisting
of gramicidin S and the surfactin variant variants (Figure 5C).
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Figure 5 Electrospray mass spectrometry spectrum of (A) gramicidin S with gramicidin S
ions denoted as MGs, (B) surf actin with the various surfactin ions denoted as SI-S
and the peptide mixture (C) witt the peptide complexes denoted as Cl-CS.
Collisionally induced dissociation of the complex molecular ion with m/z = 1090 was
performed and daughter ions corresponding to gramicidin S and one of the surf actin variants
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(m/z = 1142 and 1036, respectively) were detected (data not shown). A detailed mass
spectrometric investigation of gramicidin S and surfactin interactions will be reported in
Chapter 5.
The control peptides, vancomycin and ESF1-SAGR, were also subjected to mass
spectrometry and no complex formation for either of the peptides with gramicidin S was
observed
4.5 Discussion
Dose-dependent modification of gramicidin S biological activity by surfactin was observed
with all the target organisms used. However, the type and degree of antagonism observed with
each organism differed not only with respect to order of addition but also with the degree of
synergism/antagonism observed. The effect observed with M luteus differed from the other
target cells with respect to addition order with M luteus being very sensitive to addition order.
In addition, synergism between the peptides was observed at surfactin concentrations below
the ICso of gramicidin S. In contrast, the effect observed with E. coli was and P.
corylophilium, insensitive to addition order but did not exhibit same synergism observed at
low surf actin concentrations. The difference in antagonism observed is likely the result of
differences in membrane composition. The synergism observed with the Gram-positive
membrane is likely the result of both peptides penetrating into the lipid bilayer. Both
gramicidin Sand surf actin has been shown to disruptmembrane integrity and it is likely that
surfactin augments gramicidin S activity through membrane destabilisation before gramicidin
S addition. The lack of synergism observed with E. coli may be attributed to presence of the
lipopolisaccharide (LPS) component of the gram-negative organism. It was previously shown
that the fatty acid moiety is crucial for lipopeptide-cell membrane interaction. The presence of
the LPS component may act as a barrier preventing surfactin penetration into the cell
membrane and thus "priming" the membrane for gramicidin S disruption. The result obtained
with the fungal target cell is significant in that surfactin is considered as an antifungal peptide
in combination with iturin A [33], but in our assay it showed that surfactin can also enhance
the activity of other peptides from non-related producer organisms.
With M luteus as target cell, surf actin acted synergistically with gramicidin S at low surf actin
concentrations and antagonistically at high surfactin concentrations. This observation is
consistent with previous reports that both peptides exhibit membrane activity towards the
target cell [20]. The effect of addition order shows that antagonism of gramicidin S activity is
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more pronounced when M luteus is incubated with surfactin. This may indicate that in this
case, peptide-peptide interaction occured primarily at the membrane interface. Similarly,
synergism could be the consequence of surfactin adsorption onto the target cell membranes
thereby sensitising the membrane towards gramicidin S. The significantly lower antagonism
observed with out pre-incubation with surfactin suggest that a) peptide-peptide interaction
occurs primarily in the solution phase and b) that surfactin does not interact with gramicidin S
after the latter has been immersed in the membrane. Solution phase interaction between the
two peptides, as indicated by ESMS, resulted in the formation of complexes. These
complexes are likely to be inactive.
Similarly, surf actin similar to iturin A, readily interacts with fungal membranes and the same
mechanism for synergism and antagonism may apply. However, one can only speculate on the
insensitivity of fungal membranes to addition order. A possible explanation may be that
surfactin more readily interacts with fungal membranes as opposed to Gram-positive bacterial
membranes.
It is unknown whether a specific surfactin-LPS interaction exists. However, it was shown that
this peptide spontaneously interacts with lipid bi-layers with resultant channel formation and
solubilisation of the bilayer [34, 35]. It was also found that membrane penetration was
dependant on acyl chain length with the longer acyl change exhibiting the greatest
penetration. It is therefore possible that the LPS component of gram-negative bacteria will
allow peptide interaction without penetration into the lipid bilayer. This interaction can then
lead to a localised high surfactin concentration area, which effectively prevents gramicidin S
cell membrane interaction. Furthermore, surfactin-LPS interaction without lipid bilayer
penetration can explain the absence of synergism between the peptides. The apparent "critical
concentration" required for the antagonism of gramicidin S action may imply that a minimum
number if surfactin molecules needs to be present at the cell-environment interface. However,
it may also be possible that some of the solution phase antagonism was counterbalanced by
synergism in the cell wall, as is the case with M luteus.
The lack of antagonism observed with the non-related peptides vancomycin and ESFl-SAGR
indicates that a degree of specificity exists in surfactin-peptide interactions.
It has been shown that surfactin readily adsorbs onto the gram-positive membrane of the
producer organism [36]. During interaction with the B. subtilis membrane, surf actin is
orientated with the alkane chain exposed to the environment and thus increasing cell
hydrophobicity. All so, it has been shown that surfactin readily forms micelles [37] and in
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addition to this it has been postulated that iturin A, with similar a structure, assemble in
bilayers [38]. Therefore, we propose that at high surfactin concentrations, additional surf actin
molecules interact with previously adsorbed surfactin to form a "secondary membrane" with
the acidic residues orientated towards the environment. Such an assembly would generate a
local high surfactin concentration at the cell-environment interface resulting in the effective
antagonism of gramicidin S at membrane level. Gramicidin S will then be trapped in the
bilayer and would not be able to exert either its membrane disruptive action or intracellular
activity [8, 9, 10]. In addition, host immunity against the co-produced peptide, iturin A has
been demonstrated [39] and this may protect B. subtilis against the sensitising effect of
surfactin.
4.6 Conclusion
Current dogma dictates a survival of the fittest approach in the study of antimicrobial
compounds, i.e. survival depends on the biological activity of the compounds produced. There
is currently a growing body of evidence that this may be an oversimplified approach. The
antimicrobial activity of these cyclic peptides, and others, may represent only one of a number
of functions. Different functions have been proposed for gramicidin S and surf actin. The idea
that gramicidin S acts as a bacterial hormone stems from the observation that B. brevis
sporulation is retarded [40,41], but not arrested, by gramicidin S. Surfactin has similarly been
implicated in competence of B. subtilis spores.
Our results indicate that, in addition to numerous target cell interactions, a plethora of inter-
organism molecular interactions may exist which may playa role in determining survival. The
interactions encompass antibiotic activity, molecular cooperation, and antagonism. The
antagonistic behaviour of surfactin as well as the cooperation with gramicidin Sagainst
susceptible organisms may point to a possible new defence strategy of B. subtilis. This
reinforces multi-functionality of such peptides. Therefore, we propose another function for
surfactin, apart from its antimicrobial and surfactant functions namely: a defence molecule
against the product of another antimicrobial peptide producer i.e. an anti-antibiotic. This
hypothesis is tenable if taken into account that gramicidin S is toxic to gram-positive
organisms such as B. subtilis [20]. Furthermore, both peptides are secreted in response to
oxygen stress [15, 24, 25]. B subtilis can survive anaerobic conditions, given a suitable
electron acceptor, whereas B. brevis is a facultative aerobe [4]. The antagonism of gramicidin
S by surf actin may therefore present a mechanism to survive the presence of its competitor's
4-13
antibiotic until anaerobic conditions result - a condition under which only B. subtilis can
survive.
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Chapter 5
An electrospray mass spectrometry investigation of the
nature of gramicidin S - surfactin interaction
A revised version of this Chapter will be submitted for publication to Journal of the American
Society of Mass spectrometry (Co-authors: M Rautenbach and MJ van der Merwe)
Abstract
We have previously shown (Chapter 4) that surfactin antagonises the antimicrobial action of
gramicidin S. In this chapter we report on the possible mechanism of antagonism as
investigated through electrospray mass spectrometry. We observed the formation of surf actin-
gramicidin S complexes in 1:1 and 2: 1 ratios with complex formation favoured by an increase
in the organic component of the carrier solvent. Dissociation via cone voltage and
collisionally induced dissociation experiments showed the relative stability of the peptides
and peptide complexes. Competition studies indicated that neither Na+ nor Ca2+ affect the
stability of preformed complexes, and that metal ion association does not occur after complex
formation. Titration of ion-associated surfactin (Na+ or Ca2+ adducts) showed that gramicidin
S associates with both surfactin and the ion-complexed surf actin.
5.1 Introduction
A number of established analytical techniques are available to investigate non-covalent
interactions of macromolecules. Solution phase techniques include surface plasmon resonance
[1], optical spectrometry, nuclear magnetic resonance [2], differential scanning calorimetry,
isothermal thermal titration [3, 4], and light scattering techniques [5]. Mass spectrometry has
been added to this repertoire of solution phase techniques [6] in the form of electro spray mass
spectrometry (ESMS). The "soft ionisation" in ESMS has been used with great success in the
investigation of peptide and protein structure-function relationships, and DNA sequencing
(reviewed in [7]). Furthermore, metal ion-ligand and interactions has been studied extensively
through mass spectrometry (reviewed in [8]) as well as host-guest interactions in
biomolecules [9, 10]. The investigation of non-covalent interactions with mass spectrometry
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also benefited from the recent advances III "soft ionisation" and detection technology
(reviewed in [11]).
The investigation of electrostatic interactions between metal ions and biomolecules is of
particular importance as these interactions have been implicated in many biochemical
processes, and are therefore inextricably linked to life itself. Examples of the interactions
include Mg2+ stabilisation of nucleotide complexes; Zn2+ participation in the catalytic
mechanisms of several enzymes and Ca2+ mediated secondary messenger systems.
Furthermore, the redox pair Fé+ lFe3+ is utilised in electron transfer systems. Osmoregulation
of cells as well as nerve impulse transmittance is dependent on the alkali metal ions Na+ and
K+. Disturbances in the ion-biomolecule homeostasis or interactions that do not naturally
occur in the cell could potentially have disastrous consequences on cell vitality. The
mechanism of action of ionophores, such as the cyclic antibiotic peptide valinomycin,
involves the disruption of the osmotic balance by specifically complexing with K+ ions [12]
and transporting it over the cell membrane [13]. The chelating of alkali metal ions is
analogous to the metal ion complexes formed by crown ethers by capturing the metal ions in
its ring structure with the oxygen atoms as chelating atoms [8, 14].
In Chapter 4 the broad-spectrum antagonistic effect of surf actin on the biological activity of
gramicidin S was described. Preliminary results indicated that this phenomenon might be the
result of inactive complex formation between surfactin and gramicidin S. In this study we
explore the complex formation, and specifically the effect of Na+ and Ca2+ on complex
formation, using electrospray mass spectrometry (ESMS). Gramicidin S [15, 16] and surfactin
are known to complex metal ions [17,18,19]. Gramicidin S has ~-pleated sheet conformation
that contains two type II ~-turns [20]. The hydrophobic residues (L-Val and L-Leu) are
orientated towards one side of the plane and the charged Om residues on the opposite side of
the plane [20,21,22]. Biological activity of gramicidin S is dependent on the Om and D-Phe
residues [23]. Surfactin's conformation has been elucidated through NMR and molecular
modelling [24] and found to be a ~-sheet with a "horse saddle" topology for the ring atoms.
The L-Glu and L-Asp residues were found apposite the aliphatic chain and in a "claw"
conformation. The conformation allows the chelating of metal ions for transport across
membranes [19]. Furthermore, interactions with metal ions are essential for stabilisation of
the ring structure, which is necessary for micelliation [25].
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5.2 Materials and methods
5.2.1 Materials
Surfactin was supplied by Fluka Chemie (GmbH) and gramicidin S by (St Louis, USA).
Acetonitrile (99.9%, far- UV grade) was from BDH laboratory supplies (Poole, England).
Calcium chloride was from Associated Chemical Enterprises (Glenvista, RSA) and NaCI
from Saarchem (Midrand, RSA). Analytical quality water was prepared by filtering water
from a reverse osmoses plant through aMillipore Milli Q® water purification system
(Milford, USA).
5.2.2 Electrospray Mass Spectrometry
ESMS was performed with a Micromass Quattro triple quadrupole mass spectrometer fitted
with an electrospray ionisation source The peptides as well as the salts were dissolved in 50%
acetonitrile/water. Solvent concentration before injection was 50% acetonitrile/water.
Samples were prepared by incubating surfactin and the respective salts overnight. Gramicidin
S was added five minutes before analysis. Samples were injected into the ESMS through a
Rheodyne injector valve at 20 ~Llanalysis with the final carrier solvent concentration 50%
acetonitrile. A capillary voltage of 3.5 kV was applied with ionisation source temperature at
80 "C. The cone voltage for all analyses, except for CV experiments, was 60V the skimmer
lens offset at 5V. Data acquisition was in the positive mode through the m/z = 200-2000 at a
scan rate of 100 atomic mass units/second. Cone voltage (CV) driven dissociation was
performed as above with the cone voltage varied between 20V and 120V. Collisionally
induced dissociation (CrD) of selected molecular ions was executed at a gas pressure of 2Xl a-
3 mbar argon in MS2 with collision energy of 45eV. Fragment ions were detected by scanning
the second analyser from m/z = 10 to about 100 atomic mass units (amu) above the m/z value
of the parent ion. Data was acquired in the multiple channel acquisition mode. Cll)
experiments were also performed under above conditions with the collision energy varied
from CE=I5-75 eV. The first and second mass analysers were set to the selected parent ions
and chromatograms recorded of the change in parent-ion signal intensity.
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5.3 Results and Discussion
To explain the previously observed antagonism of gramicidin S activity, mass spectrometry
was performed on the compounds, to determine purity (results not shown, see Chapter 2) as
well as on a peptide mixture. It was found that both compounds were of high purity
containing only minor contaminants. With gramicidin S, both the doubly charged ([M+2H] 2+)
and the singly charged ([M+Ht) species were detected, as well as sodiated gramicidin S with
the expected m/z ratios of 571.7, 1142.1, and 1165.46 respectively (Figure 1). Analysis of
surfactin showed singly charged species of the variant surfactin forms (m/z = 994.72, 1008.74,
1022.77, 1036.8 and 1049.82) (Table 1). In addition to the different surfactin species, their
Na+ and Ca2+ adducts were also detected. However, no doubly charged surfactin species were
detected under the ESMS conditions.
5.3.1 Identification of surf actin-gramicidin S complexes
A mixture of gramicidin S and surf actin contained, in addition to the specific peptide species,
a range of molecular species corresponding to the m/z ratios of doubly charged surfactin-
gramicidin S complexes (Cl-CS in Figure 1, Table 1). In addition to the 1:1 complexes,2:1
surfactin:gramicidin S complexes also were detected (Figure 2, Table 2).
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Table 1 Summary of the different peptide and 1:1 complex species detected with ESMS
in a gramicidin S-surfactin mixture
Peptide or
Mr Specie Expected m/z Detected m/zcomplex
Ciramicidin S # 1141.24 [M+Ht 1142.24 1142.47
[M+2Hf+ 571.62 571.84
Surfactinl I 994.27 [Mit 994.27 994.73
Surfactin22 1008.30 [M2t 1008.30 1008.71
Surfactin3 3 1022.33 [M3t 1022.33 1022.81
Surfactin4 4 1036.36 [M4t 1036.36 1036.79
Surf actin 5 s 1050.39 [Mst 1050.39 1049.76
Complex 1 2135.51 [M+MI+2Hf+ 1068.75 1068.61
Complex 2 2149.54 [M+M2+2Hf+ 1075.77 1075.59
Complex 3 2164.24 [M+M3+2H]2+ 1082.78 1082.58
Complex 4 2177.60 [M+M4+2Hf+ 1089.80 1089.57
Complex 5 2191.63 [M+Ms+2H]2+ 1096.81 1096.18
# cyclo[D-Phe-L-Pro-L- Val-L-Om-L-Leu]
cyclo[L-Glu-L-Leu-D-Leu-L- Val-L-Asp-L-Leu-L- Val-( C 14H2S02)]
cyclo[L-Glu-L-Leu-D-Leu-L-Ala-L-Asp-L-Leu-L-Leu-(CI4H2S02)]
cyclo[L-Glu-L-Leu-D-Leu-L-Ala-L-Asp-L-Leu-L-Ile-(C14H2sO2)]
2 cyclo[L-Glu-L-Leu-D-Leu- L-Val-L-Asp-L-Leu-L-Leu-(C 13H2602)]
cyclo [L-G lu-L-Leu-D-Leu- L-Val- L-Asp- L-Leu-L-Ile-(C 13H2602)]
cyclo[L-G lu-L-Leu-D-Leu-L- Val-L-Asp-L-Leu-L- Val-(C 15H3002)]
3 cyclo[L-Glu-L-Leu-D-Leu-L- Val-L-Asp-L-Leu-L-Leu-(C 14H2S02)]
cyclo[L-Glu-L-Leu-D-Leu-L-Ala-L-Asp-L-Leu-L-Val-(CI4H2sO2)]
cyclo[L-Glu-L-Leu-D-Leu-L-Val-L-Asp-L-Leu-L-Ile-(CI4H2S02)]
4 cycIo[L-G lu-L-Leu-D-Leu-L- Val-L-Asp-L-Leu- L-Leu-(C 15H3002)]
cycIo[L-G lu-L-Leu-D-Leu- L-Val- L-Asp- L-Leu- L-Ile-( C15H3002)]
5 cycIo[L-G lu-L-Leu-D-Leu-L- Val- L-Asp-L-Leu-L-Leu-( C16H3202)]
It must be noted that even although al: 1 molar mixture in 50% acetonitrile was subjected to
ESMS, a considerably lower surfactin signal was detected. This was expected, as surf actin
[C11+2Hj2+
1600.9
is anionic and the ESMS was performed in the positive mode. No triply charged ([M+ 3H]3+)
or quadruply charged (M+4Ht+) complex species corresponding to three surf actin molecules
and gramicidin S were detected. However, if these species exist exclusively as doubly charged
ions detection was not possible as the data acquisition was done over the m/z = 200 -2000
range.
To determine the stoichiometry of complex formation, mixtures of gramicidin S and surfactin
were analysed at different surfactin-gramicidin S molar ratios. It was found that optimal
complex formation is at al: 1 ratio (Figure 3). Analysis of the spectra recorded indicated that
no complexes were formed at a 1:2 surfactin:gramicidin S ratio.
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Mass spectra of al: 1 surfactin-gramicidin S mixture. Eight different doubly
charged 2: 1 surfactin-gramicidin S complexes (C6-C13) were detected.
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Table 2 A summary of the different peptide and 1:2 complex species detected with
ESMS in a gramicidin S-surfactin mixture (S = surfactin; G = gramicidin S)
Peptide or
Mr Specie
Expected Detected
complex m/z m/z
Complex 6 3129.78 [S1+S 1+G+2Hf+ 1565.89 1565.00
Complex 7 3143.80 [S1+S2+G+ 2H]2+ 1572.90 1572.34
Complex 8 3157.84 [S1+S3+G+ 2Hf+; [S2+S2+G+ 2H]2+ 1579.92 1579.99
Complex 9 3171.86 [SI +S4+G+2H]2+; [S2+S3+G+2H]2+ 1586.93 1586.80
Complex 10 3185.52
[S1+S5+G+ 2H]2+; [S2+S4+G+ 2Hf+;
1593.76 1594.01[S3+S3+G+ 2H]2+
Complex 11 3199.48 [S2+S5+G+ 2H]2+; [S3+S4+G+ 2H]2+ 1600.74 1600.90
Complex 12 3213.56 [S3+S5+G+ 2Hf+ ;[S4+S4+G+ 2H]2+ 1607.78 1607.66
Complex 13 3227.9 [S5+S5+G+ 2Hf+ 1614.95 1615.01
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5.3.2 Stability of surfactin-gramicidin S complexes
Collisionally induced dissociation (CID in MS2) of C3 (mlz 1089) showed that this molecular
species is composed of gramicidin S and the surfactin variant with Mr = 1036.8. In addition to
molecular ions corresponding to gramicidin S and surfactin with Mr = 1036.8 the parent ion
was also detected (Figure 4). Collisionally induced dissociation of the molecular ion with m/z
= 1600.84 shows that the ion is composed of surfactin 2-5 and gramicidin S.
[C4+H)2+
1089.8
Figure 4
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Collisionally induced dissociation of gramicidin S-surfactin complex 3 (m/z =
1089.41). Cone voltage was set at 60 V and the collision energy to 20 eV.
Since slightly different conformations were reported for the different surfactin variants, cone-
voltage driven dissociation experiments were performed to evaluate the relative gas-phase
stability of the peptides and complexes (Figure 5). The cone voltage was varied from 20-
120V at a source temperature of 85° C. Surf actin variants 1-5 had an optimum signal between
50 and 80V with rapid deterioration of the signal intensity at cone voltage higher than 1OOV,
due to fragmentation. Close inspection of the results showed that optimum signal for surf actin
1 was 60V, and for surfactin 2-4 at 80 V (results not shown). This surfactin 1 specie showed
the weakest ionisation over the cone voltage range, but and was stable over the range 60-
1OOV.It is interesting to note that the strongest signal was found for surfactin 3, but that an
equal signal was not detected for surf actin 2, which differs only with respect to fatty acid
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chain length indicating that surfactin 3 possibly contains the highest concentration of surf actin
molecules (results not shown). The average CV optimum for the surfactin species was
between 50 and 80V and that of gramicidin S was found to be stable up to 100V (Figure 5).
Gramicidin S-surfactin complexes were subjected to identical ESMS conditions (Figure 5)
and the results show that the stability of the complex mirrors that of the peptide constituents.
Complexes 1-5 had similar stabilities with the highest signal at 60V (Figure 5), with complex
2 slightly more stable that the other complexes (results not shown). Complexes 6-13 showed
the same stability as complexes 1-5 with highest signal at CV of 60V. However, complex 6
was the most unstable and degraded at CV>40V (results not shown). The highest signal was
observed for complex 10 that consists of a combination of five different surfactin variants
(Table 2) followed by complex 11 and 9 (composed of 4 different surf actin forms
respectively) (results not shown). Analyses of surfactin-gramicidin S complexes indicate that
optimal signal was achieved for all the complexes, except complexes 6 and 7, at 60V,
indicating that the complexes were more unstable than the individual peptides.
During the cone voltage driven dissociation experiments we observed an initial sharp increase
in total ion current up to 60 V for all the complexes, where after it decreased again. This
decrease in signal intensity can therefore be reasonably ascribed to gas-phase dissociation
rather than fragmentation, at least up to CV of 80V. The variation in cone voltage to study
relative stability is problematic given the influence of cone voltage on ionisation. However,
CrD has also been used to induce a unimolecular decay of selected ions with sufficient
internal energy upon collision with a neutral gas. Several previous studies showed that
binding energies calculated from CrD experiments reflect solution phase binding energies [26,
27]. Therefore, we performed Cll) on the peptides and complexes to gain more accurate
information regarding the relative stabilities of the peptides and complexes (Figure 6).
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Figure 5 The influence of changing cone voltage on gramicidin S, surfactin (average of
surf actin 1-5), and surfactin-gramicidin S complexes (average of complexes 1-5;
6-13).
When the optimal CV and eV setting for maximum signal for each of the analytes were
reached, the increase in collision energy (CE) caused dissociation and fragmentation of the
analytes comparable to the stability of the analyte (Figure 6). The results indicated that all the
surfactin forms needed similar CE50 (the collision energy to dissipate 50% of the molecular
ion specie [11]) with an average of 36.7±leV. Gramicidin S ions were significantly more
stable (CE5o = 42.8±leV) than surfactin ions and this difference can be attributed to the rapid
decomposition of the lactone bond (Figure 6).
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Figure 6 Collisionally induced dissociation of gramicidin S, surf actin 1-5 (average
values) and complexes 1-4 (average values from CE =5 -75 eV with cone
voltage set to 60V.
CID of gramicidin S-surfactin complexes showed the complexes were much more unstable
than the individual peptides with average CEso of 18.7±leV (Figure 6). These results
confirmed the lower stability of the complexes detected with varying CV.
5.3.3 Type of interaction between surfactin and gramicidin S
5.3.3.1 Influence of solvent
To investigate the type of interaction, the sample solvent, as well as the carrier solvent, was
varied from 10% (v/v) to 90% (v/v) acetonitrile. If electrostatic interactions were involved, a
non-polar environment would favour complex formation with a resultant higher complex
signal. On the other hand, if the hydrophobic moieties of the peptides were responsible for the
interaction, a higher complex signal would be obtained with the polar solvents.
We observed that signal intensities of the surf actin-gramicidin S complexes increases with a
decrease in solvent polarity (Figure 7). This result suggests the involvement of electrostatic
interactions rather than hydrophobic interactions in formation of the surf actin-gramicidin S
1 .0 x 1 0 07
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Figure 7 Relationship between change in signal intensity and acetonitrile content of
sample/analysis solvent for surfactin (all species), gramicidin S and the
surf actin-gramicidin S complexes (total signal). The signal intensity has been
calculated in terms of the total molecular ion intensity in the sample with 10%
acetonitrile)
It must be noted that solvent polarity is one of the determining factors of ionisation. All the
molecular ion signal intensities showed a slight increase up to 50% acetonitrile/water, where
after the signal decreased slightly from 50-75% acetonitrile/water. All the free peptide
molecular ions showed a slight increase «10%) in signal intensity at 90% acetonitrile water.
In contrast, surf actin-gramicidin S complex signal continuously increased over the solvent
polarity range, and showed particularly significant increase of 35% from 80% to 90%
acetonitrile. Therefore, we conclude that an apolar environment probably favours surf actin-
gramicidin Sinteraction.
5.3.3.2 Influence of mono- and divalent ions
It was previously shown that the L-Glul and L-Asps residues of surf actin complexes with both
mono- and divalent cations, resulting in either partial or complete neutralisation of the acidic
;
residues [18]. Since metal ion binding neutralises the acidic residues, it offers a tool to
investigate the possibility of an ionic interaction with these residues through competition
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studies.
Addition ofNaCI to surfactin-gramicidin S mixtures did not affect the pre-formed complex up
to 35.6 mM NaCI (400 times molar excess) (Figure 8). The complexes formed with all
variants of surf actin. All remained reasonably constant over the concentration range. Similarly
gramicidin S signal intensity was unaffected by increasing NaCI concentrations. Signal
intensities of various surfactin forms showed minor fluctuations over the NaCI concentration
range with a slight drop in intensity at 35.6 mM NaCl. Furthermore, sodiated gramicidin S
(data not shown) and sodiated surf actin (Figure 8) showed an increase over the concentration
range. However, no sodiated surfactin-gramicidin S complexes were detected. A molecular
ion with m/z corresponding to a sodiated complex (m/z = 1101.5) was fragmented and found
not to consist of either gramicidin S or surfactin (data not shown). The signal intensities of the
various surf actin and surfactin-gramicidin S complexes exhibited the same general trend.
Therefore, the individual signal intensities were summed and the data presented as total
intensities (Figure 8).
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Figure 8 Influence ofNaCI addition of to al: 1 mixture of gramicidin Sand surf actin (89
uM each)
The increase in sodiated surfactin and gramicidin S signal (Figure 9) intensity over the NaCI
concentration range confirmed that sodium-peptide interaction was uninhibited. The results
indicate that Na+ does not interact with surf actin aftergramicidin S interaction. Furthermore,
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Na+ does not affect the stability of preformed surfactin-gramicidin S complexes and therefore
does not displace gramicidin S from the surfactin molecule.
The influence of sodium interaction with surfactin was investigated by pre-incubating
approximately 134 JlM surfactin (calculated from variant with highest Mr) with 1.33 mM
Nael (lO times molar excess). The mixture was diluted to approximately 89 JlM surf actin and
titrated with Gramicidin Sover 8.9-89 JlM concentration range. Ion chromatograms were
recorded to monitor the effect of increasing gramicidin S concentration on signal intensity.
The results obtained for the different surfactins and surfactin complexes exhibited the same
trends and were therefore added to present the total signal observed (Figure 9). Surfactin-
gramicidin S signal intensity increased extensively over the gramicidin S concentration range,
as did the gramicidin S signal. The free surfactin signal increased at low concentrations of
gramicidin S, indicating that some complexes may have formed by displacing sodium and
then dissociated to produce free surfactin. The sodiated and free surfactin signal decreased at
the highest gramicidin S concentration; an indication that surfactin was chelated in the
complexes, regardless if it was bound to sodium or not. However, again no sodiated surf actin-
surfactin or sodiated mixed complexes were detected.
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As with Na +, the effect of Ca2+ on complex formation was investigated through gramicidin S
titration of surf actin pre-incubated with CaCho In the samples without gramicidin S, we
observed calcium-induced surfactin complexes consistent with other reports [17, 18, 25].
These complexes all consisted of surfactin:Ca2+ in al: 1 ratio.
When the calcium-incubated surfactin was the titrated with gramicidin S, the ESMS results
indicated, as in the case with sodium-incubated surfactin, that complex formation is
uninhibited by surfactin-Ca2+ interaction (Figure 10). The presence of calciated surfactin may
even have benefited the formation of complexes, as the increase of complexes 1-5 was much
more pronounced than with the sodium pre-incubation. The signals detected for double
surfactin gramicidin S complexes (complexes 6-13) increased over the gramicidin S
concentration range, but not as pronounced as the 1:1 complexes. The free surf actin increased
over the whole gramicidin S concentration range, probably because of gramicidin-induced
dissociation of calciated surfactin.
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Figure 10 The influence of increasing gramicidin S concentrations on surf actin and
gramicidin S-surfactin complexes. Gramicidin S was titrated against Ca2+_
incubated surfactin.
In total 33 surf actin complexes, complexed either with Ca2+, surf actin, and/or gramicidin S
was clearly detected (results not shown). The addition of gramicidin S generated molecular
ions with m/z ratios within 1 amu of the surfactin species (see Addendum, Tables 1 and 2 for
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complete analysis of the molecular ions detected). Therefore, only eight of the species (four
each of [2S+2Ca+2H]2+ and [3S+3Ca+2H]2l with distinct and strong signals were selected
to represent each group (Figure 11). All the selected ions from each group exhibited the same
behaviour. Similar to the other ions monitored, the addition of gramicidin S caused an initial
increase in signal intensity. Initially, signals of all the calciated surf actin species increased
(Figure 11). This increase cannot be explained, but interaction with gramicidin may have
liberated surf actin from surfaces to which it adsorbed. However, after 22.5 J...LMof gramicidin
S has been added the calciated multi-surf actin complexes showed a sharp decline and the
mono-calcium surfactin complex remained relatively constant. The results again indicate that
calcium ion interaction does not interfere with complex formation. Furthermore, gramicidin S
does interfere with calcium induced surfactin-surf actin complexes.
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Figure 11 The influence of increasing gramicidin S concentrations on calcium induced
surfactin -surfactin complexes
Analyte complexity makes conclusive kinetic deductions difficult. However, the following is
noteworthy: 1) surf actin-gramicidin S interaction is not limited to free surfactin -If this was
the case the free surf actin would have declined over the gramicidin S concentration range; 2)
a dynamic equilibrium seems to exist between surfactin and calcium-associated surfactin as
both signals maintained similar trends in signal across the gramicidin S concentration range
and 3) gramicidin S dissociates calcium induced surf actin-surf actin complexes. Given that the
·1
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surfactin-surfactin complexes only forms upon Ca2+ -surfactin interaction, it is conceivable
that gramicidin S interferes with Ca2+ -surf actin interaction. Furthermore, single surfactin
gramicidin S complexes (complexes 1-5) increased up to 225 11Mgramicidin S after which
the signal remained constant. In contrast, double surfactin-gramicidin S complexes increased
continuously. Therefore, it appears that a saturation point exists for single surf actin-
gramicidin S complex formation and that a second surfactin molecule is then added to the 1:1
complex.
During both experiments with NaCI and CaCh as modifying agents, an initial increase in
signal intensity for all molecular ions monitor were observed. Considering the relationship
between analyte ionisation and detection in a mass spectrometer, it is possible that the
addition of a polar compound, such gramicidin S, may influence the ionisation characteristics
of the other compounds in solution. In addition, as proposed above, gramicidin S may liberate
surfactin from surfaces to which it may have absorbed. This may explain the initial increase in
signal intensity of the monitored species.
5.4 Conclusions
Our results indicate that previously observed antagonism of the antimicrobial activity of
gramicidin S by surfactin is likely the result of direct gramicidin S-surfactin interactions.
Surfactin interaction with gramicidin S was observed in al: 1 and a 2: 1 ratio. However, if
higher complexes exist exclusively as doubly charged ions, these ions could not be detected in
this study due to analyses constraints. We found that neither the minor conformational
differences reported for surfactin variants nor the acyl chain length had any major influence
on the gas phase or the collision stability of surf actin. Minor differences, however, reflected in
the stability of the corresponding surfactin-gramicidin S complex. Investigations into the
influence of solvent polarity showed that complex formation is favoured by a high organic
component in the solvent. This may indicate that the interaction is of an electrostatic nature.
Titration of preformed complexes showed that complex formation is probably unaffected by
salts such as NaCI. Furthermore, the absence of ion-associated complexes indicates that
surfactin-ion interaction is not favourable after surfactin-gramicidin S complex formation.
Titration of Ca2+ incubated surf actin specifically indicated that complex formation is
unaffected or even assisted by surf actin-calcium interaction. Furthermore, we observed a
rapid decrease in calcium induced surfactin-surfactin complexes over the gramicidin S
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concentration range, indicating that gramicidin S interferes with the surfactin-surfactin
interactions. As the Ca2+ association drives surfactin-surf actin interactions, it is conceivable
that gramicidin S interferes with Ca2+ interaction. It may also be possible that the calcium-
induced conformation of surfactin will induce binding of gramicidin S in exchange for the
Ca2+. It is unlikely that the mechanism of this interference is a direct competition for the
glutamic acid carboxyl groups by the ornitines of gramicidin S. It has been shown that
calcium associates with the carboxyl groups [17, 18, 19]. However, the significance of peptide
ring p-turns in alkali metal ion chelating has previously been demonstrated for the analogues
peptide, iturin A [28, 29]. Therefore, we propose that the ornithine residues of gramicidin S
interact with surf actin in one or both of the p-turns. Furthermore, this interaction may result in
a conformational change in the spatial orientation of the acidic residues of surfactin in such a
way that surf actin-calcium ion interaction is no longer possible.
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5.6 Addendum
Table 1 Molecular ions of surfactin and surfactin-calcium complexes detected
during ESMS analysis of a mixture of gramicidin S and surfactin.
Complex Specie Mr m/z
Detected
m/z
[SI+Ca]2+ [SI+Ca]2+ 1034.3 517.1 517.1
[S2+Ca]2+ [S2+Ca]2+ 1048.3 524.1 524.1
[S3+Ca]2+ [S3+Ca]2+ 1062.3 531.2 531.0
[S4+Ca]2+ [S4+Ca]2+ 1076.3 538.2 538.0
[S5+Ca]2+ [S5+Ca]2+ 1090.4 545.2 545.2
SI [SI]+ 994.3 994.3 994.7
S2 [S2]+ 1008.3 1008.3 1008.6
S3 [S3]+ 1022.3 1022.3 1022.7
S4 [S4]+ 1036.4 1036.4 1036.7
S5 [S5]+ 1050.4 1050.4 1050.7*
[SI+Ca]+ [SI+Ca+H]+ 1034.3 1035.3 1035.5
[S2+Ca]+ [S2+Ca+H]2+ 1048.3 1049.3 1049.1
[S3+Ca]+ [S3+Ca+H]2+ 1062.3 1063.3 1063.2
[S4+Ca]+ [S4+Ca+H]2+ 1076.4 1077.4 1077.4*
[S5+Ca]+ [S5+Ca+H]2+ 1090.4 1091.4 1091.3*
*Molecular ions detected from spectrum list because the ion signal was obscured by
other signals in the spectrum.
i·
Table 2 Molecular ions of double surfactin and surf actin-calcium complexes
detected during ESMS analysis of a mixture of gramicidin S and
surfactin. The shaded rows indicate the molecular ions that are
indistinguishable from gramicidin S-surfactin complexes. Surfactin are
denoted as S.
Complex Specie Detectedm/z
SSI [2S1+2Ca+2H]2+ 2070.6 1035.3 1035.0
SS2 [S1+S2+ 2Ca+ 2H]2+ 2084.6 1042.3 1042.0
SS3 [2S2+2Ca+2H]2+; 2098.6 1049.3 1049.1[S1+S3+ 3Ca+ 2H]2+
SS4 [S1+S4+ 2Ca+ 2H]2+; 2112.6 1056.3 1055.8[S2+S3+2Ca+2H]2+
SS5 [3S1+3Ca+2H]2+ 3102.8 1552.4 1552.3
SS6 [2S 1+S2+ 3Ca+2H]2+ 3116.8 1559.4 1559.0
SS7 [2S2+S 1+2Ca+ 2H]2+; 3130.9 1566.4 1566.5[2S 1+S3+3Ca+2H]2+
[2S2+S3+ 3Ca+2H]2+;
SS8 [S1+S2+S4+ 2Ca+ 2H]2+; 3158.8 1580.4 1580.8[2S1+S5+3Ca+2H]2+;
[2S3+S1 +3Ca+2H]2+
[2S4+S3+ 3Ca+2H]2+;
SS12 [2S 1+S5+ 3Ca+ 2H]2+; 3215.0 1608.5 1609.0
[2S5+S1+3Ca+2H]2+
[2S5+S2+ 3Ca+2H]2+;
SS13 [S3+S4+S5+ 3Ca+ 2H]2+; 3229.0 1615.5 1615.0
[3S4+3Ca+2H]2+
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Chapter 6
Preliminary investigation into the interaction of iturin A and
two synthetic linear analogues with gramicidin S
6.1 Introduction
In Chapters 4 and 5 it was shown that surfactin antagonises the antimicrobial action of
gramicidin S in a dose-dependent manner. Furthermore, this antagonism was shown to
possibly be the result of direct gramicidin S-surfactin interactions, of which the latter is
independent of surf actin-metal ion interactions [1, 2, 3, 4]. The lack of antagonism by
surfactin on non-related peptides vancomycin and ESF1-SAGR indicates that a degree of
specificity exists in the peptide-peptide interaction.
Afore mentioned results (Chapter 4 and 5) prompted the decision to investigate some of the
other Bacillus subtilis peptides. Surfactin is co-produced with iturin A in some B. subtilis
strains. In addition to a pronounced synergistic effect of surfactin on iturin A biological
activity [5, 6], surf actin shares some structural similarities with the iturins. Both surf actin and
the iturins are cyclic lipopeptides with fatty acid chain length of C13-16 (surf actin) [7, 8] and
C14-16 (iturins) [9, 10, 11]. The inclusion of D-amino acids in the primary structures of both
peptides facilitates the folding of the peptide backbone to form p-turns. The iturins have two
P turns [12, 13] where surfactin has only one [14]. In both cases the polar residues are
orientated toward one side of the molecule and the fatty acids toward to other side. This
arrangement confers a pronounced amphipatic character on the peptides. Unlike surf actin with
two acidic residues (Glu and Asp) [15] polar component of iturin A consists of three Asn
residues at positions 2, 4, and 7, and a GIn at position 5 [9, 10, 11]. This difference resulted in
surfactin having true surfactant ability but no antifungal activity [16] whereas iturin A
possesses pronounced antifungal activity but less surfactant ability [17] In both cases the
molecular orientation allows for interaction with both an aqueous phase and apolar
environments. Iturin C on the other hand possesses no antimicrobial activity. This complete
loss of biological activity can only be attributed to the mutation if Asn, to ASP2 [9].
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11]. This difference resulted in surfactin having true surfactant ability but no antifungal
activity [16] whereas iturin A possesses pronounced antifungal activity but less surfactant
ability [17] In both cases the molecular orientation allows for interaction with both an
aqueous phase and apolar environments. Iturin C on the other hand possesses no antimicrobial
activity. This complete loss of biological activity can only be attributed to the mutation if
Asn, to ASP2 [9].
These similarities with surfactin made iturin A a prime choice to extend this study. A number
of previous studies have demonstrated that peptide analogues can be used to elucidate the
structural characteristics that are important in peptide mechanism of action [9-18]. The
syntheses of both iturin A and C are accomplished through the cyclisation of a linear
precursor and this afforded the opportunity to investigate the influence of both primary and
secondary structure on peptide-peptide interaction.
In this chapter the possibility that structural similarity between iturin A and surfactin may lead
to gramicidin S antagonism is explored using iturin A and the linear analogues, 8-Beta and 8-
Beta, (see Chapter 2). Due to limited amount and impurity of cyclic 8-Betac (synthetic iturin
C), only linear 8-Betac was investigated, while both iturin A and its linear analogue 8-Beta
were evaluated. Biological experiments, with gramicidin S and Micrococcus luteus as target
cell, were performed with the linear analogues and compared to iturin A. The interaction of
these lipopeptides with gramicidin S biological was explored with mass spectrometry.
6.2 Materials
Tryptone soy broth (TSB) was supplied by Biolab Diagnosties (Midrand, RSA), the
components for Luria Broth (LB), NaCI, tryptone and yeast extract were from Saarchem
(Midrand, RSA), Unipath (Hampshire, England) and Difco Laboratories (Detroit, USA)
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broth (LB) and sub-cultured in tryptone soy broth (TSB). Broth microdilution assays [28]
were performed with 5 X 105 CFU/mL suspensions and inhibition measured
spectrophotometrically after 24 hours at 620 nm on a Titertek Multiscan Plus Mk II (Flow
Laboratories) microtiter plate reader. All microtiter plates were blocked with 0.5% casein in
Dulbeco's Phosphate Buffered Saline (PBS) [29] and sterilised under UV light before use.
6.3.2 Mass spectrometry
ESMS was performed in positive mode with a Q-TOF Ultima® mass spectrometer using an
electro spray ionisation source. All samples were prepared in 50% acetonitrile/water at 20 )-LM
before being injected into the mass spectrometer using an Agilent 1100 HPLC system at 50
)-LLlminuteacetonitrile with a final injection volume of 10 )-LL.A capillary voltage of 3.2 kV
was applied with a source temperature of 80DC. The cone voltage was set at 60 V.
6.3.3 Data analysis
Percentage inhibition was calculated by first expressing the growth observed with the test
substance present as a percentage ofthe total growth observed in the control wells without test
substance (i.e. (growth observed with test substance/growth in control well without test
substance) X 100). This value was subtracted from 100 to render percentage inhibition. Data
were analysed using GraphPad Prism 3.0 (GraphPad Software Incorporated) for curve fits and
statistical analyses. Sigmoidal dose response curves (variable slope with no weighing of data)
were fitted to all assay results. Of the eight or more determinations per concentration, only the
mean was considered for fitting the curve.
Statistical analyses of data performed with GraphPad Prism include, the absolute sum of
squares, and standard error of the mean. The 50% inhibitory concentration was calculated
from the X-value halfway between the top and bottom plateau of the log dose-response curve
[30].
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6.4 Results and discussion
6.4.1 Influence of the iturins on M. Luteus activity of gramicidin S
As observed for surf actin, iturin A also antagonised the biological activity of gramicidin S
(Figure 1). The antagonism of gramicidin S by iturin A was, however, much less pronounced
than that of surfactin. The antagonism profile is complicated by some antibiotic activity of
iturin A at the concentrations used. For example, 50% inhibition of M luteus growth was
found at 30 uM iturin A, whereas no activity was detected at lower concentrations. Iturin A
caused a 100% increase in the ICso value of gramicidin S 30 f.lM, 10 ulvl, and 5 uM iturin A
(Figures 1 and 2).
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Figure 1 The influence of 10 f.lMiturin A on gramicidin S activity. The standard error of
the mean (SEM) is shown for each data point, with eight determinations per data
point, r2 > 0.995 was found for both curves. Results obtained from two
independent experiments in quadruplicate.
Gramicidin S activity was retained at 2.5 f.lMiturin A. Synergism between gramicidin S was
not observed at iturin A concentrations below the ICso of gramicidin S, as found with
surfactin in Chapter 4. This lack of synergism might be related to the difference in surfactant
activity with surf actin being the better surfactant [31, 32] resulting a more pronounced
membrane destabilisation of lower concentrations.
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An exponential relationship was found between antagonism of gramicidin S activity and iturin
A concentration. The influence of iturin A on the biological activity of gramicidin S at
concentrations close to the ICso (6 f.lM; ICso = 4.9 f.lM) (Figure 2) is most pronounced over
the concentration range 2.5 -5 uM with a dramatic decrease at higher concentrations
Comparing this result to the results obtained with surf actin (Chapter 4; Figure 1), which
showed an almost linear increase in antagonism with P. corylophilium over the entire
concentration range, it is evident that the dynamics of peptide-peptide interaction at cellular
level is markedly different. It appears that the antagonism observed is counterbalanced by the
activity of iturin A towards this organism resulting in a decrease in the effectivity of iturin A
induced antagonism with increasing iturin A concentrations. Furthermore, it is clear that
gramicidin S also antagonises the antibiotic activity of iturin A. Less than 19% inhibition was
found at 30 uM iturin A, when 6 uM gramicidin S was present. If both peptides were fully
active at these concentrations, total inhibition of M luteus growth would be expected;
therefore more than 80% activity was lost.
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Figure 2
[iturin A] f.lM
Influence of different concentrations of iturin A on gramicidin S at
approximately its ICso concentration. In addition to the progressive loss of
gramicidin S activity with increasing iturin A concentrations approximately 60%
of iturin A activity was lost at 30 f.lMiturin A.
6.4.2 Influence of linear analogues on M. Luteus activity of gramicidin S
It was found that 8-Beta have little on no activity on M lute us after 18 hours, similar to
previously obtained results for 8-Beta I and II [33]. No effect on the activity of gramicidin S
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was found if 8-Beta was added of a brad concentration range (2.5-30 f.!M) (Figure 3). It is
therefore clear that the cyclisation of 8-Beta is essential for antagonism. The addition of 8-
Beta., over the same concentration range as iturin A, however, did result in a subtle change in
the dose-response profile of gramicidin S, especially at the high concentrations of gramicidin
S (Figure 3). This subtle difference indicated that some antagonism of gramicidin S activity
does occur at the highest peptide concentration used.
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Figure 3 Influence of 30 f.!Mlinear analogues on the biological activity of gramicidin S.
SEM = ±1.1 uM (8 BetaC), 1.0 f.!M(8 Beta) and 1.0 f.!M(gramicidin S) with r2=
0.992, 0.998 and 0.995 respectively, a minimum of 8 determination per data
point were taken. Results obtained from four independent experiments in
quadruplicate.
6.4.3 Mass spectrometry analysis of mixtures of gramicidin Sand iturins
The mass spectrum of gramicidin S (obtained from Sigma) showed, in addition to the singly
and doubly charged species (with m/z = 1141.24 and 570.72 respectively), the presence of two
isotopic species of gramicidin S with m/z = 1142.28 and 1143.38 respectively (Figure 4A). A
fragmentation ion (bg) with m/z = 881.34 was also detected. The doubly charged ion of the
isotope with m/z = 1142.28 were detected at 572.16. Three known forms of iturin namely,
iturin A2 (m/z = 1043.75), iturin A with CIS ~-amino fatty acid (iturin A CIS; m/z =1057.76),
and iturin AL (m/z = 1071.71), were detected (Figure 4B) in the commercial sample from
Sigma (only the major isotope m/z values are given). In addition, sodiated and doubly charged
species were observed.
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Figure 4 ESMS- TOF mass spectra of gramicidin S (A) and iturin A (B) obtained from
Sigma. The gramicidin S isotope signals are denote M, Mil, and Mi2
respectively. The doubly charged ions were identified as: 1) iturin A CIS, 2)
iturin A2+Na, 3) iturin A C1s+Na and 4) iturin AL+Na.
As with surf actin, all variants of iturin A formed complexes with gramicidin S (Figure 5) with
m/z = 1092.90, 1099.90 and 1106.92. The isotope variation of gramicidin S was reflected in
the formed complexes rendering complexes with C, C+0.5amu C+ 1amu, and C+2amu
(C=complex, amu=atomic mass units). The signal intensity of the complexes was, however,
much lower than that found for surf actin-gramicidin S.
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Gramicidin S was mixed with the linear peptides 8-Beta and 8-Betac in approximately a I: I
molar mixture and subjected to mass spectrometric analysis. Mass spectra of the mixtures on
the Waters Q-TOF Ultima mass spectrometer did not reveal any complex species with
gramicidin S for either 8-Betac (Figure 7A) or 8-Beta (Figure 7B), with the correct m/z ratios
(m/z = 1102.59 for complexes of gramicidin S with 8-Betac and 1102.10 for 8-Beta), under
similar analysis conditions used for iturin A. Since the analysis conditions resulted in the
excessive fragmentation of gramicidin S in presence of 8-Beta or 8-Betac the lowest energy
conditions possible with the ESMS-TOF (CV of 35V, collision energy 10V), was used.
Previously we also found complex formation between the linear analogues and gramicidin S
using the Micromass mass spectrometer.
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ESMS- TOF mass spectra of complexes between gramicidin S and iturin A. The
encircled region in A is expanded in B. The different complexes are denoted as
Cll -CI3 with 11,12 and 13 as iturin A2, iturin A Cl5 and iturin AL respectively.
The annotated peaks are those of the dominant isotope with the other isotopes
differing with increments 0.5 amu from the dominant signal.
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Figure 7 Mass spectrum of gramicidin S mixed with 8-Betac (A) and 8-Beta and
gramicidin S (B). The isotope peaks are denoted il-3.
6.5 Conclusions
As we found with surf actin, the structurally similar iturin A also influenced the biological
activity of gramicidin S. However, the interpretation of the antagonism results was more
complex, because of the activity exhibited by iturin A against the target cell. Unlike surf actin,
a dose-dependent antagonism of gramicidin S biological activity was not observed with the
lowest concentration iturin causing maximal antagonism. In addition, no synergism was
observed between iturin A and gramicidin S, but a mutual antagonism of biological activity
exists between iturin A and gramicidin S. The combination of gramicidin S (6 ulvl) and iturin
A at 30 t-tM resulted in an >80% decrease in iturin A activity. Of the two linear analogues
tested only 8-Betac caused a change in the dose-response profile indicating that some
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antagonism of gramicidin S activity did occur. It is thus possible that as with iturin A and 8-
Beta, that cyclisation of 8-Betac to form iturin C, may lead to pronounced antagonism of
gramicidin S, but this remains to be tested.
Previously obtained results indicated that at least one of the p-turns in iturin A2 [34, 35] are
conserved in the linear 8-Beta [33] and this is also possibly true for 8-Betac. We postulated in
Chapter 5 that a p-turn of surfactin may be involved in the interaction with gramicidin S and
surf actin. If the same argument holds true for the interaction of iturin A (and iturin C) with
gramicidin S, three possible scenarios exist to explain the lack of complex formation between
gramicidin S and the linear analogues: a) the conserved p-turn in 8-Beta/8-Betac is not as
stable as one in the cyclic peptide; b) interaction occurs at the disrupted p-turn or c) both p-
turns are involved in stable complex formation. When comparing iturin A and surfactin that
dramatically influenced the biological activity of gramicidin S with the linear analogues 8-
Beta and 8-Betac, it is clear that cyclic peptides formed complexes with gramicidin S that
readily detectable by ESMS.
These findings support our original hypothesis in Chapters 4 and 5 that antagonism of the
antimicrobial action of gramicidin S is related to stable, inactive complex formation with the
"shield" lipopeptide, surfactin. Furthermore, the interaction between the peptides is dependent
on the conserved secondary structure of the B. subtilis peptides as illustrated by the inability
of 8-Beta and the limited ability 8 Beta, to antagonise the antimicrobial action of gramicidin
S. Irrespective of the mechanism of interaction, it is clear that stable complex formation is
dependent on a highly conserved secondary structure.
These preliminary findings indicate that the iturins may also be "shield" lipopeptides. The
apparent correlation between structural characteristics and antagonism indicates that the other
B. subtilis lipopeptides such as mycosubtilin may also form inactive complexes with
gramicidin S. Future studies should be directed at the investigation of these peptides to
establish the generality of inactive complex formation as defence mechanism. Furthermore, it
underscores the importance of the development of an optimised synthesis protocol for the
production of iturin C in order to investigate this peptides biological role. These results, in
combination with the results obtained with surfactin, illustrate the complexity of both the
microbial environment and the interaction between species and warrants further multi-
disciplinary investigation.
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Chapter 7
Conclusions, preliminary results and future prospects
This is the first investigation into the effect of surfactin and iturin A on the biological activity
of gramicidin S. The broad aim of this ongoing project is to elucidate the influence of
different peptides from competitive, cohabiting organisms on each other, which may
eventually impact on organism survival. The objectives of this study were: 1) to evaluate the
impact of surf actin on the biological activity of gramicidin S, 2) to investigate inter-molecular
interactions involved with ESMS and 3) to evaluate the possibility of a general defence
against gramicidin S toxicity using iturin A and synthetic iturin analogues in a preliminary
study. An ancillary objective to the investigation into the influence on biological activity was
the development of sensitive antifungal assay systems.
7.1 Experimental conclusions
The identity of the various surfactin forms present in the commercially available mixture as
well as the fidelity of gramicidin S, iturin A and synthetic analogues were determined as
reported in Chapter 2. It was determined that surfactin and gramicidin S met the purity stated
by the manufacturer, but iturin A did not fully comply. In addition, for example, the
commercially obtained iturin contained trace amounts of what appears to be the related
peptide mycosubtilin. Similarly, a surf actin sample obtained from Sigma (not used in this
study) contained trace amounts of iturin A2. These findings underlines the importance of
validating commercial peptides even those acquired from reputable suppliers. Although
successful syntheses of the linear iturin precursors were performed the synthetic methods
available for this study did not allow for the successful, large scale for the synthesis of iturin
C. Results obtained with the linear analogues validated purification through the unique
method of self-assembly, which is partially related to crystallisation as separation technique.
Peptides were further purified by HPLC and final analyses of the peptides indicated that both
analogues were of suitable high purity for use in biological experiments (92.6% and 95.5%
pure for 8-Bet~ and 8-Beta respectively).
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In the antifungal assay development section (Chapter 3) we were able to develop two assays
which rendered repeatable, analytical results within analytical error limits being r2 ~ 0.998
and p= 0.78 for the broth assay and r2 ~ 0.998, and p = 0.78 for the agar based assay. The
inhibition parameters determined for gramicidin Sagainst P. corylophilium with the broth
assay were ICrnin= 2.4 11M,ICso = 5 11Mand ICrnax= 11 11M.The agar based assay rendered
ICrnin= 2.4 11M, ICso = 4.5 11Mand ICrnax=11 11M. The drastic reduction in assay time
observed for the micro agar assay indicates the importance of oxygen diffusion rate. However,
the influence of the agar as nutrition source cannot be discounted. Furthermore, the similar
inhibition parameters obtained with the microagar assay showed that peptide inactivation by
the agar did not take place and therefore cell-peptide interaction did occur in the solution
phase.
Investigation into the biological effect of gramicidin S and surfactin mixtures showed that
surfactin had a pronounced antagonistic effect on gramicidin S activity. This antagonism was
monitored with biological activity studies using Escherichia coli, Micrococcus luteus, and
Penicillium corylophilium as target organisms. A dose-dependent antagonism was observed
with all the test organisms. A markedly different antagonism profile was observed with M
luteus as target organism with respect to the profiles obtained with E. coli and P.
corylophilium. The results obtained indicate that a degree of synergism may exist between the
peptides at low concentration with regard to the Gram-positive target cell and that antagonism
at higher concentration is limited to the solution phase. This may indicate that surfactin and
gramicidin S work synergistically with respect to gram-positive organisms at low surfactin
concentrations. This may seem to contradict the hypothesis, since the producer organism is
also Gram-positive. However, host-immunity to antibiotics has been demonstrated [1, 2, 3]
and therefore this effect may not extend to the surf actin producer. Furthermore, it has been
shown that surfactin and iturin A adsorbs onto the B. subtilis membrane with the fatty acid
moiety orientated to the environment [4]. This adsorption may protect the producer against
the antimicrobial action of gramicidin S, especially 'if surf actin assembles in a "secondary
membrane" on the cell surface orientating the gramicidin S binding area towards the
environment.
Electrospray mass spectrometry revealed that the loss of gramicidin S activity is most
probably the result of non-covalent complexes formation between gramicidin S and surfactin.
7-2
Results indicate that surfactin interacts with gramicidin S in al: 1 and 2: 1 ratio. Collisionally
induced dissociation (CrD) showed the complexes to· consist of gramicidin S and surfactin.
Whether the 2: 1 complex formation is the result of two separate surfactin molecules each
interacting with an Om-residue or a surfactin dimer interacting with a gramicidin S molecule,
is unclear at this stage. Cone voltage driven dissociation and CID of the complexes showed
that the complexes were less stable than the composite peptides. Minor differences in
surf actin conformation were previously reported [5]. Although minor differences were
observed for both the surfactin forms and peptide complexes, this was most probably due to
the acyl chain length rather than peptide ring conformation as the surf actin variant with the
shortest acyl chain showed the greatest stability. Furthermore, the stability of this specie was
reflected in the stability of the corresponding complex. Therefore, differences in surfactin
composition are not reflected in gramicidin S binding ability or selectivity. The increase in
complex formation with the increase of acetonitrile concentrations indicated that the
interactions between these amphipathic peptides are most probably of polar character and not
the consequence of hydrophobic interactions.
Titration of preformed surfactin-gramicidin S complexes with NaCI revealed that the presence
of the metal ion had little or no influence on complex stability. Furthermore, no sodiated
complexes were detected, indicating that ion interaction is not favourable after complex
formation. The influence of alkali or earth metal ion interaction with surfactin on complex
formation was investigated by incubating surfactin with NaCI and CaCh before titration with
gramicidin S. Results show that complex formation was uninhibited by the presence of these
metal ions. Furthermore, the interaction of gramicidin S and metal ions with surf actin were
found to be mutually exclusive, as no ion-peptide-peptide complexes were detected. In
addition, gramicidin S had a pronounced effect on calcium-induced surfactin-surfactin
interactions. The signals observed for these species decreased after the addition of the B.
brevis peptide. The absence of a reciprocal increase in surfactin-Ca2+ or the formation of
calcium-associated complexes may indicate that these complexes are formed through the
displacement of the metal ion rather than through a "detergent" effect. At this stage it is
unclear exactly what type of electrostatic force or forces are involved in complex formation,
but it is unlikely that the mechanism involves only a direct competition of gramicidin S with
Ca2+. However, the displacement of calcium may indicate that peptide-peptide interaction
results in a conformational change that prevents surfactin-metal ion interaction. In this case,
7-3
the most likely additional area of interaction is one of the p-turns in the peptide ring.
Biological experiments with iturin A indicate that antagonism of gramicidin S activity also
extends to this related lipopeptide. The evaluation of the iturin data was complicated by the
biological activity of iturin A. However, clear antagonism of gramicidin S activity was
observed at concentrations as low as 5 11Miturin A and no synergism between gramicidin S
and iturin was observed, as with surfactin. The interpretation of the biological results obtained
was complicated by the membrane activity of iturin A. Iturin A caused a 50% inhibition of M
luteus growth at 30 11M. The activity of iturin A decreased with decreasing iturin A
concentrations and no activity were observed at 2.5 11M.Furthermore, iturin A caused 50%
inhibition of M. luteus growth at 30 11Mbut in the presence of 6 11Monly 19% inhibition was
observed for iturin A. These results indicate that 80% of iturin A activity was lost and that
mutual antagonism if biological activity takes place. Clear antagonism of gramicidin S
biological activity could not be shown for the linear iturin analogues. However, subtle
changes observed in the dose-response profile when 8-Betac was present indicates that some
antagonism occurs at high gramicidin S concentrations, which may be a strong indication
indicates that antagonism of gramicidin S activity may also extend to iturin C.
Mass spectrometry of peptide mixtures reinforced the conclusion derived from the surfactin
data that antagonism is related to the formation of inactive complexes. Gramicidin S formed
complexes with al the forms of iturin A, whereas no complex formation was observed for the
linear analogues, 8-Beta and 8-Betac under the same ESMS conditions as the iturin A-
gramicidin S analysis. However, complexes were observed at extremely low energy
conditions. Both the linear analogues influenced the mass spectrometric character of
gramicidin S resulting excessive gramicidin S fragmentation in the presence either 8-Betac or
8-Beta. This indicates that interaction between the molecules do exist under ESMS conditions
but this interaction is not reflected in biological activity. The inability of the analogues to
form stable complexes points to rigid conformational requirements. The linear analogues
retain at least one of the two p-turns of the native molecule [6], whether this indicates that
both p-turns are involved in complex formation or that backbone rigidity is required for stable
(+~
complex formation may be the topic of a further investigation. Furthermore, this also supports
the exclusion of hydrophobic interaction as the sole contributor to complex formation.
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A concern in this investigation was the possibility of non-specific interactions especially
under ESMS conditions. These concerns were addressed by investigating two control
peptides, the glycopeptide vancomycin, [7] and the ESFl-SAGR, a model with a symmetrical
a-helical structure [8]. Surfactin did not enhance or antagonise the activity of either peptide.
Furthermore, no interaction between the peptides and surfactin was observed under MS
. conditions. These results further illustrate that a degree of specificity exists between
gramicidin Sand surfactin. Furthermore, this specificity is not only dependant charge but may
be related to the ~-turn structure and the spatial arrangement of the positive residue. Although
ESFl-SAGR (ESFl with Ala substituted for Ser and Arg substituted for Gly) carries the same
polarity as Om the spatial arrangement of the atoms might preclude interactions based on
charge and atomic geometry. A more appropriate control peptide may be the model KLK
peptide [9], which was not available at the time this study was performed. As Lys is
analogous to Om (R = (CH2)4NH3+ for Lys and R = (CH2)3NH3+) this might give a better
indication of the spatial orientation requirements of the polar groups involved. However, the
combined results of the interaction of gramicidin S with surfactin, iturin A, and other iturin
analogues do indicate that a) electrostatic interactions are involved in peptide-peptide
interaction, b) that a fixed stoichiometry is involved in these interactions and c) that the
structural integrity of the peptide is necessary for complex formation. As the ~-turns are a
common denominator in both surfactin and iturin structures, it is conceivable that gramicidin
S interaction with both peptides may revolve round the presence if these structures. If
interactions occur in the ~-turns, it indicates a degree of specificity in peptide-peptide
interaction. Therefore, the formation of complexes between the B. subtilis products and
gramicidin S does appear to form part of the host defence of B. subtilis. This extends the
concepts of synergism and biological activity beyond the augmentation of antibiotic activity
and the ability to induce cell death.
7.2 New preliminary results
This study has raised a number of questions regarding specificity and area of interaction.
Unfortunately time constraints did not allow the full investigation of these questions.
However, several pilot studies have been launched and the preliminary results will be
discussed briefly.
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Central to the hypothesis of an "anti-antibiotic" or "shield" peptide is compound specificity.
The control peptides showed that this interaction is not a non-specific peptide-peptide
interaction. The question that remained is whether this phenomenon is limited to interaction
of gramicidin S with surfactin and iturin. Therefore, a. pilot study was initiated using
gramicidin D (a mixture of gramicidins A-C and E). Initial biological experiments, using M
lute us as target cell, indicate that surfactin increased the ICso concentration of the peptide
mixture with >100% (from 6.7 11Mto 15.2 11M).The inactive complex hypothesis was tested
with mass spectrometry using tyrothricin - a mixture of gramicidin D, gramicidin S, and the
tyrocidines. Results indicated that surfactin not only formed complexes with all the
gramicidins present, but also with all the forms of tyrocidin present. It is therefore likely that
surfactin-induced antagonism of biological activity extends to all the B. brevis peptides. The
tyrocidins, with only one Om residue and varying number of Phe residues, offer an
opportunity to explore the relative contribution of the polar/hydrophobic interactions in
complex formation. Future studies will necessitate the purification to homogeneity of these
compounds. In addition to the iturins, another B. subtilis peptide may have been present in
trace amounts in the commercially obtained peptide mixture. This compound's mass to charge
ratio corresponds to that of a related peptide, mycosubtilin. Complex formation was observed
between this specie and gramicidin S. This compound needs to be positively identified as
mycosubtilin, and if it is indeed mycosubtilin this will further extend the specificity of these
interactions. These preliminary results indicate that complex formation between the B. subtilis
peptides and the B. brevis peptides may indeed by a general defence mechanism.
Ancillary to the issue of specificity is the interaction environment i. e. whether the interaction
takes place in solution phase or at membrane-environment interface with surf actin being
membrane bound. By extension, this will determine whether intra-cellular targets are affected
or not. The emergence of atomic force microscopy (AFM) as an analytical tool in biological
sciences [10] offered an exciting, visual way of investigating possible membrane effects. In
previous studies Holroyd et al. [11] and Rautenbach et al. [12] clearly showed peptide-
induced changes in membrane topology in erythrocytes and E. coli respectively. The authors
found the formation of legions on the surface erythrocytes and showed the difference in cell
surface vesiclisation induced by different peptides including gramicidin S. We have found in
preliminary studies that the surfactin coated both the E. coli cell surface as well as the silica
slide used for sample preparation. Upon the addition of gramicidin S, the silica bound
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surfactin formed vesicles and the cell surface topology changed slightly, but membrane
vesiclisation was not observed. Therefore, it seems that gramicidin S is "trapped" at the cell
wall-membrane interface and is not available to intracellular targets. However, the effect on
the Gram-positive organisms is likely to be more complicated given that surfactin does
possess membrane activity against Gram-positive cells.
Another aspect of the specificity of interaction is molecular specificity i.e. how do the
molecules "fit". Tandem mass spectrometry has successfully been used to elucidate the
structure surf actin and iturin A2 [13]. Furthermore, MS/MS was successfully used to study the
interaction of the peptides and peptide analogues with metal ions [13, 14]. We used tandem
mass spectrometry in a preliminary study on the molecular interaction of surf actin with
gramicidin S. Collisionally induced dissociation of the peptide complex with mlz = 1082
resulted in a number of unique fragments that cannot be ascribed to the primary sequence of
either surfactin or gramicidin S. In particular, a fragment with m/z = 450.00 were assigned to
a doubly charged, hydrated, fragment ion complex between gramicidin S b, and surf actin b6Y7
(calculated m/z =450.02). In addition, a surfactin fragment was observed with m/z =569.8
(b6/Y7; calculated m/z = 569.65), that was not generated upon CID of surfactin alone.
However, this sodiated fragment (b6Y7+Na+H) was observed upon CrD of sodiated surfactin
(m/z = 594.0; calculated m/z = 593.65). These results point to the protection of the p-turn
during Cll) when surfactin is complexed with either Na+ or gramicidin S, similar to what
Rautenbach et al. found for linear 8-beta and sodium [14]. Although this data needs to be
confirmed with further MS experiments the results indicate that: 1) mass spectrometry can
successfully be used to characterise non-covalent interaction between the peptides, 2) that the
interaction is sequence specific and it is unlikely that non-specific (non-polar) interactions are
the primary contributors to complex formation, ana 3) that the p-turn of surfactin is a
probable site for interaction with gramicidin S.
7.3 Future prospects
An immediate and specific area of future research would involve both the determination the
type of interaction involved, as well as the testing of the hypothesis that this phenomenon
represents a novel, defence mechanism. A multitude of analytical techniques such as nuclear
magnetic resonance, surface plasmon resonance, Fourier transform infrared spectroscopy,
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circular dichroism and mass spectroscopy exists to investigate the physical characteristics
molecular interactions. These techniques, together with chemical manipulation and/or the
generation of synthetic analogue libraries, can be used to elucidate the nature of peptide
interaction. Monitoring bacterial growth in mixed peptide producer cultures, under different
culture conditions, will reveal the significance of peptide interaction in terms of organism
survival.
Establishing the generality of antibiotic-antibiotic interaction as defence mechanism is a long-
term research prospect that may proof to be of paramount importance as this may aid in our
understanding of bacterial resistance, especially in relation to human pathogenesis.
7.4 Hypothesis
The results of this study indicated that a novel defence mechanism might exist for Bacillus
subtilis i.e. a mechanism that involves the synthesis and secretion of peptides to act as
molecular shields against the toxic product of a competitor. In addition to shielding B. subtilis
surfactin acts cooperatively with gramicidin S against other Gram-positive bacteria.
Furthermore, should the cooperative behaviour not lead to sufficient resources for both
bacteria, the molecular shield or anti-antibiotic will allow B. subtilis to survive until it can
enter an anaerobic phase. A condition that it's competitor, Bacillus brevis, cannot survive.
The hypothesis is illustrated in Figure 1 with the simplified life cycle of the B. brevis (A), B.
subtilis, (B) and the hypothetical mixed culture (C).
An anomaly seems to exist within the hypothesis in that fungi and Gram-negative bacteria are
protected from the antibiotic action of gramicidin S. The origin of the contradiction might be
found on the source data of the hypothesis. In vitro systems were used to gather the data, and
these systems cannot give a true reflection of in vivo behaviour. The apparent protection
might therefore be an experimental artefact created by concentration effect and membrane
characteristics. However, the anomalies observed should not detract from the basis on which
this hypothesis was build: surfactin causes a dose-dependent antagonism of gramicidin S,
possibly through the formation of stable, inactive complexes. Furthermore, it appears that this
interaction occurs at membrane level, which is consistent with reports stating that surf actin
readily adsorbs onto the producer membrane upon secretion [15]. In addition, the synergism
observed between gramicidin Sand surfactin casts a new light on the intricacies and
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complexity of the microbial environment - an environment where symbioses and antibiosis
are two sides of the same coin.
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Figure 1 A Simplified illustration of the anti-antibiotic hypothesis with the B. brevis
cycle (A) and the B. subtilis cycle (B). The hypothetical mixed culture as
illustrated in (C) shows cooperation between surf actin and gramicidin S when
the action of gramicidin S is directed at organisms other than B. subtilis. The
effect of gramicidin S on B. subtilis is negated by surfactin (indicated with (9).
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